HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
112508.0,247400,2176-04-15 07:12:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2176-4-14**] 08:07 AM
   MRSA admit swab
 BLOOD CULTURED - At [**2176-4-14**] 02:01 PM
   central line
 URINE CULTURE - At [**2176-4-14**] 02:01 PM
 INVASIVE VENTILATION - START [**2176-4-15**] 01:53 AM
 FEVER - 102.6
F - [**2176-4-14**] 08:00 PM
   - d/w son her current disposition
   - ABG still respiratory alkalosis
   - CSF from shunt:  263 WBC, 94% PMN
   - IVIg x 1 per BMT
   - continuing meropenem, changed gent to cipro for better CSF
   penetration, increased dose of dapto for better CSF penetration
   - nasopharyngeal aspirate negative viral screen
   - induced sputum not done
   - has contrast allergy, got non-contrast CT chest with infiltrate vs
   atelectasis LLL
   - 10-15 beat NSVT, having lots of ectopy, lytes repleted
   - 2400:  SVT to the 170s, given fluid, metoprolol 5 mg IV x 2 followed
   by diltiazem 15 mg IV-->HR fell to 60s, but BP also dropped from SBP
   110 to SBP 60s-70s
   - 0030-0130:  attempting to place radial arterial line unsuccessfully,
   BP on the cuff mostly 60s-80s
   - 0130:  asystole, code blue, regained perfusing rhythm after epi x 2
   mg, atropine x 2mg, 2 amps calcium chloride
   - received 4 grams calcium gluconate + 2 amps calcium chloride for
   presumed calcium channel blocker toxicity, also gave glucagon 5 mg x 1
   for possible component of beta blocker toxicity
   - sedating with fentanyl/midazolam to try to improve vent synchrony
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-14**] 06:30 PM
   Acyclovir - [**2176-4-14**] 06:54 PM
   Micafungin - [**2176-4-14**] 08:17 PM
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Meropenem - [**2176-4-15**] 04:00 AM
   Infusions:
   Phenylephrine - 2 mcg/Kg/min
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 0.5 mg/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-14**] 09:39 AM
   Fentanyl - [**2176-4-15**] 03:08 AM
   Midazolam (Versed) - [**2176-4-15**] 03:09 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-15**] 06:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.2
C (102.6
   Tcurrent: 35.7
C (96.3
   HR: 101 (68 - 139) bpm
   BP: 114/79(87) {76/35(52) - 199/118(122)} mmHg
   RR: 30 (18 - 41) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  5,009 mL
                                                                  3,141 mL
   PO:
             TF:
   IVF:
                                                                  3,456 mL
                                                                  3,128 mL
   Blood products:
                                                                     74 mL
   Total out:
                                                                  3,050 mL
                                                                  1,685 mL
   Urine:
                                                                  3,050 mL
                                                                  1,685 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,959 mL
                                                                  1,456 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   RR (Set): 24
   PEEP: 10 cmH2O
   FiO2: 50%
   RSBI Deferred: PEEP > 10, FiO2 > 60%
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.28/26/269/13/-12
   Ve: 15.9 L/min
   PaO2 / FiO2: 538
   Physical Examination
   General:  intubated, sedated but flickers eyes in reponse to voice
   HEENT:  dry mucous membranes
   Heart:  regular, no audible murmur
   Lungs:  clear anteriorly
   Abdomen:  soft
   Extremities:  cool, distal pulses palpable but thready
   Labs / Radiology
   37 K/uL
   9.8 g/dL
   40 mg/dL
   0.8 mg/dL
   13 mEq/L
   5.0 mEq/L
   23 mg/dL
   117 mEq/L
   142 mEq/L
   30.6 %
   0.9 K/uL
        [image002.jpg]
                             [**2176-4-14**]  04:42 PM
                             [**2176-4-14**]  06:50 PM
                             [**2176-4-14**]  10:44 PM
                             [**2176-4-15**]  01:30 AM
                             [**2176-4-15**]  01:43 AM
                             [**2176-4-15**]  02:47 AM
                             [**2176-4-15**]  03:15 AM
                             [**2176-4-15**]  04:32 AM
                             [**2176-4-15**]  04:50 AM
   WBC
   0.9
   Hct
   26.6
   30.6
   Plt
   37
   Cr
   0.6
   0.3
   0.8
   0.8
   TCO2
   23
   22
   7
   9
   13
   Glucose
   118
   99
   83
   40
   Other labs: PT / PTT / INR:22.5/102.0/2.2, ALT / AST:[**Telephone/Fax (1) 6012**], Alk Phos
   / T Bili:336/1.6, Fibrinogen:784 mg/dL, Lactic Acid:4.7 mmol/L,
   Albumin:2.0 g/dL, LDH:341 IU/L, Ca++:13.4 mg/dL, Mg++:2.1 mg/dL,
   PO4:6.0 mg/dL
   CSF:  263 WBC, 94% PMN, 6 lymphs, 33 RBC, 123 protein, 73 glucose.
   HSV, toxo, CMV, EBV pending
   Non-contrast chest CT:
   1. Peripheral wedge-shaped left upper lobe consolidation, previously
   seen as
   an area of bronchiectasis ([**2169-12-30**]), ground-glass ([**2172-4-8**]), and
   consolidation ([**2172-3-31**]) - findings suggest recurrent infection in a
   region
   of focal bronchiectasis.
   2. New small left and tiny right pleural effusions.
   3. Scattered tree-in-[**Male First Name (un) **] opacities which may represent inflammation or
   infection.
   4. Extensive chest wall and mediastinal collateral vascularization and
   prominence of the azygos vein, likely due to known occlusion of the SVC
   and
   brachiocephalic veins.
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   #) s/p asystolic arrest:  Likely cause was toxicity from calcium
   channel blockade.  Her tachyarthymia may have been secondary to
   sympathetic output from fevers in the setting of a heart compromised by
   prior anthracycline toxicity.  Currently her pupils are reactive and
   she responds to stimulation.
   - monitor electrolytes q6h and replete PRN
   - trend lactate
   - no further nodal agents
   - head CT to evaluate for severe neurologic damage
   .
   #) respiratory failure:  intubated in the peri-code setting.  ABGs
   during the day yesterday indicated primary metabolic alkalosis.
   Possibilities for etiology include intracranial process, drug effect,
   PE.  Could not evaluate for PE yesterday because of reported allergy to
   contrast (patient was unable to define further.)  No obvious drug
   offenders on her list.
   - CT head to evaluate for intracranial process
   - LENIs to evaluate for source of PE
   - wean FiO2 and PEEP as tolerated
   .
   #) hypotension:  blood pressures were very labile prior to the code.
   She is currently requiring a small dose of neo.
   - wean neo as tolerated
   .
   #) fevers:  On ciprofloxacin+dapto+meropenem.  Recent cultures with VRE
   but none since [**4-11**]. CSF findings concerning for infection seeding her
   CSF.  It is possible that her Ommaya is confaminated.  Also would be
   concerned for infected clots given her known upper extremity DVTs
   and/or for cardiac vegetations.  No evidence of septic emboli on lung
   CT yesterday.  Nasopharyngeal aspirate negative, induced sputum to be
   done today.
   - continue antibiotics, changed to improve CSF penetration
   - discuss with ID antibiotic coverage
   - discuss with oncology the possibility of an infected Ommaya
   - TTE to evaluate valves for vegetation
   - f/u CSF studies
   - induced sputum
   .
   #) ALL:  with recent recurrent CNS disease.   This hospitalization she
   was treated with intrathecal chemotherapy and DLI with resolution of
   CSF blasts as of [**2176-4-1**].    Her CSF picture currently
   - f/u cytology of spinal fluid
   - TTE today to evaluate for endocarditis
   - s/p IVIg yesterday
   - continue filgastrim
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis)
   - discuss with
   .
   #) increased LFTs:  appears to be shock liver
   - continue to monitor
   .
   #)  increased urin output:  concerning for DI in the setting of a
   possible intra-cranial process
   - check serum/urine osms
   .
   #) Coagulopathy:  concerning for DIC
   - follow DIC labs q4h today
   - transfuse blood and products PRN
   .
   #)  Hypoglycemia:  noted on morning labs, s/p
 amp d50.  Possibly
   secondary to insulin in TPN, which was stopped overnight.
   - follow FSBG
   - D5
   ICU Care
   Nutrition: nutrition consult for TF recs
   Glycemic Control:
   Lines:   contact IR for arterial line placement today given difficulty
   placing at bedside
   Indwelling Port (PortaCath) - [**2176-4-14**] 06:30 AM
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:  full code (confirmed last night with her healthcare
   proxy)
   Disposition: ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2176-4-14**] 08:07 AM
   MRSA admit swab
 BLOOD CULTURED - At [**2176-4-14**] 02:01 PM
   central line
 URINE CULTURE - At [**2176-4-14**] 02:01 PM
 INVASIVE VENTILATION - START [**2176-4-15**] 01:53 AM
 FEVER - 102.6
F - [**2176-4-14**] 08:00 PM
   - d/w son her current disposition
   - ABG still respiratory alkalosis
   - CSF from shunt:  263 WBC, 94% PMN
   - IVIg x 1 per BMT
   - continuing meropenem, changed gent to cipro for better CSF
   penetration, increased dose of dapto for better CSF penetration
   - nasopharyngeal aspirate negative viral screen
   - induced sputum not done
   - has contrast allergy, got non-contrast CT chest with infiltrate vs
   atelectasis LLL
   - 10-15 beat NSVT, having lots of ectopy, lytes repleted
   - 2400:  SVT to the 170s, given fluid, metoprolol 5 mg IV x 2 followed
   by diltiazem 15 mg IV-->HR fell to 60s, but BP also dropped from SBP
   110 to SBP 60s-70s
   - 0030-0130:  attempting to place radial arterial line unsuccessfully,
   BP on the cuff mostly 60s-80s
   - 0130:  asystole, code blue, regained perfusing rhythm after epi x 2
   mg, atropine x 2mg, 2 amps calcium chloride
   - received 4 grams calcium gluconate + 2 amps calcium chloride for
   presumed calcium channel blocker toxicity, also gave glucagon 5 mg x 1
   for possible component of beta blocker toxicity
   - sedating with fentanyl/midazolam to try to improve vent synchrony
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-14**] 06:30 PM
   Acyclovir - [**2176-4-14**] 06:54 PM
   Micafungin - [**2176-4-14**] 08:17 PM
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Meropenem - [**2176-4-15**] 04:00 AM
   Infusions:
   Phenylephrine - 2 mcg/Kg/min
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 0.5 mg/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-14**] 09:39 AM
   Fentanyl - [**2176-4-15**] 03:08 AM
   Midazolam (Versed) - [**2176-4-15**] 03:09 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-15**] 06:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.2
C (102.6
   Tcurrent: 35.7
C (96.3
   HR: 101 (68 - 139) bpm
   BP: 114/79(87) {76/35(52) - 199/118(122)} mmHg
   RR: 30 (18 - 41) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  5,009 mL
                                                                  3,141 mL
   PO:
             TF:
   IVF:
                                                                  3,456 mL
                                                                  3,128 mL
   Blood products:
                                                                     74 mL
   Total out:
                                                                  3,050 mL
                                                                  1,685 mL
   Urine:
                                                                  3,050 mL
                                                                  1,685 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,959 mL
                                                                  1,456 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   RR (Set): 24
   PEEP: 10 cmH2O
   FiO2: 50%
   RSBI Deferred: PEEP > 10, FiO2 > 60%
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.28/26/269/13/-12
   Ve: 15.9 L/min
   PaO2 / FiO2: 538
   Physical Examination
   General:  intubated, sedated but flickers eyes in reponse to voice
   HEENT:  dry mucous membranes
   Heart:  regular, no audible murmur
   Lungs:  clear anteriorly
   Abdomen:  soft
   Extremities:  cool, distal pulses palpable but thready
   Labs / Radiology
   37 K/uL
   9.8 g/dL
   40 mg/dL
   0.8 mg/dL
   13 mEq/L
   5.0 mEq/L
   23 mg/dL
   117 mEq/L
   142 mEq/L
   30.6 %
   0.9 K/uL
        [image002.jpg]
                             [**2176-4-14**]  04:42 PM
                             [**2176-4-14**]  06:50 PM
                             [**2176-4-14**]  10:44 PM
                             [**2176-4-15**]  01:30 AM
                             [**2176-4-15**]  01:43 AM
                             [**2176-4-15**]  02:47 AM
                             [**2176-4-15**]  03:15 AM
                             [**2176-4-15**]  04:32 AM
                             [**2176-4-15**]  04:50 AM
   WBC
   0.9
   Hct
   26.6
   30.6
   Plt
   37
   Cr
   0.6
   0.3
   0.8
   0.8
   TCO2
   23
   22
   7
   9
   13
   Glucose
   118
   99
   83
   40
   Other labs: PT / PTT / INR:22.5/102.0/2.2, ALT / AST:[**Telephone/Fax (1) 6012**], Alk Phos
   / T Bili:336/1.6, Fibrinogen:784 mg/dL, Lactic Acid:4.7 mmol/L,
   Albumin:2.0 g/dL, LDH:341 IU/L, Ca++:13.4 mg/dL, Mg++:2.1 mg/dL,
   PO4:6.0 mg/dL
   CSF:  263 WBC, 94% PMN, 6 lymphs, 33 RBC, 123 protein, 73 glucose.
   HSV, toxo, CMV, EBV pending
   Non-contrast chest CT:
   1. Peripheral wedge-shaped left upper lobe consolidation, previously
   seen as
   an area of bronchiectasis ([**2169-12-30**]), ground-glass ([**2172-4-8**]), and
   consolidation ([**2172-3-31**]) - findings suggest recurrent infection in a
   region
   of focal bronchiectasis.
   2. New small left and tiny right pleural effusions.
   3. Scattered tree-in-[**Male First Name (un) **] opacities which may represent inflammation or
   infection.
   4. Extensive chest wall and mediastinal collateral vascularization and
   prominence of the azygos vein, likely due to known occlusion of the SVC
   and
   brachiocephalic veins.
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   #) s/p asystolic arrest:  Likely cause was toxicity from calcium
   channel blockade.  Her tachyarthymia may have been secondary to
   sympathetic output from fevers in the setting of a heart compromised by
   prior anthracycline toxicity.  Currently her pupils are reactive and
   she responds to stimulation.
   - monitor electrolytes q6h and replete PRN
   - trend lactate
   - no further nodal agents
   - head CT to evaluate for severe neurologic damage
   .
   #) respiratory failure:  intubated in the peri-code setting.  ABGs
   during the day yesterday indicated primary metabolic alkalosis.
   Possibilities for etiology include intracranial process, drug effect,
   PE.  Could not evaluate for PE yesterday because of reported allergy to
   contrast (patient was unable to define further.)  No obvious drug
   offenders on her list.
   - CT head to evaluate for intracranial process
   - LENIs to evaluate for source of PE
   - wean FiO2 and PEEP as tolerated
   .
   #) hypotension:  blood pressures were very labile prior to the code.
   She is currently requiring a small dose of neo.
   - wean neo as tolerated
   .
   #) fevers:  On ciprofloxacin+dapto+meropenem.  Recent cultures with VRE
   but none since [**4-11**]. CSF findings concerning for infection seeding her
   CSF.  It is possible that her Ommaya is confaminated.  Also would be
   concerned for infected clots given her known upper extremity DVTs
   and/or for cardiac vegetations.  No evidence of septic emboli on lung
   CT yesterday.  Nasopharyngeal aspirate negative, induced sputum to be
   done today.
   - continue antibiotics, changed to improve CSF penetration
   - discuss with ID antibiotic coverage
   - discuss with oncology the possibility of an infected Ommaya
   - TTE to evaluate valves for vegetation
   - f/u CSF studies
   - induced sputum
   .
   #) ALL:  with recent recurrent CNS disease.   This hospitalization she
   was treated with intrathecal chemotherapy and DLI with resolution of
   CSF blasts as of [**2176-4-1**].    Her CSF picture currently
   - f/u cytology of spinal fluid
   - TTE today to evaluate for endocarditis
   - s/p IVIg yesterday
   - continue filgastrim
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis)
   - discuss with
   .
   #) increased LFTs:  appears to be shock liver
   - continue to monitor
   .
   #)  increased urin output:  concerning for DI in the setting of a
   possible intra-cranial process
   - check serum/urine osms
   .
   #) Coagulopathy:  concerning for DIC
   - follow DIC labs q4h today
   - transfuse blood and products PRN
   .
   #)  Hypoglycemia:  noted on morning labs, s/p
 amp d50.  Possibly
   secondary to insulin in TPN, which was stopped overnight.
   - follow FSBG
   - D5
   ICU Care
   Nutrition: nutrition consult for TF recs
   Glycemic Control:
   Lines:   contact IR for arterial line placement today given difficulty
   placing at bedside
   Indwelling Port (PortaCath) - [**2176-4-14**] 06:30 AM
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:  full code (confirmed last night with her healthcare
   proxy)
   Disposition: ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient is a 60-year-old woman with acute lymphoblastic leukemia (ALL) who presented with acute-on-chronic poor medical status, increasing tachypnea, tachycardia, and temperature. She had a history of VRE bacteremia and was treated with intrathecal chemotherapy and donor lymphocyte infusion (DLI) with resolution of CSF blasts.

The patient's condition has deteriorated significantly, with the following complications:

1. Cardiac Arrest: The patient had a code blue event due to suspected calcium channel blocker toxicity. She received epinephrine, atropine, and calcium chloride, and regained perfusing rhythm.
2. Respiratory Failure: The patient is intubated and has primary metabolic alkalosis, with possible etiologies including intracranial process, drug effect, or pulmonary embolism (PE).
3. Hypotension: The patient has labile blood pressures and is currently requiring a small dose of neosynephrine.
4. Fevers: The patient has persistent fevers despite antibiotics, with concern for infection seeding her CSF, infected clots, or cardiac vegetations.
5. Increased LFTs: The patient has elevated liver enzymes, which may be due to shock liver.
6. Increased Urine Output: The patient has increased urine output, which may be concerning for diabetes insipidus (DI) in the setting of a possible intra-cranial process.
7. Coagulopathy: The patient has a coagulopathy, which may be due to disseminated intravascular coagulation (DIC).
8. Hypoglycemia: The patient had hypoglycemia, which was treated with dextrose 50%.

The patient is being treated with antibiotics, including ciprofloxacin, dapto, and meropenem, and has received IVIg. She is also receiving filgastrim and has been treated with intrathecal chemotherapy and DLI.

The patient's laboratory results show:

* White blood cell count (WBC): 37 K/uL
* Hemoglobin (Hb): 9.8 g/dL
* Platelet count (Plt): 37
* Creatinine (Cr): 0.6 mg/dL
* Blood urea nitrogen (BUN): 40 mg/dL
* Glucose: 118 mg/dL
* Lactic acid: 4.7 mmol/L
* Albumin: 2.0 g/dL
* LDH: 341 IU/L
* Calcium: 13.4 mg/dL
* Magnesium: 2.1 mg/dL
* Phosphorus: 6.0 mg/dL

The patient's radiology results show:

* Non-contrast chest CT: Peripheral wedge-shaped left upper lobe consolidation, new small left and tiny right pleural effusions, and scattered tree-in-bud opacities.

The patient's plan of care includes:

1. Monitoring electrolytes and repleting as needed.
2. Trending lactate levels.
3. No further nodal agents.
4. Head CT to evaluate for severe neurologic damage.
5. CT head to evaluate for intracranial process.
6. LENIs to evaluate for source of PE.
7. Weaning FiO2 and PEEP as tolerated.
8. Continuing antibiotics, changed to improve CSF penetration.
9. Discussing with ID antibiotic coverage.
10. Discussing with oncology the possibility of an infected Ommaya.
11. TTE to evaluate valves for vegetation.
12. F/u CSF studies.
13. Induced sputum.
14. F/u cytology of spinal fluid.
15. TTE today to evaluate for endocarditis.
16. Continuing filgastrim.
17. During neutropenic period, continuing acyclovir, micafungin, and nystatin.
18. Discussing with ID and oncology.

The patient's code status is full code, and she is being cared for in the ICU."
112508.0,247400,2176-04-15 07:12:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2176-4-14**] 08:07 AM
   MRSA admit swab
 BLOOD CULTURED - At [**2176-4-14**] 02:01 PM
   central line
 URINE CULTURE - At [**2176-4-14**] 02:01 PM
 INVASIVE VENTILATION - START [**2176-4-15**] 01:53 AM
 FEVER - 102.6
F - [**2176-4-14**] 08:00 PM
   - d/w son her current disposition
   - ABG still respiratory alkalosis
   - CSF from shunt:  263 WBC, 94% PMN
   - IVIg x 1 per BMT
   - continuing meropenem, changed gent to cipro for better CSF
   penetration, increased dose of dapto for better CSF penetration
   - nasopharyngeal aspirate negative viral screen
   - induced sputum not done
   - has contrast allergy, got non-contrast CT chest with infiltrate vs
   atelectasis LLL
   - 10-15 beat NSVT, having lots of ectopy, lytes repleted
   - 2400:  SVT to the 170s, given fluid, metoprolol 5 mg IV x 2 followed
   by diltiazem 15 mg IV-->HR fell to 60s, but BP also dropped from SBP
   110 to SBP 60s-70s
   - 0030-0130:  attempting to place radial arterial line unsuccessfully,
   BP on the cuff mostly 60s-80s
   - 0130:  asystole, code blue, regained perfusing rhythm after epi x 2
   mg, atropine x 2mg, 2 amps calcium chloride
   - received 4 grams calcium gluconate + 2 amps calcium chloride for
   presumed calcium channel blocker toxicity, also gave glucagon 5 mg x 1
   for possible component of beta blocker toxicity
   - sedating with fentanyl/midazolam to try to improve vent synchrony
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-14**] 06:30 PM
   Acyclovir - [**2176-4-14**] 06:54 PM
   Micafungin - [**2176-4-14**] 08:17 PM
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Meropenem - [**2176-4-15**] 04:00 AM
   Infusions:
   Phenylephrine - 2 mcg/Kg/min
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 0.5 mg/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-14**] 09:39 AM
   Fentanyl - [**2176-4-15**] 03:08 AM
   Midazolam (Versed) - [**2176-4-15**] 03:09 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-15**] 06:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.2
C (102.6
   Tcurrent: 35.7
C (96.3
   HR: 101 (68 - 139) bpm
   BP: 114/79(87) {76/35(52) - 199/118(122)} mmHg
   RR: 30 (18 - 41) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  5,009 mL
                                                                  3,141 mL
   PO:
             TF:
   IVF:
                                                                  3,456 mL
                                                                  3,128 mL
   Blood products:
                                                                     74 mL
   Total out:
                                                                  3,050 mL
                                                                  1,685 mL
   Urine:
                                                                  3,050 mL
                                                                  1,685 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,959 mL
                                                                  1,456 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   RR (Set): 24
   PEEP: 10 cmH2O
   FiO2: 50%
   RSBI Deferred: PEEP > 10, FiO2 > 60%
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.28/26/269/13/-12
   Ve: 15.9 L/min
   PaO2 / FiO2: 538
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   37 K/uL
   9.8 g/dL
   40 mg/dL
   0.8 mg/dL
   13 mEq/L
   5.0 mEq/L
   23 mg/dL
   117 mEq/L
   142 mEq/L
   30.6 %
   0.9 K/uL
        [image002.jpg]
                             [**2176-4-14**]  04:42 PM
                             [**2176-4-14**]  06:50 PM
                             [**2176-4-14**]  10:44 PM
                             [**2176-4-15**]  01:30 AM
                             [**2176-4-15**]  01:43 AM
                             [**2176-4-15**]  02:47 AM
                             [**2176-4-15**]  03:15 AM
                             [**2176-4-15**]  04:32 AM
                             [**2176-4-15**]  04:50 AM
   WBC
   0.9
   Hct
   26.6
   30.6
   Plt
   37
   Cr
   0.6
   0.3
   0.8
   0.8
   TCO2
   23
   22
   7
   9
   13
   Glucose
   118
   99
   83
   40
   Other labs: PT / PTT / INR:22.5/102.0/2.2, ALT / AST:[**Telephone/Fax (1) 6012**], Alk Phos
   / T Bili:336/1.6, Fibrinogen:784 mg/dL, Lactic Acid:4.7 mmol/L,
   Albumin:2.0 g/dL, LDH:341 IU/L, Ca++:13.4 mg/dL, Mg++:2.1 mg/dL,
   PO4:6.0 mg/dL
   CSF:  263 WBC, 94% PMN, 6 lymphs, 33 RBC, 123 protein, 73 glucose.
   HSV, toxo, CMV, EBV pending
   Non-contrast chest CT:
   1. Peripheral wedge-shaped left upper lobe consolidation, previously
   seen as
   an area of bronchiectasis ([**2169-12-30**]), ground-glass ([**2172-4-8**]), and
   consolidation ([**2172-3-31**]) - findings suggest recurrent infection in a
   region
   of focal bronchiectasis.
   2. New small left and tiny right pleural effusions.
   3. Scattered tree-in-[**Male First Name (un) **] opacities which may represent inflammation or
   infection.
   4. Extensive chest wall and mediastinal collateral vascularization and
   prominence of the azygos vein, likely due to known occlusion of the SVC
   and
   brachiocephalic veins.
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   #) s/p asystolic arrest:  Likely cause was toxicity from calcium
   channel blockade.  Her tachyarthymia may have been secondary to
   sympathetic output from fevers.
   - monitor electrolytes and replete PRN
   - no further nodal agents
   #) respiratory failure:  intubated for hypoxic respiratory failure.
   ABGs prior indicated primary metabolic alkalosis. Possibly secondary to
   intracranial process.  Could not evaluate for PE yesterday because of
   reported allergy to contrast (patient was unable to define further.)
   #) fevers:  On ciprofloxacin+dapto+meropenem.  Recent cultures with VRE
   but none since [**4-11**]. Nasopharyngeal aspirate negative, induced sputum
   to be done today.  CSF findings concerning for infection seeding her
   CSF
   - continue antibiotics, changed to improve CSF penetration
   - discuss with ID
   #) ALL:  with recent recurrent CNS disease.   Her hospital course thus
   far has been characterized by:
   The patient was found to have recurrent bone marrow as well as CNS
   disease after presenting with dizziness. After C/T/L spine imaging, the
   patient's CSF was sampled and she was given IT MTX through an Ommaya
   biweekly for 2 weeks after her CSF cleared on [**2176-4-1**].  The was then
   treated on a weekly basis starting on XXXX.  The patient was unable to
   tolerate AraC due to severe nausea and vomiting. After one treatment
   with Ara-C, the patient instead recevied intra-thecal methotrexate
   approximately twice per week. Her CSF remained positive for blasts
   until tap on [**2176-4-1**].  She also received a cycle of HyperCVAD. She
   received part A as well as dexamethasone on D11-14 but vincristine was
   not given on D11 due to poor ostomy output and concern for further
   ileus. Peripheral blood smears showed resolution of peripheral blasts
   after 1-2 days of systemic chemotherapy. Her course was complicated by
   mucositis, poorly healing aphthous ulcers and poor po intake secondary
   to pain, which complicated healing and cause electrolyte abnormalities
   requiring significant repletion.  She was changed from oral pain
   medication to a low dose morphine PCA with good effect. She was also
   started on TPN for nutrition and her electrolytes abnormalities
   resolved.
   - f/u cytology of spinal fluid
   - TTE today to evaluate for endocarditis
   - s/p IVIg yesterday
   - continue filgastrim
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis)
   WORSENING FUNCTIONAL STATUS
   Likely secondary to worsening bacteremia. She has been on daptomycin as
   well as micafungin and meropenem. She has not been growing VRE
   recently, but it is possible that she is continuing to have
   complications of VRE through dapto. Gentamicin was added shortly before
   her transfer. Lisinopril was d/c
ed yesterday, suggesting continued
   decline in BP is masked somewhat by d/c
ing antihypertensive, adds to
   this slow-moving but potentially serious likely infectious picture. No
   clear source currently. Still neutropenic but large number of
   metas/myelos/etc may suggest imminent recovery.
   - consider CT torso
 w CTA for PE rule-out
   - aggressive fluid resuscitation, continue to evaluate if this either
   brings down O2 sat (consider fluid overload) and/or brings down tachy,
   brings up BP (c/w sepsis); would expect the latter effect to
   predominate
   - continue dapto/gent
   - additional blood cultures, continue surveillance cultures, CIS
   - UA/Ucx
   - follow blood counts closely
   - continue filgrastim
   - has been getting morphine PCA for pain; would emphasize to only have
   pt trigger PCA given increasingly sedated picture
   - MRA/MRV was c/w clot in SVC but appeared to show collateral
   circulation, no indication of SVC syndrome clinically
   - viral assays
   - sputum cultures
induced sputum
   - echocardiogram tomorrow
   ALL
   Has been getting methotrexate evidently, held [**4-12**] for bacteremia.
   Getting neupogen.
   - continue filgrastim
   - check in w heme/onc re recommendations; in particular, discuss
   question of whether IVIG would be indicated now or in future
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis),
   - CNS tap to evaluate for blasts, new process
   - 4 days ago DLI
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   ICU Care
   Nutrition: nutrition consult for TF recs
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2176-4-14**] 06:30 AM
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2176-4-14**] 08:07 AM
   MRSA admit swab
 BLOOD CULTURED - At [**2176-4-14**] 02:01 PM
   central line
 URINE CULTURE - At [**2176-4-14**] 02:01 PM
 INVASIVE VENTILATION - START [**2176-4-15**] 01:53 AM
 FEVER - 102.6
F - [**2176-4-14**] 08:00 PM
   - d/w son her current disposition
   - ABG still respiratory alkalosis
   - CSF from shunt:  263 WBC, 94% PMN
   - IVIg x 1 per BMT
   - continuing meropenem, changed gent to cipro for better CSF
   penetration, increased dose of dapto for better CSF penetration
   - nasopharyngeal aspirate negative viral screen
   - induced sputum not done
   - has contrast allergy, got non-contrast CT chest with infiltrate vs
   atelectasis LLL
   - 10-15 beat NSVT, having lots of ectopy, lytes repleted
   - 2400:  SVT to the 170s, given fluid, metoprolol 5 mg IV x 2 followed
   by diltiazem 15 mg IV-->HR fell to 60s, but BP also dropped from SBP
   110 to SBP 60s-70s
   - 0030-0130:  attempting to place radial arterial line unsuccessfully,
   BP on the cuff mostly 60s-80s
   - 0130:  asystole, code blue, regained perfusing rhythm after epi x 2
   mg, atropine x 2mg, 2 amps calcium chloride
   - received 4 grams calcium gluconate + 2 amps calcium chloride for
   presumed calcium channel blocker toxicity, also gave glucagon 5 mg x 1
   for possible component of beta blocker toxicity
   - sedating with fentanyl/midazolam to try to improve vent synchrony
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-14**] 06:30 PM
   Acyclovir - [**2176-4-14**] 06:54 PM
   Micafungin - [**2176-4-14**] 08:17 PM
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Meropenem - [**2176-4-15**] 04:00 AM
   Infusions:
   Phenylephrine - 2 mcg/Kg/min
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 0.5 mg/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-14**] 09:39 AM
   Fentanyl - [**2176-4-15**] 03:08 AM
   Midazolam (Versed) - [**2176-4-15**] 03:09 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-15**] 06:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.2
C (102.6
   Tcurrent: 35.7
C (96.3
   HR: 101 (68 - 139) bpm
   BP: 114/79(87) {76/35(52) - 199/118(122)} mmHg
   RR: 30 (18 - 41) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  5,009 mL
                                                                  3,141 mL
   PO:
             TF:
   IVF:
                                                                  3,456 mL
                                                                  3,128 mL
   Blood products:
                                                                     74 mL
   Total out:
                                                                  3,050 mL
                                                                  1,685 mL
   Urine:
                                                                  3,050 mL
                                                                  1,685 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,959 mL
                                                                  1,456 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   RR (Set): 24
   PEEP: 10 cmH2O
   FiO2: 50%
   RSBI Deferred: PEEP > 10, FiO2 > 60%
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.28/26/269/13/-12
   Ve: 15.9 L/min
   PaO2 / FiO2: 538
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   37 K/uL
   9.8 g/dL
   40 mg/dL
   0.8 mg/dL
   13 mEq/L
   5.0 mEq/L
   23 mg/dL
   117 mEq/L
   142 mEq/L
   30.6 %
   0.9 K/uL
        [image002.jpg]
                             [**2176-4-14**]  04:42 PM
                             [**2176-4-14**]  06:50 PM
                             [**2176-4-14**]  10:44 PM
                             [**2176-4-15**]  01:30 AM
                             [**2176-4-15**]  01:43 AM
                             [**2176-4-15**]  02:47 AM
                             [**2176-4-15**]  03:15 AM
                             [**2176-4-15**]  04:32 AM
                             [**2176-4-15**]  04:50 AM
   WBC
   0.9
   Hct
   26.6
   30.6
   Plt
   37
   Cr
   0.6
   0.3
   0.8
   0.8
   TCO2
   23
   22
   7
   9
   13
   Glucose
   118
   99
   83
   40
   Other labs: PT / PTT / INR:22.5/102.0/2.2, ALT / AST:[**Telephone/Fax (1) 6012**], Alk Phos
   / T Bili:336/1.6, Fibrinogen:784 mg/dL, Lactic Acid:4.7 mmol/L,
   Albumin:2.0 g/dL, LDH:341 IU/L, Ca++:13.4 mg/dL, Mg++:2.1 mg/dL,
   PO4:6.0 mg/dL
   CSF:  263 WBC, 94% PMN, 6 lymphs, 33 RBC, 123 protein, 73 glucose.
   HSV, toxo, CMV, EBV pending
   Non-contrast chest CT:
   1. Peripheral wedge-shaped left upper lobe consolidation, previously
   seen as
   an area of bronchiectasis ([**2169-12-30**]), ground-glass ([**2172-4-8**]), and
   consolidation ([**2172-3-31**]) - findings suggest recurrent infection in a
   region
   of focal bronchiectasis.
   2. New small left and tiny right pleural effusions.
   3. Scattered tree-in-[**Male First Name (un) **] opacities which may represent inflammation or
   infection.
   4. Extensive chest wall and mediastinal collateral vascularization and
   prominence of the azygos vein, likely due to known occlusion of the SVC
   and
   brachiocephalic veins.
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   #) s/p asystolic arrest:  Likely cause was toxicity from calcium
   channel blockade.  Her tachyarthymia may have been secondary to
   sympathetic output from fevers.
   - monitor electrolytes and replete PRN
   - no further nodal agents
   #) respiratory failure:  intubated for hypoxic respiratory failure.
   ABGs prior indicated primary metabolic alkalosis. Possibly secondary to
   intracranial process.  Could not evaluate for PE yesterday because of
   reported allergy to contrast (patient was unable to define further.)
   #) fevers:  On ciprofloxacin+dapto+meropenem.  Recent cultures with VRE
   but none since [**4-11**]. Nasopharyngeal aspirate negative, induced sputum
   to be done today.  CSF findings concerning for infection seeding her
   CSF
   - continue antibiotics, changed to improve CSF penetration
   - discuss with ID
   #) ALL:  with recent recurrent CNS disease.   Her hospital course thus
   far has been characterized by:
   The patient was found to have recurrent bone marrow as well as CNS
   disease after presenting with dizziness. After C/T/L spine imaging, the
   patient's CSF was sampled and she was given IT MTX through an Ommaya
   biweekly for 2 weeks after her CSF cleared on [**2176-4-1**].  The was then
   treated on a weekly basis starting on XXXX.  The patient was unable to
   tolerate AraC due to severe nausea and vomiting. After one treatment
   with Ara-C, the patient instead recevied intra-thecal methotrexate
   approximately twice per week. Her CSF remained positive for blasts
   until tap on [**2176-4-1**].  She also received a cycle of HyperCVAD. She
   received part A as well as dexamethasone on D11-14 but vincristine was
   not given on D11 due to poor ostomy output and concern for further
   ileus. Peripheral blood smears showed resolution of peripheral blasts
   after 1-2 days of systemic chemotherapy. Her course was complicated by
   mucositis, poorly healing aphthous ulcers and poor po intake secondary
   to pain, which complicated healing and cause electrolyte abnormalities
   requiring significant repletion.  She was changed from oral pain
   medication to a low dose morphine PCA with good effect. She was also
   started on TPN for nutrition and her electrolytes abnormalities
   resolved.
   - f/u cytology of spinal fluid
   - TTE today to evaluate for endocarditis
   - s/p IVIg yesterday
   - continue filgastrim
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis)
   WORSENING FUNCTIONAL STATUS
   Likely secondary to worsening bacteremia. She has been on daptomycin as
   well as micafungin and meropenem. She has not been growing VRE
   recently, but it is possible that she is continuing to have
   complications of VRE through dapto. Gentamicin was added shortly before
   her transfer. Lisinopril was d/c
ed yesterday, suggesting continued
   decline in BP is masked somewhat by d/c
ing antihypertensive, adds to
   this slow-moving but potentially serious likely infectious picture. No
   clear source currently. Still neutropenic but large number of
   metas/myelos/etc may suggest imminent recovery.
   - consider CT torso
 w CTA for PE rule-out
   - aggressive fluid resuscitation, continue to evaluate if this either
   brings down O2 sat (consider fluid overload) and/or brings down tachy,
   brings up BP (c/w sepsis); would expect the latter effect to
   predominate
   - continue dapto/gent
   - additional blood cultures, continue surveillance cultures, CIS
   - UA/Ucx
   - follow blood counts closely
   - continue filgrastim
   - has been getting morphine PCA for pain; would emphasize to only have
   pt trigger PCA given increasingly sedated picture
   - MRA/MRV was c/w clot in SVC but appeared to show collateral
   circulation, no indication of SVC syndrome clinically
   - viral assays
   - sputum cultures
induced sputum
   - echocardiogram tomorrow
   ALL
   Has been getting methotrexate evidently, held [**4-12**] for bacteremia.
   Getting neupogen.
   - continue filgrastim
   - check in w heme/onc re recommendations; in particular, discuss
   question of whether IVIG would be indicated now or in future
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis),
   - CNS tap to evaluate for blasts, new process
   - 4 days ago DLI
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   ICU Care
   Nutrition: nutrition consult for TF recs
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2176-4-14**] 06:30 AM
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with acute lymphoblastic leukemia (ALL) who has been admitted to the ICU due to worsening respiratory failure, fever, and altered mental status. She has a history of recurrent CNS disease and has received various treatments, including chemotherapy and intrathecal methotrexate. The patient has been experiencing tachypnea, tachycardia, and fever, and has had several episodes of asystole, which were likely caused by calcium channel blocker toxicity.

The patient has been intubated for hypoxic respiratory failure and has been receiving various medications, including antibiotics, antivirals, and antifungals. Her CSF has been cultured and shows signs of infection, and she has been receiving IVIg.

The patient's condition is critical, and she requires close monitoring and aggressive management to prevent further complications. She is at risk for sepsis, respiratory failure, and cardiac arrest, and requires careful management of her electrolytes, fluids, and blood pressure.

Potential medical complications:

1. Sepsis: The patient is at risk for sepsis due to her underlying infection and her immunocompromised state.
2. Respiratory failure: The patient is already intubated and requires close monitoring of her respiratory status to prevent further deterioration.
3. Cardiac arrest: The patient has had several episodes of asystole and is at risk for further cardiac arrest due to her underlying condition and medication toxicity.
4. Infection seeding: The patient's CSF has shown signs of infection, and she is at risk for further seeding of her CNS with bacteria.
5. Mucositis: The patient has a history of mucositis and is at risk for further complications, including infection and bleeding.
6. Nutritional deficiencies: The patient is at risk for nutritional deficiencies due to her poor oral intake and her need for total parenteral nutrition (TPN).
7. Electrolyte imbalances: The patient is at risk for electrolyte imbalances due to her underlying condition and her medication regimen.
8. Blood stream infections: The patient is at risk for blood stream infections due to her central line and her immunocompromised state.

Recommendations:

1. Continue to monitor the patient's respiratory status closely and adjust her ventilator settings as needed.
2. Continue to manage the patient's electrolytes and fluids carefully to prevent further complications.
3. Continue to monitor the patient's blood pressure and adjust her medication regimen as needed to prevent further cardiac complications.
4. Consider performing a CT scan of the patient's torso to rule out a pulmonary embolism.
5. Continue to monitor the patient's CSF cultures and adjust her antibiotic regimen as needed to prevent further infection.
6. Consider performing a lumbar puncture to evaluate for further infection in the patient's CNS.
7. Continue to monitor the patient's blood counts closely and adjust her medication regimen as needed to prevent further complications.
8. Consider performing a viral assay to evaluate for further viral infections.
9. Continue to monitor the patient's nutritional status closely and adjust her nutrition regimen as needed to prevent further complications.
10. Consider performing a stress test to evaluate for further cardiac complications."
112508.0,247400,2176-04-15 07:12:00,Physician ,Physician Attending Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2176-4-14**] 08:07 AM
   MRSA admit swab
 BLOOD CULTURED - At [**2176-4-14**] 02:01 PM
   central line
 URINE CULTURE - At [**2176-4-14**] 02:01 PM
 INVASIVE VENTILATION - START [**2176-4-15**] 01:53 AM
 FEVER - 102.6
F - [**2176-4-14**] 08:00 PM
   - d/w son her current disposition
   - ABG still respiratory alkalosis
   - CSF from shunt:  263 WBC, 94% PMN
   - IVIg x 1 per BMT
   - continuing meropenem, changed gent to cipro for better CSF
   penetration, increased dose of dapto for better CSF penetration
   - nasopharyngeal aspirate negative viral screen
   - induced sputum not done
   - has contrast allergy, got non-contrast CT chest with infiltrate vs
   atelectasis LLL
   - 10-15 beat NSVT, having lots of ectopy, lytes repleted
   - 2400:  SVT to the 170s, given fluid, metoprolol 5 mg IV x 2 followed
   by diltiazem 15 mg IV-->HR fell to 60s, but BP also dropped from SBP
   110 to SBP 60s-70s
   - 0030-0130:  attempting to place radial arterial line unsuccessfully,
   BP on the cuff mostly 60s-80s
   - 0130:  asystole, code blue, regained perfusing rhythm after epi x 2
   mg, atropine x 2mg, 2 amps calcium chloride
   - received 4 grams calcium gluconate + 2 amps calcium chloride for
   presumed calcium channel blocker toxicity, also gave glucagon 5 mg x 1
   for possible component of beta blocker toxicity
   - sedating with fentanyl/midazolam to try to improve vent synchrony
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-14**] 06:30 PM
   Acyclovir - [**2176-4-14**] 06:54 PM
   Micafungin - [**2176-4-14**] 08:17 PM
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Meropenem - [**2176-4-15**] 04:00 AM
   Infusions:
   Phenylephrine - 2 mcg/Kg/min
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 0.5 mg/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-14**] 09:39 AM
   Fentanyl - [**2176-4-15**] 03:08 AM
   Midazolam (Versed) - [**2176-4-15**] 03:09 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-15**] 06:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.2
C (102.6
   Tcurrent: 35.7
C (96.3
   HR: 101 (68 - 139) bpm
   BP: 114/79(87) {76/35(52) - 199/118(122)} mmHg
   RR: 30 (18 - 41) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  5,009 mL
                                                                  3,141 mL
   PO:
             TF:
   IVF:
                                                                  3,456 mL
                                                                  3,128 mL
   Blood products:
                                                                     74 mL
   Total out:
                                                                  3,050 mL
                                                                  1,685 mL
   Urine:
                                                                  3,050 mL
                                                                  1,685 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,959 mL
                                                                  1,456 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   RR (Set): 24
   PEEP: 10 cmH2O
   FiO2: 50%
   RSBI Deferred: PEEP > 10, FiO2 > 60%
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.28/26/269/13/-12
   Ve: 15.9 L/min
   PaO2 / FiO2: 538
   Physical Examination
   General:  intubated, sedated but flickers eyes in reponse to voice
   HEENT:  dry mucous membranes
   Heart:  regular, no audible murmur
   Lungs:  clear anteriorly
   Abdomen:  soft
   Extremities:  cool, distal pulses palpable but thready
   Labs / Radiology
   37 K/uL
   9.8 g/dL
   40 mg/dL
   0.8 mg/dL
   13 mEq/L
   5.0 mEq/L
   23 mg/dL
   117 mEq/L
   142 mEq/L
   30.6 %
   0.9 K/uL
        [image002.jpg]
                             [**2176-4-14**]  04:42 PM
                             [**2176-4-14**]  06:50 PM
                             [**2176-4-14**]  10:44 PM
                             [**2176-4-15**]  01:30 AM
                             [**2176-4-15**]  01:43 AM
                             [**2176-4-15**]  02:47 AM
                             [**2176-4-15**]  03:15 AM
                             [**2176-4-15**]  04:32 AM
                             [**2176-4-15**]  04:50 AM
   WBC
   0.9
   Hct
   26.6
   30.6
   Plt
   37
   Cr
   0.6
   0.3
   0.8
   0.8
   TCO2
   23
   22
   7
   9
   13
   Glucose
   118
   99
   83
   40
   Other labs: PT / PTT / INR:22.5/102.0/2.2, ALT / AST:[**Telephone/Fax (1) 6012**], Alk Phos
   / T Bili:336/1.6, Fibrinogen:784 mg/dL, Lactic Acid:4.7 mmol/L,
   Albumin:2.0 g/dL, LDH:341 IU/L, Ca++:13.4 mg/dL, Mg++:2.1 mg/dL,
   PO4:6.0 mg/dL
   CSF:  263 WBC, 94% PMN, 6 lymphs, 33 RBC, 123 protein, 73 glucose.
   HSV, toxo, CMV, EBV pending
   Non-contrast chest CT:
   1. Peripheral wedge-shaped left upper lobe consolidation, previously
   seen as
   an area of bronchiectasis ([**2169-12-30**]), ground-glass ([**2172-4-8**]), and
   consolidation ([**2172-3-31**]) - findings suggest recurrent infection in a
   region
   of focal bronchiectasis.
   2. New small left and tiny right pleural effusions.
   3. Scattered tree-in-[**Male First Name (un) **] opacities which may represent inflammation or
   infection.
   4. Extensive chest wall and mediastinal collateral vascularization and
   prominence of the azygos vein, likely due to known occlusion of the SVC
   and
   brachiocephalic veins.
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   #) s/p asystolic arrest:  Likely cause was toxicity from calcium
   channel blockade.  Her tachyarthymia may have been secondary to
   sympathetic output from fevers in the setting of a heart compromised by
   prior anthracycline toxicity.  Currently her pupils are reactive and
   she responds to stimulation.
   - monitor electrolytes q6h and replete PRN
   - trend lactate
   - no further nodal agents
   - head CT to evaluate for severe neurologic damage
   .
   #) respiratory failure:  intubated in the peri-code setting.  ABGs
   during the day yesterday indicated primary metabolic alkalosis.
   Possibilities for etiology include intracranial process, drug effect,
   PE.  Could not evaluate for PE yesterday because of reported allergy to
   contrast (patient was unable to define further.)  No obvious drug
   offenders on her list.
   - CT head to evaluate for intracranial process
   - LENIs to evaluate for source of PE
   - wean FiO2 and PEEP as tolerated
   .
   #) hypotension:  blood pressures were very labile prior to the code.
   She is currently requiring a small dose of neo.
   - wean neo as tolerated
   .
   #) fevers:  On ciprofloxacin+dapto+meropenem.  Recent cultures with VRE
   but none since [**4-11**]. CSF findings concerning for infection seeding her
   CSF.  It is possible that her Ommaya is confaminated.  Also would be
   concerned for infected clots given her known upper extremity DVTs
   and/or for cardiac vegetations.  No evidence of septic emboli on lung
   CT yesterday.  Nasopharyngeal aspirate negative, induced sputum to be
   done today.
   - continue antibiotics, changed to improve CSF penetration
   - discuss with ID antibiotic coverage
   - discuss with oncology the possibility of an infected Ommaya
   - TTE to evaluate valves for vegetation
   - f/u CSF studies
   - induced sputum
   .
   #) ALL:  with recent recurrent CNS disease.   This hospitalization she
   was treated with intrathecal chemotherapy and DLI with resolution of
   CSF blasts as of [**2176-4-1**].    Her CSF picture currently
   - f/u cytology of spinal fluid
   - TTE today to evaluate for endocarditis
   - s/p IVIg yesterday
   - continue filgastrim
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis)
   - discuss with
   .
   #) increased LFTs:  appears to be shock liver
   - continue to monitor
   .
   #)  increased urin output:  concerning for DI in the setting of a
   possible intra-cranial process
   - check serum/urine osms
   .
   #) Coagulopathy:  concerning for DIC
   - follow DIC labs q4h today
   - transfuse blood and products PRN
   .
   #)  Hypoglycemia:  noted on morning labs, s/p
 amp d50.  Possibly
   secondary to insulin in TPN, which was stopped overnight.
   - follow FSBG
   - D5
   ICU Care
   Nutrition: nutrition consult for TF recs
   Glycemic Control:
   Lines:   contact IR for arterial line placement today given difficulty
   placing at bedside
   Indwelling Port (PortaCath) - [**2176-4-14**] 06:30 AM
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:  full code (confirmed last night with her healthcare
   proxy)
   Disposition: ICU
   ------ Protected Section ------
   I saw and examined the patient, and was physically present with the ICU
   team for the key portions of the services provided. I agree with Dr
   [**Last Name (STitle) **]
s note, including the assessment and plan. I would emphasize and
   add the following points:
   60 yo F with ALL relapse, transferred to with tachypnea, tachycardia,
   fevers. She received IT methotrexate recently and has an Ommaya shunt.
   VRE bacteremia..  She has a h/o svt/atrial tach with chemo related
   cardiotoxicity. Yesterday had continued resp alkalosis. Ommaya shunt
   tapped
new leukocytosis, neg gram stain, cx pending.  Noncontrast
   chest CT showed LLL infiltrate/atelectasis.  Increased ectopy/svt with
   HR to 160's--without hypotension.  Was given 5 Lopressor IV X 2, 15 IV
   dilt with initial improved rate control then developed hypotension and
   asystolic arrest. Intubated.  Started on Neo. Suspected calcium channel
   blocker toxicity.  Received calcium chloride/gluconate/glucagon.
   102.6-->96.3  68-139  118/60  acv 500/24/10/50%
   perrla, withdraws to touch, but minimally responsive on small amt
   sedated, intubated, coarse, rr tachy, + BS soft, L fem line
   Labs reviewed and noted above
   cxr with diffuse patchy airspace ds r > l, l effusion/atelectasis
   Agree with plan to evaluate with head CT given persistent resp
   alkalosis yesterday, CSF findings, and increased urine output
   concerning for central process (?DI). Awaiting lenis given some concern
   for possible pe contributing to this prior alkalotic picture as has
   contrast allergy and unable to tolerate CTA. Consult neurosurgery about
   whether Ommaya may be contaminated given leukocytosis on tap.  Continue
   broad antibx coverage including csf coverage following id recs and f/u
   all cx data.  Check TTE to reeval for vegetations/sbe.  Potential
   infectious nedis includes also port and known UE DVT as well as pna.
   Continue ACV support and wean neo for maps > 65.  Increased lfts appear
   most c/w shock liver given cardiac arrest
continue to trend.  Given
   elevated INR
follow coags and dic labs.  Hypoglycemia felt [**1-1**] to
   TPN/insulin
now without dedicated port. Continue D5 and follow. Check
   serum/urine osms given increased urine output.  Maintain adequate fluid
   support.   Access is an issue given multiple clotted vessels.   Has IR
   placed fem line 1 PIV, port.  Continue boots, PPI.  Remains full code.
   Remainder as above.
   Critically ill
   Time spent: 50 min
   ------ Protected Section Addendum Entered By:[**Name (NI) 209**] [**Last Name (NamePattern1) 210**], MD
   on:[**2176-4-15**] 06:21 PM ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2176-4-14**] 08:07 AM
   MRSA admit swab
 BLOOD CULTURED - At [**2176-4-14**] 02:01 PM
   central line
 URINE CULTURE - At [**2176-4-14**] 02:01 PM
 INVASIVE VENTILATION - START [**2176-4-15**] 01:53 AM
 FEVER - 102.6
F - [**2176-4-14**] 08:00 PM
   - d/w son her current disposition
   - ABG still respiratory alkalosis
   - CSF from shunt:  263 WBC, 94% PMN
   - IVIg x 1 per BMT
   - continuing meropenem, changed gent to cipro for better CSF
   penetration, increased dose of dapto for better CSF penetration
   - nasopharyngeal aspirate negative viral screen
   - induced sputum not done
   - has contrast allergy, got non-contrast CT chest with infiltrate vs
   atelectasis LLL
   - 10-15 beat NSVT, having lots of ectopy, lytes repleted
   - 2400:  SVT to the 170s, given fluid, metoprolol 5 mg IV x 2 followed
   by diltiazem 15 mg IV-->HR fell to 60s, but BP also dropped from SBP
   110 to SBP 60s-70s
   - 0030-0130:  attempting to place radial arterial line unsuccessfully,
   BP on the cuff mostly 60s-80s
   - 0130:  asystole, code blue, regained perfusing rhythm after epi x 2
   mg, atropine x 2mg, 2 amps calcium chloride
   - received 4 grams calcium gluconate + 2 amps calcium chloride for
   presumed calcium channel blocker toxicity, also gave glucagon 5 mg x 1
   for possible component of beta blocker toxicity
   - sedating with fentanyl/midazolam to try to improve vent synchrony
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-14**] 06:30 PM
   Acyclovir - [**2176-4-14**] 06:54 PM
   Micafungin - [**2176-4-14**] 08:17 PM
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Meropenem - [**2176-4-15**] 04:00 AM
   Infusions:
   Phenylephrine - 2 mcg/Kg/min
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 0.5 mg/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-14**] 09:39 AM
   Fentanyl - [**2176-4-15**] 03:08 AM
   Midazolam (Versed) - [**2176-4-15**] 03:09 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-15**] 06:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.2
C (102.6
   Tcurrent: 35.7
C (96.3
   HR: 101 (68 - 139) bpm
   BP: 114/79(87) {76/35(52) - 199/118(122)} mmHg
   RR: 30 (18 - 41) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  5,009 mL
                                                                  3,141 mL
   PO:
             TF:
   IVF:
                                                                  3,456 mL
                                                                  3,128 mL
   Blood products:
                                                                     74 mL
   Total out:
                                                                  3,050 mL
                                                                  1,685 mL
   Urine:
                                                                  3,050 mL
                                                                  1,685 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,959 mL
                                                                  1,456 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   RR (Set): 24
   PEEP: 10 cmH2O
   FiO2: 50%
   RSBI Deferred: PEEP > 10, FiO2 > 60%
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.28/26/269/13/-12
   Ve: 15.9 L/min
   PaO2 / FiO2: 538
   Physical Examination
   General:  intubated, sedated but flickers eyes in reponse to voice
   HEENT:  dry mucous membranes
   Heart:  regular, no audible murmur
   Lungs:  clear anteriorly
   Abdomen:  soft
   Extremities:  cool, distal pulses palpable but thready
   Labs / Radiology
   37 K/uL
   9.8 g/dL
   40 mg/dL
   0.8 mg/dL
   13 mEq/L
   5.0 mEq/L
   23 mg/dL
   117 mEq/L
   142 mEq/L
   30.6 %
   0.9 K/uL
        [image002.jpg]
                             [**2176-4-14**]  04:42 PM
                             [**2176-4-14**]  06:50 PM
                             [**2176-4-14**]  10:44 PM
                             [**2176-4-15**]  01:30 AM
                             [**2176-4-15**]  01:43 AM
                             [**2176-4-15**]  02:47 AM
                             [**2176-4-15**]  03:15 AM
                             [**2176-4-15**]  04:32 AM
                             [**2176-4-15**]  04:50 AM
   WBC
   0.9
   Hct
   26.6
   30.6
   Plt
   37
   Cr
   0.6
   0.3
   0.8
   0.8
   TCO2
   23
   22
   7
   9
   13
   Glucose
   118
   99
   83
   40
   Other labs: PT / PTT / INR:22.5/102.0/2.2, ALT / AST:[**Telephone/Fax (1) 6012**], Alk Phos
   / T Bili:336/1.6, Fibrinogen:784 mg/dL, Lactic Acid:4.7 mmol/L,
   Albumin:2.0 g/dL, LDH:341 IU/L, Ca++:13.4 mg/dL, Mg++:2.1 mg/dL,
   PO4:6.0 mg/dL
   CSF:  263 WBC, 94% PMN, 6 lymphs, 33 RBC, 123 protein, 73 glucose.
   HSV, toxo, CMV, EBV pending
   Non-contrast chest CT:
   1. Peripheral wedge-shaped left upper lobe consolidation, previously
   seen as
   an area of bronchiectasis ([**2169-12-30**]), ground-glass ([**2172-4-8**]), and
   consolidation ([**2172-3-31**]) - findings suggest recurrent infection in a
   region
   of focal bronchiectasis.
   2. New small left and tiny right pleural effusions.
   3. Scattered tree-in-[**Male First Name (un) **] opacities which may represent inflammation or
   infection.
   4. Extensive chest wall and mediastinal collateral vascularization and
   prominence of the azygos vein, likely due to known occlusion of the SVC
   and
   brachiocephalic veins.
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with ALL and recent VRE bacteremia who
   comes with acute-on-chronic poor medical status, with increasing
   tachypnea, tachycardia, and temperature.
   #) s/p asystolic arrest:  Likely cause was toxicity from calcium
   channel blockade.  Her tachyarthymia may have been secondary to
   sympathetic output from fevers in the setting of a heart compromised by
   prior anthracycline toxicity.  Currently her pupils are reactive and
   she responds to stimulation.
   - monitor electrolytes q6h and replete PRN
   - trend lactate
   - no further nodal agents
   - head CT to evaluate for severe neurologic damage
   .
   #) respiratory failure:  intubated in the peri-code setting.  ABGs
   during the day yesterday indicated primary metabolic alkalosis.
   Possibilities for etiology include intracranial process, drug effect,
   PE.  Could not evaluate for PE yesterday because of reported allergy to
   contrast (patient was unable to define further.)  No obvious drug
   offenders on her list.
   - CT head to evaluate for intracranial process
   - LENIs to evaluate for source of PE
   - wean FiO2 and PEEP as tolerated
   .
   #) hypotension:  blood pressures were very labile prior to the code.
   She is currently requiring a small dose of neo.
   - wean neo as tolerated
   .
   #) fevers:  On ciprofloxacin+dapto+meropenem.  Recent cultures with VRE
   but none since [**4-11**]. CSF findings concerning for infection seeding her
   CSF.  It is possible that her Ommaya is confaminated.  Also would be
   concerned for infected clots given her known upper extremity DVTs
   and/or for cardiac vegetations.  No evidence of septic emboli on lung
   CT yesterday.  Nasopharyngeal aspirate negative, induced sputum to be
   done today.
   - continue antibiotics, changed to improve CSF penetration
   - discuss with ID antibiotic coverage
   - discuss with oncology the possibility of an infected Ommaya
   - TTE to evaluate valves for vegetation
   - f/u CSF studies
   - induced sputum
   .
   #) ALL:  with recent recurrent CNS disease.   This hospitalization she
   was treated with intrathecal chemotherapy and DLI with resolution of
   CSF blasts as of [**2176-4-1**].    Her CSF picture currently
   - f/u cytology of spinal fluid
   - TTE today to evaluate for endocarditis
   - s/p IVIg yesterday
   - continue filgastrim
   - during neutropenic period, continue acyclovir, micafungin, nystatin
   (had past mucositis)
   - discuss with
   .
   #) increased LFTs:  appears to be shock liver
   - continue to monitor
   .
   #)  increased urin output:  concerning for DI in the setting of a
   possible intra-cranial process
   - check serum/urine osms
   .
   #) Coagulopathy:  concerning for DIC
   - follow DIC labs q4h today
   - transfuse blood and products PRN
   .
   #)  Hypoglycemia:  noted on morning labs, s/p
 amp d50.  Possibly
   secondary to insulin in TPN, which was stopped overnight.
   - follow FSBG
   - D5
   ICU Care
   Nutrition: nutrition consult for TF recs
   Glycemic Control:
   Lines:   contact IR for arterial line placement today given difficulty
   placing at bedside
   Indwelling Port (PortaCath) - [**2176-4-14**] 06:30 AM
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:  full code (confirmed last night with her healthcare
   proxy)
   Disposition: ICU
   ------ Protected Section ------
   I saw and examined the patient, and was physically present with the ICU
   team for the key portions of the services provided. I agree with Dr
   [**Last Name (STitle) **]
s note, including the assessment and plan. I would emphasize and
   add the following points:
   60 yo F with ALL relapse, transferred to with tachypnea, tachycardia,
   fevers. She received IT methotrexate recently and has an Ommaya shunt.
   VRE bacteremia..  She has a h/o svt/atrial tach with chemo related
   cardiotoxicity. Yesterday had continued resp alkalosis. Ommaya shunt
   tapped
new leukocytosis, neg gram stain, cx pending.  Noncontrast
   chest CT showed LLL infiltrate/atelectasis.  Increased ectopy/svt with
   HR to 160's--without hypotension.  Was given 5 Lopressor IV X 2, 15 IV
   dilt with initial improved rate control then developed hypotension and
   asystolic arrest. Intubated.  Started on Neo. Suspected calcium channel
   blocker toxicity.  Received calcium chloride/gluconate/glucagon.
   102.6-->96.3  68-139  118/60  acv 500/24/10/50%
   perrla, withdraws to touch, but minimally responsive on small amt
   sedated, intubated, coarse, rr tachy, + BS soft, L fem line
   Labs reviewed and noted above
   cxr with diffuse patchy airspace ds r > l, l effusion/atelectasis
   Agree with plan to evaluate with head CT given persistent resp
   alkalosis yesterday, CSF findings, and increased urine output
   concerning for central process (?DI). Awaiting lenis given some concern
   for possible pe contributing to this prior alkalotic picture as has
   contrast allergy and unable to tolerate CTA. Consult neurosurgery about
   whether Ommaya may be contaminated given leukocytosis on tap.  Continue
   broad antibx coverage including csf coverage following id recs and f/u
   all cx data.  Check TTE to reeval for vegetations/sbe.  Potential
   infectious nedis includes also port and known UE DVT as well as pna.
   Continue ACV support and wean neo for maps > 65.  Increased lfts appear
   most c/w shock liver given cardiac arrest
continue to trend.  Given
   elevated INR
follow coags and dic labs.  Hypoglycemia felt [**1-1**] to
   TPN/insulin
now without dedicated port. Continue D5 and follow. Check
   serum/urine osms given increased urine output.  Maintain adequate fluid
   support.   Access is an issue given multiple clotted vessels.   Has IR
   placed fem line 1 PIV, port.  Continue boots, PPI.  Remains full code.
   Remainder as above.
   Critically ill
   Time spent: 50 min
   ------ Protected Section Addendum Entered By:[**Name (NI) 209**] [**Last Name (NamePattern1) 210**], MD
   on:[**2176-4-15**] 06:21 PM ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, I summarize the following information:

The patient is a 60-year-old woman with acute lymphoblastic leukemia (ALL) who was admitted with tachypnea, tachycardia, and fever. She has a history of recurrent central nervous system (CNS) disease and was treated with intrathecal chemotherapy and donor lymphocyte infusion (DLI) with resolution of CSF blasts. She has an Ommaya shunt and has been receiving antibiotics for suspected VRE bacteremia.

The patient's current condition is critical, with:

* Fever (102.6F) and altered mental status
* Respiratory failure requiring intubation
* Hypotension and asystolic arrest requiring code blue
* Coagulopathy and potential disseminated intravascular coagulation (DIC)
* Increased liver function tests (LFTs) and potential shock liver
* Hypoglycemia and potential diabetes insipidus (DI)
* Increased urine output and potential central process
* Ongoing antibiotic therapy for suspected VRE bacteremia and potential CNS infection
* Potential infectious niduses including port, upper extremity deep vein thrombosis (DVT), and pneumonia

The patient's medical team is concerned about several potential complications, including:

* Calcium channel blocker toxicity
* Infection seeding the CSF
* Infected clots or cardiac vegetations
* Central process or DI
* DIC
* Shock liver
* Hypoglycemia

The patient's plan of care includes:

* Monitoring electrolytes, lactate, and coagulation studies
* Trending LFTs and coagulation studies
* Weaning FiO2 and PEEP as tolerated
* Continuing antibiotics and adjusting coverage based on CSF findings
* Discussing with ID and oncology teams about potential infectious niduses
* Evaluating for endocarditis and potential cardiac vegetations
* Following up on CSF studies and induced sputum
* Monitoring for signs of septic shock and DIC

The patient remains critically ill and requires close monitoring and management to address her complex medical conditions."
112508.0,247400,2176-04-16 11:59:00,Physician ,Physician Resident Progress Note,"Chief Complaint: VRE infection associated with Omaya port, s/p
   neurosurgical procedure to remove port
   24 Hour Events:
 TRANS ESOPHAGEAL ECHO - At [**2176-4-15**] 12:49 PM
   Read: ""The left atrium is normal in size. No atrial septal defect is
   seen by 2D or color Doppler. Left ventricular wall thicknesses and
   cavity size are normal. There is severe global left ventricular
   hypokinesis (LVEF = 20 %). No masses or thrombi are seen in the left
   ventricle. There is no ventricular septal defect. Right ventricular
   chamber size is normal. with mild global free wall hypokinesis. The
   aortic valve leaflets (3) are mildly thickened but aortic stenosis is
   not present. No masses or vegetations are seen on the aortic valve. No
   aortic regurgitation is seen. The mitral valve leaflets are mildly
   thickened. No mass or vegetation is seen on the mitral valve. Mild (1+)
   mitral regurgitation is seen. The pulmonary artery systolic pressure
   could not be determined. There is a small pericardial effusion. There
   are no echocardiographic signs of tamponade.  IMPRESSION:
   Cardiomyopathy. No valvular vegetations seen.""
 ULTRASOUND - At [**2176-4-15**] 01:50 PM
   No DVT.
 OR SENT - At [**2176-4-15**] 09:30 PM
   Pt transferred from [**Hospital Ward Name 77**] 4 and arrived on unit at 2045.  Anesthesia
   and neuro sug up to unit and escorted pt to OR at 2130.
 OR RECEIVED - At [**2176-4-15**] 11:45 PM
   No op note in OMR at time of re-admission to [**Hospital Unit Name 10**]; per brief chart
   note, operation involved:
   * removal of Omaya port (PATHOLOGY # [**-7/1942**])
   * craniotomy for exploration and evacuation of SDH
   Note reports no significant blood loss
   2 units RBC and 2 units FFP given
   Culture sent, NGTD; gram stain showed:
      GRAM STAIN (Final [**2176-4-16**]):
         2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
         2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                       IN PAIRS.
 ARTERIAL LINE - START [**2176-4-16**] 12:48 AM
   History obtained from Medical records
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Linezolid - [**2176-4-16**] 02:17 PM
   Meropenem - [**2176-4-16**] 03:54 PM
   Gentamicin - [**2176-4-16**] 10:05 PM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Metoprolol - [**2176-4-16**] 03:00 AM
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-17**] 12:44 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 99 (98 - 128) bpm
   BP: 117/81(95) {98/66(79) - 146/101(119)} mmHg
   RR: 26 (16 - 39) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  6,475 mL
                                                                     40 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                     40 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                      0 mL
   Urine:
                                                                  1,395 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                     40 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 131
   RSBI Deferred: No Spon Resp
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   Compliance: 34.6 cmH2O/mL
   SpO2: 99%
   ABG: 7.50/26/135/17/0  (TAKEN 10:50 am [**4-15**])
   Ve: 9.7 L/min
   PaO2 / FiO2: 270
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, No(t) Sclera edema, pupils from 3 mm to 1 mm
   in setting of sedation
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ),
   in limited anterior exam
   Abdominal: Bowel sounds present, Distended
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, Rash: some mild erythematous rash on upper chest, none
   seen on torso, no morbilliform rash
   Neurologic: Responds to: Noxious stimuli, Movement: Not assessed,
   Sedated
   Labs / Radiology
   116 K/uL
   9.9 g/dL
   109 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.1 mEq/L
   33 mg/dL
   112 mEq/L
   143 mEq/L
   27.2 %
   4.2 K/uL
        [image002.jpg]
                             [**2176-4-15**]  09:34 AM
                             [**2176-4-15**]  03:56 PM
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
   WBC
   3.5
   3.1
   4.2
   4.2
   Hct
   26.1
   19
   25.9
   30.0
   27.2
   Plt
   54
   128
   120
   116
   Cr
   0.9
   1.0
   1.0
   TCO2
   20
   21
   19
   20
   21
   Glucose
   82
   71
   84
   109
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:288/3.5, Amylase / Lipase:250/111, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.4 mmol/L, Albumin:2.0 g/dL, LDH:5880 IU/L, Ca++:8.0
   mg/dL, Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication: ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: VRE infection associated with Omaya port, s/p
   neurosurgical procedure to remove port
   24 Hour Events:
 TRANS ESOPHAGEAL ECHO - At [**2176-4-15**] 12:49 PM
   Read: ""The left atrium is normal in size. No atrial septal defect is
   seen by 2D or color Doppler. Left ventricular wall thicknesses and
   cavity size are normal. There is severe global left ventricular
   hypokinesis (LVEF = 20 %). No masses or thrombi are seen in the left
   ventricle. There is no ventricular septal defect. Right ventricular
   chamber size is normal. with mild global free wall hypokinesis. The
   aortic valve leaflets (3) are mildly thickened but aortic stenosis is
   not present. No masses or vegetations are seen on the aortic valve. No
   aortic regurgitation is seen. The mitral valve leaflets are mildly
   thickened. No mass or vegetation is seen on the mitral valve. Mild (1+)
   mitral regurgitation is seen. The pulmonary artery systolic pressure
   could not be determined. There is a small pericardial effusion. There
   are no echocardiographic signs of tamponade.  IMPRESSION:
   Cardiomyopathy. No valvular vegetations seen.""
 ULTRASOUND - At [**2176-4-15**] 01:50 PM
   No DVT.
 OR SENT - At [**2176-4-15**] 09:30 PM
   Pt transferred from [**Hospital Ward Name 77**] 4 and arrived on unit at 2045.  Anesthesia
   and neuro sug up to unit and escorted pt to OR at 2130.
 OR RECEIVED - At [**2176-4-15**] 11:45 PM
   No op note in OMR at time of re-admission to [**Hospital Unit Name 10**]; per brief chart
   note, operation involved:
   * removal of Omaya port (PATHOLOGY # [**-7/1942**])
   * craniotomy for exploration and evacuation of SDH
   Note reports no significant blood loss
   2 units RBC and 2 units FFP given
   Culture sent, NGTD; gram stain showed:
      GRAM STAIN (Final [**2176-4-16**]):
         2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
         2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                       IN PAIRS.
 ARTERIAL LINE - START [**2176-4-16**] 12:48 AM
   History obtained from Medical records
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Linezolid - [**2176-4-16**] 02:17 PM
   Meropenem - [**2176-4-16**] 03:54 PM
   Gentamicin - [**2176-4-16**] 10:05 PM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Metoprolol - [**2176-4-16**] 03:00 AM
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-17**] 12:44 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 99 (98 - 128) bpm
   BP: 117/81(95) {98/66(79) - 146/101(119)} mmHg
   RR: 26 (16 - 39) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  6,475 mL
                                                                     40 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                     40 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                      0 mL
   Urine:
                                                                  1,395 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                     40 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 131
   RSBI Deferred: No Spon Resp
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   Compliance: 34.6 cmH2O/mL
   SpO2: 99%
   ABG: 7.50/26/135/17/0  (TAKEN 10:50 am [**4-15**])
   Ve: 9.7 L/min
   PaO2 / FiO2: 270
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, No(t) Sclera edema, pupils from 3 mm to 1 mm
   in setting of sedation
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ),
   in limited anterior exam
   Abdominal: Bowel sounds present, Distended
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, Rash: some mild erythematous rash on upper chest, none
   seen on torso, no morbilliform rash
   Neurologic: Responds to: Noxious stimuli, Movement: Not assessed,
   Sedated
   Labs / Radiology
   116 K/uL
   9.9 g/dL
   109 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.1 mEq/L
   33 mg/dL
   112 mEq/L
   143 mEq/L
   27.2 %
   4.2 K/uL
        [image002.jpg]
                             [**2176-4-15**]  09:34 AM
                             [**2176-4-15**]  03:56 PM
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
   WBC
   3.5
   3.1
   4.2
   4.2
   Hct
   26.1
   19
   25.9
   30.0
   27.2
   Plt
   54
   128
   120
   116
   Cr
   0.9
   1.0
   1.0
   TCO2
   20
   21
   19
   20
   21
   Glucose
   82
   71
   84
   109
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:288/3.5, Amylase / Lipase:250/111, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.4 mmol/L, Albumin:2.0 g/dL, LDH:5880 IU/L, Ca++:8.0
   mg/dL, Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication: ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) and past successful treatment of this condition. She has had a recurrence of ALL, including central nervous system (CNS) involvement, and likely has an enterococcal infection of an Omaya port used for intrathecal chemotherapy. The patient has undergone cardiac arrest, removal of the Omaya port, and evacuation of subdural hematoma (SDH).

The patient's current condition is as follows:

* Cardiomyopathy with severe global left ventricular hypokinesis (LVEF = 20%)
* Mild mitral regurgitation
* Small pericardial effusion
* No signs of tamponade

The patient is receiving various medications, including antibiotics, antifungals, and antivirals, as well as supportive care, such as fluid management, nutrition, and respiratory support.

The potential medical complications that can arise from this condition include:

* Cardiac arrhythmias and heart failure due to cardiomyopathy
* Infection and sepsis due to the enterococcal infection
* Respiratory failure due to pneumonia or other respiratory complications
* Neurological complications due to the CNS involvement of ALL
* Bleeding complications due to the removal of the Omaya port and evacuation of SDH
* Thrombocytopenia and bleeding complications due to the patient's history of leukemia

The patient's laboratory results show:

* Leukopenia with a WBC count of 3.5
* Thrombocytopenia with a platelet count of 54
* Elevated liver enzymes, including ALT and AST
* Elevated lactate dehydrogenase (LDH) and alkaline phosphatase (ALP)
* Abnormal kidney function, including elevated creatinine and blood urea nitrogen (BUN)

The patient's management plan includes:

* Continued antibiotic therapy for the enterococcal infection
* Cardiac monitoring and management for cardiomyopathy
* Respiratory support, including mechanical ventilation and oxygen therapy
* Neurological monitoring and management for CNS involvement
* Bleeding management, including platelet transfusions and coagulation factor replacement
* Thrombocytopenia management, including platelet transfusions and antithrombotic therapy
* Supportive care, including nutrition, fluid management, and pain management."
112508.0,247400,2176-04-16 23:59:00,Physician ,Physician Resident Progress Note,"ACCEPT NOTE:
   Ms. [**Known lastname 5996**] was transferred back to the [**Hospital Unit Name 10**] from [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **]
   MICU/SICU after being transferred from the [**Hospital Unit Name 10**] to the [**Hospital Ward Name **] for
   neurosurgical intervention, detailed below. Metavision vitals reflect
   the 24 hour period of [**4-16**] essentially midnight-to-midnight. She was
   transferred to the [**Hospital Unit Name 10**] earlier in the evening, and remained stable
   during this time. This note is written reflecting my exam at that time
   and reflecting re-exam at 2330.
   Chief Complaint: VRE infection associated with Omaya port, s/p
   neurosurgical procedure to remove port
   24 Hour Events:
 TRANS ESOPHAGEAL ECHO - At [**2176-4-15**] 12:49 PM
   Read: ""The left atrium is normal in size. No atrial septal defect is
   seen by 2D or color Doppler. Left ventricular wall thicknesses and
   cavity size are normal. There is severe global left ventricular
   hypokinesis (LVEF = 20 %). No masses or thrombi are seen in the left
   ventricle. There is no ventricular septal defect. Right ventricular
   chamber size is normal. with mild global free wall hypokinesis. The
   aortic valve leaflets (3) are mildly thickened but aortic stenosis is
   not present. No masses or vegetations are seen on the aortic valve. No
   aortic regurgitation is seen. The mitral valve leaflets are mildly
   thickened. No mass or vegetation is seen on the mitral valve. Mild (1+)
   mitral regurgitation is seen. The pulmonary artery systolic pressure
   could not be determined. There is a small pericardial effusion. There
   are no echocardiographic signs of tamponade.  IMPRESSION:
   Cardiomyopathy. No valvular vegetations seen.""
 ULTRASOUND - At [**2176-4-15**] 01:50 PM
   No DVT.
 OR SENT - At [**2176-4-15**] 09:30 PM
   Pt transferred from [**Hospital Ward Name 77**] 4 and arrived on unit at 2045.  Anesthesia
   and neuro sug up to unit and escorted pt to OR at 2130.
 OR RECEIVED - At [**2176-4-15**] 11:45 PM
   No op note in OMR at time of re-admission to [**Hospital Unit Name 10**]; per brief chart
   note, operation involved:
   * removal of Omaya port (PATHOLOGY # [**-7/1942**])
   * craniotomy for exploration and evacuation of SDH
   Note reports no significant blood loss
   2 units RBC and 2 units FFP given
   CSF culture sent, NGTD; gram stain showed:
      GRAM STAIN (Final [**2176-4-16**]):
         2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
         2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                       IN PAIRS.
 ARTERIAL LINE - START [**2176-4-16**] 12:48 AM
   History obtained from Medical records
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Linezolid - [**2176-4-16**] 02:17 PM
   Meropenem - [**2176-4-16**] 03:54 PM
   Gentamicin - [**2176-4-16**] 10:05 PM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Metoprolol - [**2176-4-16**] 03:00 AM
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-17**] 00:44 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 99 (98 - 128) bpm
   BP: 117/81(95) {98/66(79) - 146/101(119)} mmHg
   RR: 26 (16 - 39) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  6,475 mL
                                                                     40 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                     40 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                      0 mL
   Urine:
                                                                  1,395 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                     40 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 131
   RSBI Deferred: No Spon Resp
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   Compliance: 34.6 cmH2O/mL
   SpO2: 99%
   ABG: 7.50/26/135/17/0  (TAKEN 10:50 am [**4-15**])
   Ve: 9.7 L/min
   PaO2 / FiO2: 270
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, No(t) Sclera edema, pupils from 3 mm to 1 mm
   in setting of sedation
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ),
   in limited anterior exam
   Abdominal: Bowel sounds present, Distended; Ostomy in place w
   protuberant ostomy, dark tea-colored fluid in bag. Femoral line in
   place as prior; no infectious signs at line site
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, Rash: some mild erythematous rash on upper chest, none
   seen on torso, no morbilliform rash
   Neurologic: Responds to: Noxious stimuli, Movement: Not assessed,
   Sedated
   Labs / Radiology
   116 K/uL
   9.9 g/dL
   109 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.1 mEq/L
   33 mg/dL
   112 mEq/L
   143 mEq/L
   27.2 %
   4.2 K/uL
        [image002.jpg]
                             [**2176-4-15**]  09:34 AM
                             [**2176-4-15**]  03:56 PM
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
   WBC
   3.5
   3.1
   4.2
   4.2
   Hct
   26.1
   19
   25.9
   30.0
   27.2
   Plt
   54
   128
   120
   116
   Cr
   0.9
   1.0
   1.0
   TCO2
   20
   21
   19
   20
   21
   Glucose
   82
   71
   84
   109
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:288/3.5, Amylase / Lipase:250/111, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.4 mmol/L, Albumin:2.0 g/dL, LDH:5880 IU/L, Ca++:8.0
   mg/dL, Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   ALTERED MENTAL STATUS
   CNS involvement by ALL as well as by enterococcus in association with
   the Omaya port, and SDH of chronic appearance seen on head CT s/p
   cardiac arrest, now s/p neurosurgical procedure as above. In
   retrospect, the subdural hematoma and gram-positive (likely
   enterococcal) infection may have been responsible for a considerable
   portion of what was described on her prior arrival to the [**Hospital Unit Name 10**] as
poor
   functional status
a vague worsening of cognition and function
   consistent with a diffuse cerebral process. Neurological exam currently
   showing promptly reactive pupils and some retreat of feet to noxious
   stimuli, but otherwise non-responsive in setting of sedation on vent.
   Assessment of neuro status confounded somewhat by her cardiac arrest,
   which may have created some anoxic brain injury.
   -          follow up neurosurgical recommendations
   -          continue to follow neurological exam
   -          titrate down sedation as tolerated, continue to evaluate
   mental status closely in this setting
   -          follow up CNS cultures, culture from Omaya device
   -          continue antibiotics as detailed below.
   -          Discuss w BMT service whether there are criteria that would
   allow return to treatment of CNS disease; may simply require ongoing
   assessment of relative risks and benefits in context
   [**Name (NI) 6041**] INFECTION, c/w VRE
   Per ID recommendations, linezolid superior to daptomycin for coverage
   of CNS infection. Has the unfortunate advantage of suppressing bone
   marrow in immune-compromised patient. Immediate treatment of infection
   is current priority. Should continue to weigh risks and benefits of
   anti-VRE abx choice.
   -          continue linezolid with gentamicin
   ALL
   Lengthy history with ALL, now recurring. S/p donor lymphocyte infusion.
   Giving G-CSF. Will need treatment for CNS disease at some point.
   -          follow up BMT recommendations
   -          has extensive medications for symptomatic treatment of
   mucositis and esophagitis; continue for now but continue to evaluate
   oral health, consider d/c
ing in setting of ventilation
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication: ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

ACCEPT NOTE:
   Ms. [**Known lastname 5996**] was transferred back to the [**Hospital Unit Name 10**] from [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **]
   MICU/SICU after being transferred from the [**Hospital Unit Name 10**] to the [**Hospital Ward Name **] for
   neurosurgical intervention, detailed below. Metavision vitals reflect
   the 24 hour period of [**4-16**] essentially midnight-to-midnight. She was
   transferred to the [**Hospital Unit Name 10**] earlier in the evening, and remained stable
   during this time. This note is written reflecting my exam at that time
   and reflecting re-exam at 2330.
   Chief Complaint: VRE infection associated with Omaya port, s/p
   neurosurgical procedure to remove port
   24 Hour Events:
 TRANS ESOPHAGEAL ECHO - At [**2176-4-15**] 12:49 PM
   Read: ""The left atrium is normal in size. No atrial septal defect is
   seen by 2D or color Doppler. Left ventricular wall thicknesses and
   cavity size are normal. There is severe global left ventricular
   hypokinesis (LVEF = 20 %). No masses or thrombi are seen in the left
   ventricle. There is no ventricular septal defect. Right ventricular
   chamber size is normal. with mild global free wall hypokinesis. The
   aortic valve leaflets (3) are mildly thickened but aortic stenosis is
   not present. No masses or vegetations are seen on the aortic valve. No
   aortic regurgitation is seen. The mitral valve leaflets are mildly
   thickened. No mass or vegetation is seen on the mitral valve. Mild (1+)
   mitral regurgitation is seen. The pulmonary artery systolic pressure
   could not be determined. There is a small pericardial effusion. There
   are no echocardiographic signs of tamponade.  IMPRESSION:
   Cardiomyopathy. No valvular vegetations seen.""
 ULTRASOUND - At [**2176-4-15**] 01:50 PM
   No DVT.
 OR SENT - At [**2176-4-15**] 09:30 PM
   Pt transferred from [**Hospital Ward Name 77**] 4 and arrived on unit at 2045.  Anesthesia
   and neuro sug up to unit and escorted pt to OR at 2130.
 OR RECEIVED - At [**2176-4-15**] 11:45 PM
   No op note in OMR at time of re-admission to [**Hospital Unit Name 10**]; per brief chart
   note, operation involved:
   * removal of Omaya port (PATHOLOGY # [**-7/1942**])
   * craniotomy for exploration and evacuation of SDH
   Note reports no significant blood loss
   2 units RBC and 2 units FFP given
   CSF culture sent, NGTD; gram stain showed:
      GRAM STAIN (Final [**2176-4-16**]):
         2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
         2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                       IN PAIRS.
 ARTERIAL LINE - START [**2176-4-16**] 12:48 AM
   History obtained from Medical records
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Linezolid - [**2176-4-16**] 02:17 PM
   Meropenem - [**2176-4-16**] 03:54 PM
   Gentamicin - [**2176-4-16**] 10:05 PM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Metoprolol - [**2176-4-16**] 03:00 AM
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-17**] 00:44 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 99 (98 - 128) bpm
   BP: 117/81(95) {98/66(79) - 146/101(119)} mmHg
   RR: 26 (16 - 39) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  6,475 mL
                                                                     40 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                     40 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                      0 mL
   Urine:
                                                                  1,395 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                     40 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 131
   RSBI Deferred: No Spon Resp
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   Compliance: 34.6 cmH2O/mL
   SpO2: 99%
   ABG: 7.50/26/135/17/0  (TAKEN 10:50 am [**4-15**])
   Ve: 9.7 L/min
   PaO2 / FiO2: 270
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, No(t) Sclera edema, pupils from 3 mm to 1 mm
   in setting of sedation
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ),
   in limited anterior exam
   Abdominal: Bowel sounds present, Distended; Ostomy in place w
   protuberant ostomy, dark tea-colored fluid in bag. Femoral line in
   place as prior; no infectious signs at line site
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, Rash: some mild erythematous rash on upper chest, none
   seen on torso, no morbilliform rash
   Neurologic: Responds to: Noxious stimuli, Movement: Not assessed,
   Sedated
   Labs / Radiology
   116 K/uL
   9.9 g/dL
   109 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.1 mEq/L
   33 mg/dL
   112 mEq/L
   143 mEq/L
   27.2 %
   4.2 K/uL
        [image002.jpg]
                             [**2176-4-15**]  09:34 AM
                             [**2176-4-15**]  03:56 PM
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
   WBC
   3.5
   3.1
   4.2
   4.2
   Hct
   26.1
   19
   25.9
   30.0
   27.2
   Plt
   54
   128
   120
   116
   Cr
   0.9
   1.0
   1.0
   TCO2
   20
   21
   19
   20
   21
   Glucose
   82
   71
   84
   109
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:288/3.5, Amylase / Lipase:250/111, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.4 mmol/L, Albumin:2.0 g/dL, LDH:5880 IU/L, Ca++:8.0
   mg/dL, Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   ALTERED MENTAL STATUS
   CNS involvement by ALL as well as by enterococcus in association with
   the Omaya port, and SDH of chronic appearance seen on head CT s/p
   cardiac arrest, now s/p neurosurgical procedure as above. In
   retrospect, the subdural hematoma and gram-positive (likely
   enterococcal) infection may have been responsible for a considerable
   portion of what was described on her prior arrival to the [**Hospital Unit Name 10**] as
poor
   functional status
a vague worsening of cognition and function
   consistent with a diffuse cerebral process. Neurological exam currently
   showing promptly reactive pupils and some retreat of feet to noxious
   stimuli, but otherwise non-responsive in setting of sedation on vent.
   Assessment of neuro status confounded somewhat by her cardiac arrest,
   which may have created some anoxic brain injury.
   -          follow up neurosurgical recommendations
   -          continue to follow neurological exam
   -          titrate down sedation as tolerated, continue to evaluate
   mental status closely in this setting
   -          follow up CNS cultures, culture from Omaya device
   -          continue antibiotics as detailed below.
   -          Discuss w BMT service whether there are criteria that would
   allow return to treatment of CNS disease; may simply require ongoing
   assessment of relative risks and benefits in context
   [**Name (NI) 6041**] INFECTION, c/w VRE
   Per ID recommendations, linezolid superior to daptomycin for coverage
   of CNS infection. Has the unfortunate advantage of suppressing bone
   marrow in immune-compromised patient. Immediate treatment of infection
   is current priority. Should continue to weigh risks and benefits of
   anti-VRE abx choice.
   -          continue linezolid with gentamicin
   ALL
   Lengthy history with ALL, now recurring. S/p donor lymphocyte infusion.
   Giving G-CSF. Will need treatment for CNS disease at some point.
   -          follow up BMT recommendations
   -          has extensive medications for symptomatic treatment of
   mucositis and esophagitis; continue for now but continue to evaluate
   oral health, consider d/c
ing in setting of ventilation
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication: ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

Ms. [**Known lastname 5996**], a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL), was transferred to the ICU from the neurosurgical intensive care unit (SICU) after undergoing a neurosurgical procedure to remove an Omaya port and evacuate a subdural hematoma (SDH). She was found to have a severe global left ventricular hypokinesis (LVEF = 20%) and mild mitral regurgitation. The patient is currently intubated and mechanically ventilated due to respiratory failure.

The patient's condition is complex, with multiple medical issues, including:

1. VRE infection associated with the Omaya port, which was removed during the neurosurgical procedure.
2. Cardiomyopathy with severe global left ventricular hypokinesis.
3. Mitral regurgitation.
4. Possible anoxic brain injury due to cardiac arrest.
5. ALL recurrence with CNS involvement.
6. Enterococcal infection of the Omaya port.
7. SDH of chronic appearance.
8. Fever, unknown origin (FUO).

The patient is currently receiving antibiotics for the VRE infection, including linezolid, which is superior to daptomycin for coverage of CNS infections. She is also receiving gentamicin and other medications for symptomatic treatment of mucositis and esophagitis.

Potential medical complications:

1. Sepsis and septic shock due to the VRE infection.
2. Cardiac arrhythmias and cardiac arrest due to cardiomyopathy.
3. Respiratory failure and acute respiratory distress syndrome (ARDS) due to pneumonia or other respiratory complications.
4. Neurological deterioration due to anoxic brain injury or CNS involvement by ALL.
5. Infection-related complications, such as bacteremia or endocarditis.
6. Hemorrhagic complications due to the SDH.
7. Gastrointestinal complications, such as bleeding or perforation, due to mucositis and esophagitis.

Assessment and Plan:

The patient will require close monitoring and management of her multiple medical issues. The ICU team will continue to follow her neurological exam, titrate down sedation as tolerated, and evaluate her mental status closely. The patient will also require ongoing antibiotics for the VRE infection, as well as treatment for her ALL and other medical conditions. The BMT team will be consulted to discuss criteria for returning to treatment of CNS disease and to follow up on recommendations for further management."
112508.0,247400,2176-04-16 23:59:00,Physician ,Physician Resident Progress Note,"Chief Complaint: VRE infection associated with Omaya port, s/p
   neurosurgical procedure to remove port
   24 Hour Events:
 TRANS ESOPHAGEAL ECHO - At [**2176-4-15**] 12:49 PM
   Read: ""The left atrium is normal in size. No atrial septal defect is
   seen by 2D or color Doppler. Left ventricular wall thicknesses and
   cavity size are normal. There is severe global left ventricular
   hypokinesis (LVEF = 20 %). No masses or thrombi are seen in the left
   ventricle. There is no ventricular septal defect. Right ventricular
   chamber size is normal. with mild global free wall hypokinesis. The
   aortic valve leaflets (3) are mildly thickened but aortic stenosis is
   not present. No masses or vegetations are seen on the aortic valve. No
   aortic regurgitation is seen. The mitral valve leaflets are mildly
   thickened. No mass or vegetation is seen on the mitral valve. Mild (1+)
   mitral regurgitation is seen. The pulmonary artery systolic pressure
   could not be determined. There is a small pericardial effusion. There
   are no echocardiographic signs of tamponade.  IMPRESSION:
   Cardiomyopathy. No valvular vegetations seen.""
 ULTRASOUND - At [**2176-4-15**] 01:50 PM
   No DVT.
 OR SENT - At [**2176-4-15**] 09:30 PM
   Pt transferred from [**Hospital Ward Name 77**] 4 and arrived on unit at 2045.  Anesthesia
   and neuro sug up to unit and escorted pt to OR at 2130.
 OR RECEIVED - At [**2176-4-15**] 11:45 PM
   No op note in OMR at time of re-admission to [**Hospital Unit Name 10**]; per brief chart
   note, operation involved:
   * removal of Omaya port (PATHOLOGY # [**-7/1942**])
   * craniotomy for exploration and evacuation of SDH
   Note reports no significant blood loss
   2 units RBC and 2 units FFP given
   Culture sent, NGTD; gram stain showed:
      GRAM STAIN (Final [**2176-4-16**]):
         2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
         2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                       IN PAIRS.
 ARTERIAL LINE - START [**2176-4-16**] 12:48 AM
   History obtained from Medical records
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Linezolid - [**2176-4-16**] 02:17 PM
   Meropenem - [**2176-4-16**] 03:54 PM
   Gentamicin - [**2176-4-16**] 10:05 PM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Metoprolol - [**2176-4-16**] 03:00 AM
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-17**] 12:44 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 99 (98 - 128) bpm
   BP: 117/81(95) {98/66(79) - 146/101(119)} mmHg
   RR: 26 (16 - 39) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  6,475 mL
                                                                     40 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                     40 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                      0 mL
   Urine:
                                                                  1,395 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                     40 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 131
   RSBI Deferred: No Spon Resp
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   Compliance: 34.6 cmH2O/mL
   SpO2: 99%
   ABG: 7.50/26/135/17/0  (TAKEN 10:50 am [**4-15**])
   Ve: 9.7 L/min
   PaO2 / FiO2: 270
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, No(t) Sclera edema, pupils from 3 mm to 1 mm
   in setting of sedation
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ),
   in limited anterior exam
   Abdominal: Bowel sounds present, Distended
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, Rash: some mild erythematous rash on upper chest, none
   seen on torso, no morbilliform rash
   Neurologic: Responds to: Noxious stimuli, Movement: Not assessed,
   Sedated
   Labs / Radiology
   116 K/uL
   9.9 g/dL
   109 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.1 mEq/L
   33 mg/dL
   112 mEq/L
   143 mEq/L
   27.2 %
   4.2 K/uL
        [image002.jpg]
                             [**2176-4-15**]  09:34 AM
                             [**2176-4-15**]  03:56 PM
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
   WBC
   3.5
   3.1
   4.2
   4.2
   Hct
   26.1
   19
   25.9
   30.0
   27.2
   Plt
   54
   128
   120
   116
   Cr
   0.9
   1.0
   1.0
   TCO2
   20
   21
   19
   20
   21
   Glucose
   82
   71
   84
   109
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:288/3.5, Amylase / Lipase:250/111, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.4 mmol/L, Albumin:2.0 g/dL, LDH:5880 IU/L, Ca++:8.0
   mg/dL, Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication: ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: VRE infection associated with Omaya port, s/p
   neurosurgical procedure to remove port
   24 Hour Events:
 TRANS ESOPHAGEAL ECHO - At [**2176-4-15**] 12:49 PM
   Read: ""The left atrium is normal in size. No atrial septal defect is
   seen by 2D or color Doppler. Left ventricular wall thicknesses and
   cavity size are normal. There is severe global left ventricular
   hypokinesis (LVEF = 20 %). No masses or thrombi are seen in the left
   ventricle. There is no ventricular septal defect. Right ventricular
   chamber size is normal. with mild global free wall hypokinesis. The
   aortic valve leaflets (3) are mildly thickened but aortic stenosis is
   not present. No masses or vegetations are seen on the aortic valve. No
   aortic regurgitation is seen. The mitral valve leaflets are mildly
   thickened. No mass or vegetation is seen on the mitral valve. Mild (1+)
   mitral regurgitation is seen. The pulmonary artery systolic pressure
   could not be determined. There is a small pericardial effusion. There
   are no echocardiographic signs of tamponade.  IMPRESSION:
   Cardiomyopathy. No valvular vegetations seen.""
 ULTRASOUND - At [**2176-4-15**] 01:50 PM
   No DVT.
 OR SENT - At [**2176-4-15**] 09:30 PM
   Pt transferred from [**Hospital Ward Name 77**] 4 and arrived on unit at 2045.  Anesthesia
   and neuro sug up to unit and escorted pt to OR at 2130.
 OR RECEIVED - At [**2176-4-15**] 11:45 PM
   No op note in OMR at time of re-admission to [**Hospital Unit Name 10**]; per brief chart
   note, operation involved:
   * removal of Omaya port (PATHOLOGY # [**-7/1942**])
   * craniotomy for exploration and evacuation of SDH
   Note reports no significant blood loss
   2 units RBC and 2 units FFP given
   Culture sent, NGTD; gram stain showed:
      GRAM STAIN (Final [**2176-4-16**]):
         2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
         2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                       IN PAIRS.
 ARTERIAL LINE - START [**2176-4-16**] 12:48 AM
   History obtained from Medical records
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Linezolid - [**2176-4-16**] 02:17 PM
   Meropenem - [**2176-4-16**] 03:54 PM
   Gentamicin - [**2176-4-16**] 10:05 PM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Metoprolol - [**2176-4-16**] 03:00 AM
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-17**] 12:44 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 99 (98 - 128) bpm
   BP: 117/81(95) {98/66(79) - 146/101(119)} mmHg
   RR: 26 (16 - 39) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  6,475 mL
                                                                     40 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                     40 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                      0 mL
   Urine:
                                                                  1,395 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                     40 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 131
   RSBI Deferred: No Spon Resp
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   Compliance: 34.6 cmH2O/mL
   SpO2: 99%
   ABG: 7.50/26/135/17/0  (TAKEN 10:50 am [**4-15**])
   Ve: 9.7 L/min
   PaO2 / FiO2: 270
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, No(t) Sclera edema, pupils from 3 mm to 1 mm
   in setting of sedation
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ),
   in limited anterior exam
   Abdominal: Bowel sounds present, Distended
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, Rash: some mild erythematous rash on upper chest, none
   seen on torso, no morbilliform rash
   Neurologic: Responds to: Noxious stimuli, Movement: Not assessed,
   Sedated
   Labs / Radiology
   116 K/uL
   9.9 g/dL
   109 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.1 mEq/L
   33 mg/dL
   112 mEq/L
   143 mEq/L
   27.2 %
   4.2 K/uL
        [image002.jpg]
                             [**2176-4-15**]  09:34 AM
                             [**2176-4-15**]  03:56 PM
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
   WBC
   3.5
   3.1
   4.2
   4.2
   Hct
   26.1
   19
   25.9
   30.0
   27.2
   Plt
   54
   128
   120
   116
   Cr
   0.9
   1.0
   1.0
   TCO2
   20
   21
   19
   20
   21
   Glucose
   82
   71
   84
   109
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:288/3.5, Amylase / Lipase:250/111, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.4 mmol/L, Albumin:2.0 g/dL, LDH:5880 IU/L, Ca++:8.0
   mg/dL, Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication: ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) who has undergone treatment, including intrathecal chemotherapy via an Omaya port. She has developed a ventriculitis (infection of the cerebrospinal fluid) associated with the Omaya port, which led to a cardiac arrest and subsequent removal of the port and evacuation of a subdural hematoma (SDH).

The patient is currently in the ICU, where she is receiving treatment for her infection, including antibiotics and antifungal medications. She has a central venous catheter and an arterial line in place.

The patient's physical examination is significant for a thin build, with a mild erythematous rash on her upper chest. Her vital signs are stable, with a temperature of 37.4C, heart rate of 99 beats per minute, and blood pressure of 117/81 mmHg. She is receiving mechanical ventilation with a tidal volume of 450 mL and a respiratory rate of 12 breaths per minute.

The patient's laboratory results are significant for an elevated white blood cell count, with a neutrophil count of 68.0%, and a mild anemia, with a hemoglobin level of 9.9 g/dL. Her liver function tests are elevated, with an aspartate aminotransferase (AST) level of 3393 IU/L and an alanine aminotransferase (ALT) level of 1757 IU/L.

The patient's medical history is significant for a history of leukemia, altered mental status, and fever of unknown origin. She is at risk for developing complications such as sepsis, respiratory failure, and cardiac arrhythmias.

Potential medical complications that can arise in this patient include:

1. Sepsis: The patient is at risk for developing sepsis due to her underlying infection and compromised immune system.
2. Respiratory failure: The patient is receiving mechanical ventilation, which increases her risk for developing respiratory failure.
3. Cardiac arrhythmias: The patient's history of cardiac arrest and her current cardiac status make her at risk for developing cardiac arrhythmias.
4. Neurological complications: The patient's history of SDH and her current neurological status make her at risk for developing neurological complications such as seizures or stroke.
5. Renal failure: The patient's history of cancer treatment and her current laboratory results make her at risk for developing renal failure.

The patient's care plan should focus on managing her infection, optimizing her respiratory and cardiac function, and monitoring her neurological and renal status closely."
112508.0,247400,2176-04-17 05:52:00,Physician ,Physician Resident Progress Note,"Chief Complaint: ALL; altered mental status
   24 Hour Events:
   - Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
   - sedation weaned because she was intermittently hypotensive,  but
   patient not any more responsive
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.  Currently off all sedation, with reactive pupils but not
   following commands.  CSF drawn off of Omaya with gram positive cocci,
   likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now likely VRE in
   CSF.  Omaya port, the likely source, has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, suspicion is high for endocarditis.
   - continue linezolid and gentamicin
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   .
   # ALL:  s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - continue filgastrim
   - follow ANC
   .
   # RESPIRATORY FAILURE:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.
   - no change in ventilator management right now given other acute issues
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:
   Thought to be immediately associated with increase in calcium channel
   blocker dose; this was in response to tachyarrythmia in setting of
   infection. Recent echo shows ongoing cardiac compromise, worsened EF
   compared to earlier in this admission. Difficult to tell at this point
   whether this is a feature of the acute setting of infection and s/p
   arrest, vs an earlier decline that predisposed her to arrest.
   -          follow up echo in [**3-4**] weeks
   -          avoid nodal agents
   -          replete lytes closely
   -          no longer requiring pressors
   ICU Care
   Nutrition:
   Comments: npo for now; put in for tube feeding recs
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: ALL; altered mental status
   24 Hour Events:
   - Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
   - sedation weaned because she was intermittently hypotensive,  but
   patient not any more responsive
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.  Currently off all sedation, with reactive pupils but not
   following commands.  CSF drawn off of Omaya with gram positive cocci,
   likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now likely VRE in
   CSF.  Omaya port, the likely source, has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, suspicion is high for endocarditis.
   - continue linezolid and gentamicin
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   .
   # ALL:  s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - continue filgastrim
   - follow ANC
   .
   # RESPIRATORY FAILURE:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.
   - no change in ventilator management right now given other acute issues
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:
   Thought to be immediately associated with increase in calcium channel
   blocker dose; this was in response to tachyarrythmia in setting of
   infection. Recent echo shows ongoing cardiac compromise, worsened EF
   compared to earlier in this admission. Difficult to tell at this point
   whether this is a feature of the acute setting of infection and s/p
   arrest, vs an earlier decline that predisposed her to arrest.
   -          follow up echo in [**3-4**] weeks
   -          avoid nodal agents
   -          replete lytes closely
   -          no longer requiring pressors
   ICU Care
   Nutrition:
   Comments: npo for now; put in for tube feeding recs
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided daily progress note, I summarize the patient's condition as follows:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) and a recent recurrence of the disease, including central nervous system (CNS) involvement. She was admitted to the ICU after a cardiac arrest and underwent removal of an Omaya port used for intrathecal chemotherapy, as well as evacuation of a subdural hematoma (SDH). She is currently intubated and receiving mechanical ventilation due to respiratory failure.

The patient's altered mental status is likely multifactorial, including recent SDH, prolonged asystolic arrest, CNS infection, and possible recurrent CNS lymphoma. Her CSF showed gram-positive cocci, likely vancomycin-resistant enterococci (VRE), which seeded from her blood.

The patient is receiving antibiotics for suspected VRE infection, including linezolid and gentamicin. Her cardiac function is compromised, with a recent echo showing worsened left ventricular ejection fraction (EF) compared to earlier in her admission.

Potential medical complications that can arise include:

1. Worsening of her CNS infection, leading to further neurological decline or sepsis.
2. Development of endocarditis, given the suspicion of VRE infection.
3. Respiratory failure, which may require further interventions, such as tracheostomy or non-invasive ventilation.
4. Cardiac compromise, which may require further management, such as adjustment of medications or invasive monitoring.
5. Hematological complications, such as bleeding or infection, due to her underlying leukemia and treatment with chemotherapy and antibiotics.
6. Nutritional deficiencies, given her current NPO status and need for tube feeding.
7. Worsening of her liver enzymes, which may indicate ongoing liver injury or toxicity.

Further management and monitoring are necessary to address these potential complications and optimize the patient's care."
112508.0,247400,2176-04-17 05:52:00,Physician ,Physician Resident Progress Note,"Chief Complaint: ALL; altered mental status
   24 Hour Events:
   Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: (S1: Normal), (S2: Normal), Rub
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm
   Neurologic: No(t) Attentive, No(t) Follows simple commands, Responds
   to: Noxious stimuli, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   ICU Care
   Nutrition:
   Comments: npo for now; put in for tube feeding recs
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: ALL; altered mental status
   24 Hour Events:
   Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: (S1: Normal), (S2: Normal), Rub
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm
   Neurologic: No(t) Attentive, No(t) Follows simple commands, Responds
   to: Noxious stimuli, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   ICU Care
   Nutrition:
   Comments: npo for now; put in for tube feeding recs
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a critically ill individual with altered mental status, transferred from a neurosurgical unit to the ICU. They have a history of leukemia and are currently undergoing treatment. The patient is sedated and unable to provide a medical history. They have multiple allergies, including sulfa, penicillins, latex, and red dye. The patient has been receiving various antibiotics and medications, including propofol, fentanyl, and lasix.

The patient's vital signs are stable, with a temperature of 37.4C, heart rate of 102 bpm, and blood pressure of 114/80 mmHg. They are receiving respiratory support with an endotracheal tube and mechanical ventilation. The patient's laboratory results show elevated white blood cell count, hemoglobin, and lactate levels, as well as abnormal liver function tests.

Potential medical complications:

1. Sepsis: The patient's fever, elevated white blood cell count, and abnormal laboratory results suggest the possibility of sepsis.
2. Respiratory failure: The patient's need for mechanical ventilation and elevated respiratory rate indicate respiratory failure.
3. Neurological complications: The patient's altered mental status and sedation may be indicative of neurological complications, such as cerebral edema or brain herniation.
4. Infection: The patient's fever and abnormal laboratory results suggest the possibility of infection, which could be related to the patient's underlying medical condition or a complication of their treatment.
5. Bleeding: The patient's elevated platelet count and abnormal liver function tests may indicate bleeding complications.
6. Electrolyte imbalance: The patient's abnormal electrolyte levels, such as hypocalcemia and hypomagnesemia, may indicate an electrolyte imbalance.
7. Renal failure: The patient's elevated creatinine and blood urea nitrogen levels suggest the possibility of renal failure.
8. Hepatic failure: The patient's abnormal liver function tests may indicate hepatic failure.
9. Cardiovascular complications: The patient's abnormal heart rhythm and elevated blood pressure may indicate cardiovascular complications, such as cardiac arrhythmia or hypertension.

These potential medical complications require close monitoring and management to prevent or treat them effectively."
112508.0,247400,2176-04-17 05:52:00,Physician ,Physician Resident Progress Note,"Chief Complaint: ALL; altered mental status
   24 Hour Events:
   - Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
   - sedation weaned because she was intermittently hypotensive,  but
   patient not any more responsive
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.  Currently off all sedation, with reactive pupils but not
   following commands.  CSF drawn off of Omaya with gram positive cocci,
   likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now likely VRE in
   CSF.  Omaya port, the likely source, has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, suspicion is high for endocarditis.
   - continue linezolid and gentamicin
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   .
   # ALL:  s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - continue filgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: npo for now, will place NGT and put in for tube feeding recs,
   plan to restart bowel regimen when feeding tube in place
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: ALL; altered mental status
   24 Hour Events:
   - Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
   - sedation weaned because she was intermittently hypotensive,  but
   patient not any more responsive
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.  Currently off all sedation, with reactive pupils but not
   following commands.  CSF drawn off of Omaya with gram positive cocci,
   likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now likely VRE in
   CSF.  Omaya port, the likely source, has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, suspicion is high for endocarditis.
   - continue linezolid and gentamicin
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   .
   # ALL:  s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - continue filgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: npo for now, will place NGT and put in for tube feeding recs,
   plan to restart bowel regimen when feeding tube in place
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) who has recently had a recurrence of the disease, including central nervous system (CNS) involvement. She was admitted to the ICU after a cardiac arrest and underwent removal of an Omaya port and evacuation of a subdural hematoma (SDH). She is currently intubated and receiving mechanical ventilation for respiratory alkalosis. Her mental status is altered, likely due to a combination of factors including recent SDH, prolonged asystolic arrest, CNS infection, and possible recurrent CNS lymphoma.

Potential Medical Complications:

1. VRE (Vancomycin-resistant Enterococcus) infection: The patient has likely VRE in her CSF, which seeded from her blood and may have originated from her Omaya port. This requires continued treatment with linezolid and gentamicin.
2. Endocarditis: Given the new finding of VRE in her CSF, suspicion is high for endocarditis. A transesophageal echocardiogram (TEE) will be performed when stable to rule out vegetation.
3. Seizure risk: The patient's alkalemia may increase the risk of seizure. Small boluses of sedation will be given to attempt to control hyperventilation.
4. Recurrent CNS lymphoma: The patient will need further treatment for CNS lymphoma in the future, as recommended by the BMT team.
5. Respiratory alkalosis: The patient's respiratory alkalosis may be caused by an intracranial process, such as ongoing infection or recent surgery. Prolonged mechanical ventilation may be necessary.
6. Shock liver: The patient's liver enzymes are elevated, consistent with shock liver. This will be closely monitored.
7. Cardiac compromise: The patient's cardiac function is compromised, with a significant decline in ejection fraction (EF) over the past two weeks. This will be monitored with repeat echocardiograms.

ICU Care Plan:

1. Nutrition: NPO for now, with plans to place a nasogastric tube and restart bowel regimen when feeding tube is in place.
2. Glycemic control: Insulin sliding scale.
3. Lines: Multi-lumen, 20-gauge, and arterial lines will be maintained.
4. Prophylaxis: Pneumoboots for DVT, PPI for stress ulcer, and VAP prophylaxis.
5. Code status: Full code, discussed with BMT and HCP."
112508.0,247400,2176-04-17 05:52:00,Physician ,Physician Resident Progress Note,"Chief Complaint: ALL; altered mental status
   24 Hour Events:
   - Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
   - sedation weaned because she was intermittently hypotensive,  but
   patient not any more responsive
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.  Currently off all sedation, with reactive pupils but not
   following commands.  CSF drawn off of Omaya with gram positive cocci,
   likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now likely VRE in
   CSF.  Omaya port, the likely source, has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, suspicion is high for endocarditis.
   - continue linezolid and gentamicin
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   .
   # ALL:  s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - continue filgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: npo for now, will place NGT and put in for tube feeding recs,
   plan to restart bowel regimen when feeding tube in place
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: ALL; altered mental status
   24 Hour Events:
   - Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
   - sedation weaned because she was intermittently hypotensive,  but
   patient not any more responsive
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.  Currently off all sedation, with reactive pupils but not
   following commands.  CSF drawn off of Omaya with gram positive cocci,
   likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now likely VRE in
   CSF.  Omaya port, the likely source, has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, suspicion is high for endocarditis.
   - continue linezolid and gentamicin
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   .
   # ALL:  s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - continue filgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: npo for now, will place NGT and put in for tube feeding recs,
   plan to restart bowel regimen when feeding tube in place
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) and recurrent CNS involvement. She was admitted to the ICU after a cardiac arrest, removal of an Omaya port, and evacuation of a subdural hematoma (SDH). She is currently intubated and sedated, with altered mental status and a diagnosis of likely multifactorial etiology including recent SDH, prolonged asystolic arrest, CNS infection, and possible recurrent CNS lymphoma.

Potential Medical Complications:

1. Recurrent CNS lymphoma: The patient's history of ALL and recurrent CNS involvement increases the risk of recurrent CNS lymphoma, which may require further treatment.
2. Ventilator-associated pneumonia (VAP): The patient is intubated and at risk of developing VAP, which can be life-threatening.
3. Respiratory alkalosis: The patient's primary metabolic alkalosis and over-breathing of the ventilator may increase the risk of seizure and require careful management.
4. Endocarditis: The patient's history of VRE in her blood and recent finding of likely VRE in her CSF increases the risk of endocarditis, which may require further evaluation and treatment.
5. Liver dysfunction: The patient's elevated liver enzymes may indicate shock liver, which requires close monitoring and management.
6. Cardiac complications: The patient's recent cardiac arrest and compromised cardiac function may increase the risk of further cardiac complications, such as arrhythmias or cardiogenic shock.
7. Seizure risk: The patient's altered mental status and risk of recurrent CNS lymphoma may increase the risk of seizure, which requires careful monitoring and management.
8. Infection: The patient's history of ALL and recurrent CNS involvement increases the risk of infection, which may require further evaluation and treatment.

Plan:

1. Continue linezolid and gentamicin for VRE infection.
2. Follow neuro exam and consider re-imaging if exam changes.
3. Follow BMT recommendations for further treatment of CNS lymphoma.
4. Manage respiratory alkalosis with small boluses of sedation.
5. Monitor liver enzymes and manage liver dysfunction.
6. Avoid nodal agents and replete lytes aggressively.
7. Repeat echo in 3-4 weeks to monitor cardiac function.
8. Continue to monitor for signs of infection and adjust treatment as necessary."
112508.0,247400,2176-04-17 05:52:00,Physician ,Physician Resident Progress Note,"Chief Complaint: ALL; altered mental status
   24 Hour Events:
   Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: (S1: Normal), (S2: Normal), Rub
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm
   Neurologic: No(t) Attentive, No(t) Follows simple commands, Responds
   to: Noxious stimuli, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS
   CNS involvement by ALL as well as by enterococcus in association with
   the Omaya port, and SDH of chronic appearance seen on head CT s/p
   cardiac arrest, now s/p neurosurgical procedure as above. In
   retrospect, the subdural hematoma and gram-positive (likely
   enterococcal) infection may have been responsible for a considerable
   portion of what was described on her prior arrival to the [**Hospital Unit Name 10**] as
poor
   functional status
a vague worsening of cognition and function
   consistent with a diffuse cerebral process. Neurological exam currently
   showing promptly reactive pupils and some retreat of feet to noxious
   stimuli, but otherwise non-responsive in setting of sedation on vent.
   Assessment of neuro status confounded somewhat by her cardiac arrest,
   which may have created some anoxic brain injury.
   -          follow up neurosurgical recommendations
   -          continue to follow neurological exam
   -          titrate down sedation as tolerated, continue to evaluate
   mental status closely in this setting
   -          follow up CNS cultures, culture from Omaya device
   -          continue antibiotics as detailed below; current increase in
   neutrophils may allow sooner d/c of these
   -          Discuss w BMT service whether there are criteria that would
   allow return to treatment of CNS disease; may simply require ongoing
   assessment of relative risks and benefits in context
   # GRAM-POSITIVE INFECTION, c/w VRE
   Per ID recommendations, linezolid superior to daptomycin for coverage
   of CNS infection. Has the unfortunate advantage of suppressing bone
   marrow in immune-compromised patient. Immediate treatment of infection
   is current priority. Should continue to weigh risks and benefits of
   anti-VRE abx choice.
   -          continue linezolid with gentamicin
   # ALL
   Lengthy history with ALL, now recurring. S/p donor lymphocyte infusion.
   Giving G-CSF. Will need treatment for CNS disease at some point.
   -          follow up BMT recommendations
   -          has extensive medications for symptomatic treatment of
   mucositis and esophagitis; continue for now but continue to evaluate
   oral health, consider d/c
ing in setting of ventilation
   -          continue filgrastim
   -          follow ANC, appears to be normalizing by CBC/diff
   # S/P ASYSTOLIC ARREST
   Thought to be immediately associated with increase in calcium channel
   blocker dose; this was in response to tachyarrythmia in setting of
   infection. Recent echo shows ongoing cardiac compromise, worsened EF
   compared to earlier in this admission. Difficult to tell at this point
   whether this is a feature of the acute setting of infection and s/p
   arrest, vs an earlier decline that predisposed her to arrest.
   -          follow up echo in [**3-4**] weeks
   -          avoid nodal agents
   -          replete lytes closely
   -          no longer requiring pressors
   RESPIRATORY FAILURE
   Originally intubated in setting of cardiac arrest; kept on vent since
   then. ABGs have suggested metabolic alkalosis. LENIs negative for DVT;
   PE-CT unable to perform because of reported CT contrast allergy.
   Currently on AC settings. Getting ABG to evaluate current status.
   - wean FiO2 and PEEP as tolerated
   .
   FEVERS
   Afebrile post-op. On vanc, linezolid, meropenem, gentamicin,
   micafungin, and acyclovir. This should ensure the death of most of the
   microbial universe. As above, changed to linezolid to cover CNS VRE.
   Following up cultures, etc.
   -          heartening to see increase in WBC, neuts, bands.
   -          Continue filgrastim
   -          Continue abx as above
   ELEVATED LIVER ENZYMES
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   In summary, this is a 60 year old woman with ALL and a difficult
   hospital course s/p DLI, with apparently resolving neutropenia but now
   s/p craniotomy, cardiac arrest, respiratory failure, and shock liver.
   Currently stable on the vent; hope for improvement with improvement in
   WBC, antibiotics, removal of CNS source of infection. Following cardiac
   and liver function to evaluate for recovery s/p arrest.
   ICU Care
   Nutrition:
   Comments: npo for now; put in for tube feeding recs
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: ALL; altered mental status
   24 Hour Events:
   Transferred to [**Hospital Unit Name 10**] from [**Hospital Ward Name **], s/p neurosurgical intervention
   overnight [**2086-4-14**]
 INDWELLING PORT (PORTACATH) - STOP [**2176-4-16**] 07:05 PM
   OMAYA port (IT) (removed in surgery)
 BLOOD CULTURED - At [**2176-4-17**] 04:18 AM (surveillance cultures
   ordered)
   Patient unable to provide history: Sedated
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Ciprofloxacin - [**2176-4-14**] 10:46 PM
   Daptomycin - [**2176-4-14**] 11:39 PM
   Vancomycin - [**2176-4-16**] 12:00 AM
   Micafungin - [**2176-4-16**] 10:15 PM
   Acyclovir - [**2176-4-16**] 10:57 PM
   Meropenem - [**2176-4-17**] 01:03 AM
   Linezolid - [**2176-4-17**] 01:50 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-16**] 07:37 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Ear, Nose, Throat: OG / NG tube
   Nutritional Support: NPO
   Genitourinary: Foley
   Flowsheet Data as of  [**2176-4-17**] 05:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 36.7
C (98.1
   HR: 102 (97 - 108) bpm
   BP: 114/80(93) {98/66(79) - 117/84(98)} mmHg
   RR: 26 (16 - 33) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                  6,475 mL
                                                                    922 mL
   PO:
             TF:
   IVF:
                                                                  4,763 mL
                                                                    922 mL
   Blood products:
                                                                  1,712 mL
   Total out:
                                                                  2,545 mL
                                                                    313 mL
   Urine:
                                                                  1,395 mL
                                                                    313 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,930 mL
                                                                    609 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 470 (470 - 470) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%-->40% this morning
   RSBI: 138
   PIP: 19 cmH2O
   Plateau: 17 cmH2O
   Compliance: 37.5 cmH2O/mL
   SpO2: 100%
   ABG: 7.50/25/187/17/-1 (on 50% FiO2)
   Ve: 9.4 L/min
   PaO2 / FiO2: 374
   Physical Examination
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: (S1: Normal), (S2: Normal), Rub
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric)
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm
   Neurologic: No(t) Attentive, No(t) Follows simple commands, Responds
   to: Noxious stimuli, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   116 K/uL
   10.4 g/dL
   162 mg/dL
   1.1 mg/dL
   17 mEq/L
   3.5 mEq/L
   35 mg/dL
   113 mEq/L
   143 mEq/L
   29.1 %
   11.3 K/uL
        [image002.jpg]
                             [**2176-4-15**]  10:15 PM
                             [**2176-4-15**]  10:49 PM
                             [**2176-4-16**]  01:27 AM
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
   WBC
   3.1
   4.2
   4.2
   11.3
   Hct
   19
   25.9
   30.0
   27.2
   29.1
   Plt
   128
   120
   116
   Cr
   1.0
   1.1
   TCO2
   20
   21
   19
   20
   21
   20
   Glucose
   84
   109
   162
   Other labs: PT / PTT / INR:16.7/42.9/1.5, ALT / AST:1757/3393, Alk Phos
   / T Bili:275/3.0, Amylase / Lipase:76/50, Differential-Neuts:68.0 %,
   Band:7.0 %, Lymph:10.0 %, Mono:2.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:2.1 mmol/L, Albumin:2.3 g/dL, LDH:5880 IU/L, Ca++:7.7
   mg/dL, Mg++:1.6 mg/dL, PO4:2.0 mg/dL
   Lactate:  8.5
   CMV/HSV/EBV/Toxo pending
CSF [**4-16**] pre-op:  2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
            2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI in pairs.
CSF cx [**4-15**]:  NGTD
Omaya [**4-16**]:  No PMN, no micro-organisms
SDH [**4-16**]:  1+ PMN
   Assessment and Plan
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS
   CNS involvement by ALL as well as by enterococcus in association with
   the Omaya port, and SDH of chronic appearance seen on head CT s/p
   cardiac arrest, now s/p neurosurgical procedure as above. In
   retrospect, the subdural hematoma and gram-positive (likely
   enterococcal) infection may have been responsible for a considerable
   portion of what was described on her prior arrival to the [**Hospital Unit Name 10**] as
poor
   functional status
a vague worsening of cognition and function
   consistent with a diffuse cerebral process. Neurological exam currently
   showing promptly reactive pupils and some retreat of feet to noxious
   stimuli, but otherwise non-responsive in setting of sedation on vent.
   Assessment of neuro status confounded somewhat by her cardiac arrest,
   which may have created some anoxic brain injury.
   -          follow up neurosurgical recommendations
   -          continue to follow neurological exam
   -          titrate down sedation as tolerated, continue to evaluate
   mental status closely in this setting
   -          follow up CNS cultures, culture from Omaya device
   -          continue antibiotics as detailed below; current increase in
   neutrophils may allow sooner d/c of these
   -          Discuss w BMT service whether there are criteria that would
   allow return to treatment of CNS disease; may simply require ongoing
   assessment of relative risks and benefits in context
   # GRAM-POSITIVE INFECTION, c/w VRE
   Per ID recommendations, linezolid superior to daptomycin for coverage
   of CNS infection. Has the unfortunate advantage of suppressing bone
   marrow in immune-compromised patient. Immediate treatment of infection
   is current priority. Should continue to weigh risks and benefits of
   anti-VRE abx choice.
   -          continue linezolid with gentamicin
   # ALL
   Lengthy history with ALL, now recurring. S/p donor lymphocyte infusion.
   Giving G-CSF. Will need treatment for CNS disease at some point.
   -          follow up BMT recommendations
   -          has extensive medications for symptomatic treatment of
   mucositis and esophagitis; continue for now but continue to evaluate
   oral health, consider d/c
ing in setting of ventilation
   -          continue filgrastim
   -          follow ANC, appears to be normalizing by CBC/diff
   # S/P ASYSTOLIC ARREST
   Thought to be immediately associated with increase in calcium channel
   blocker dose; this was in response to tachyarrythmia in setting of
   infection. Recent echo shows ongoing cardiac compromise, worsened EF
   compared to earlier in this admission. Difficult to tell at this point
   whether this is a feature of the acute setting of infection and s/p
   arrest, vs an earlier decline that predisposed her to arrest.
   -          follow up echo in [**3-4**] weeks
   -          avoid nodal agents
   -          replete lytes closely
   -          no longer requiring pressors
   RESPIRATORY FAILURE
   Originally intubated in setting of cardiac arrest; kept on vent since
   then. ABGs have suggested metabolic alkalosis. LENIs negative for DVT;
   PE-CT unable to perform because of reported CT contrast allergy.
   Currently on AC settings. Getting ABG to evaluate current status.
   - wean FiO2 and PEEP as tolerated
   .
   FEVERS
   Afebrile post-op. On vanc, linezolid, meropenem, gentamicin,
   micafungin, and acyclovir. This should ensure the death of most of the
   microbial universe. As above, changed to linezolid to cover CNS VRE.
   Following up cultures, etc.
   -          heartening to see increase in WBC, neuts, bands.
   -          Continue filgrastim
   -          Continue abx as above
   ELEVATED LIVER ENZYMES
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   In summary, this is a 60 year old woman with ALL and a difficult
   hospital course s/p DLI, with apparently resolving neutropenia but now
   s/p craniotomy, cardiac arrest, respiratory failure, and shock liver.
   Currently stable on the vent; hope for improvement with improvement in
   WBC, antibiotics, removal of CNS source of infection. Following cardiac
   and liver function to evaluate for recovery s/p arrest.
   ICU Care
   Nutrition:
   Comments: npo for now; put in for tube feeding recs
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 60-year-old woman with a lengthy history of acute lymphoblastic leukemia (ALL) and past successful treatment, now with recurrence including central nervous system (CNS) involvement and likely enterococcal infection of an Omaya port used for intrathecal chemotherapy.

The patient has been experiencing altered mental status, which is attributed to CNS involvement by ALL as well as by enterococcus in association with the Omaya port and subdural hematoma (SDH) of chronic appearance seen on head CT. The patient has also had a cardiac arrest, which may have created some anoxic brain injury.

The patient's condition is complicated by a gram-positive infection, likely caused by enterococcus, which is being treated with linezolid and gentamicin. The patient has also been experiencing respiratory failure, which is being managed with mechanical ventilation.

The patient's liver enzymes are elevated, consistent with shock liver, and are being closely monitored.

The patient has a complex medical history, including a history of ALL, past successful treatment, and recurrence. She has also had a cardiac arrest, which may have created some anoxic brain injury. The patient's condition is critical, and she requires close monitoring and management of her various medical issues.

Potential medical complications that can arise from the patient's condition include:

1. Central nervous system (CNS) infection: The patient's altered mental status and SDH suggest a possible CNS infection, which can lead to further complications such as meningitis, encephalitis, or brain abscess.
2. Cardiac complications: The patient's cardiac arrest and ongoing cardiac compromise may lead to further cardiac complications such as arrhythmias, heart failure, or cardiogenic shock.
3. Respiratory failure: The patient's respiratory failure may worsen, leading to further complications such as pneumonia, respiratory distress syndrome, or respiratory failure.
4. Infection: The patient's gram-positive infection may spread to other parts of the body, leading to sepsis, septic shock, or multiple organ dysfunction syndrome.
5. Liver dysfunction: The patient's elevated liver enzymes may worsen, leading to further liver dysfunction, liver failure, or bleeding complications.
6. Neurological complications: The patient's anoxic brain injury may lead to further neurological complications such as seizures, stroke, or brain death.

To mitigate these potential complications, the patient requires close monitoring and management of her various medical issues, including antibiotics, mechanical ventilation, and cardiac support."
112508.0,247400,2176-04-18 06:47:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2176-4-18**] 01:36 AM
   - Neurosurgery recs Q4H neuro recs, avoid subQ heparin until [**4-18**],
   staples out in 2 weeks
   - ID recs decrease gentamicin from Q8H to Q12H, check peak/trough after
   4th dose
   - VRE in CSF
   - code status clarified with BMT and HCP:   full code
   - discussed current status with family including son/HCP
   - stopped Neupogen as counts are recovering
   - OGT placed, TF started
   - off sedation all day but not waking up (switched from fent/midaz
   drips to boluses)
   - NPO for ?TEE in AM, consented by TEE fellow
   - overnight BP trending down into the 80s, lactate rising
giving NS
   bolus in the morning
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Vancomycin - [**2176-4-16**] 12:00 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Micafungin - [**2176-4-17**] 07:53 PM
   Acyclovir - [**2176-4-17**] 09:31 PM
   Meropenem - [**2176-4-18**] 12:24 AM
   Linezolid - [**2176-4-18**] 02:13 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-18**] 06:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.7
   Tcurrent: 36.6
C (97.9
   HR: 96 (91 - 116) bpm
   BP: 86/60(70) {86/60(70) - 120/83(97)} mmHg
   RR: 21 (20 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  2,764 mL
                                                                  1,425 mL
   PO:
             TF:
                                                                     58 mL
   IVF:
                                                                  2,706 mL
                                                                  1,425 mL
   Blood products:
   Total out:
                                                                  1,418 mL
                                                                    563 mL
   Urine:
                                                                  1,368 mL
                                                                    388 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,346 mL
                                                                    862 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 346 (346 - 346) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 65
   PIP: 17 cmH2O
   Plateau: 15 cmH2O
   Compliance: 45 cmH2O/mL
   SpO2: 95%
   ABG: 7.49/25/104/17/-1
   Ve: 10.2 L/min
   PaO2 / FiO2: 260
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   97 K/uL
   11.3 g/dL
   102 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.7 mEq/L
   34 mg/dL
   114 mEq/L
   145 mEq/L
   33.0 %
   27.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
   WBC
   4.2
   7.9
   27.3
   Hct
   27.2
   29.1
   33.0
   Plt
   116
   97
   Cr
   1.1
   1.0
   TCO2
   21
   19
   20
   21
   20
   20
   20
   Glucose
   162
   102
   Other labs: PT / PTT / INR:16.2/38.8/1.4, ALT / AST:1205/385, Alk Phos
   / T Bili:355/2.5, Amylase / Lipase:76/50, Differential-Neuts:71.0 %,
   Band:1.0 %, Lymph:3.0 %, Mono:3.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:3.3 mmol/L, Albumin:2.3 g/dL, LDH:1843 IU/L, Ca++:7.8
   mg/dL, Mg++:2.0 mg/dL, PO4:2.2 mg/dL
   Blood cultures:  NGTD since [**4-11**] VRE
   CSF [**4-16**]:  enterococcus
   CXR [**4-17**]:
   Nasogastric tube ends in the mid stomach, ET tube in standard
   placement.
   Opacification at the lung bases is probably a combination of
   atelectasis and
   small bilateral pleural effusion. Pulmonary edema has cleared from the
   upper
   lungs. Heart size normal although the configuration suggests left
   atrial
   enlargement. ET tube in standard placement. No pneumothorax.
   Assessment and Plan
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Improved today in that Likely multifactorial
   including recent SDH, prolonged asystolic arrest, CNS infection,
   possible recurrent CNS lymphoma.  Currently off all sedation, with
   reactive pupils but not following commands.  CSF drawn off of Omaya
   with gram positive cocci, likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port, the likely source, has
   now been removed.    Daptomycin was switched to linezolid for better
   CSF penetration, although linezolid will cause BM suppression.
   Gentamicin for synergy.  TTE was negative for vegetation [**4-15**], but
   given new finding of likely VRE in CSF, suspicion is high for
   endocarditis.
   - continue linezolid and gentamicin
   - gentamicin dose changed per BMT recs:  will check level after 3^rd
   dose
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   - may d/c meropenem now that low suspicion for any GNR process
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   She is s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off ilgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: NPO for TEE today, restart TF after
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2176-4-18**] 01:36 AM
   - Neurosurgery recs Q4H neuro recs, avoid subQ heparin until [**4-18**],
   staples out in 2 weeks
   - ID recs decrease gentamicin from Q8H to Q12H, check peak/trough after
   4th dose
   - VRE in CSF
   - code status clarified with BMT and HCP:   full code
   - discussed current status with family including son/HCP
   - stopped Neupogen as counts are recovering
   - OGT placed, TF started
   - off sedation all day but not waking up (switched from fent/midaz
   drips to boluses)
   - NPO for ?TEE in AM, consented by TEE fellow
   - overnight BP trending down into the 80s, lactate rising
giving NS
   bolus in the morning
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Vancomycin - [**2176-4-16**] 12:00 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Micafungin - [**2176-4-17**] 07:53 PM
   Acyclovir - [**2176-4-17**] 09:31 PM
   Meropenem - [**2176-4-18**] 12:24 AM
   Linezolid - [**2176-4-18**] 02:13 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-18**] 06:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.7
   Tcurrent: 36.6
C (97.9
   HR: 96 (91 - 116) bpm
   BP: 86/60(70) {86/60(70) - 120/83(97)} mmHg
   RR: 21 (20 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  2,764 mL
                                                                  1,425 mL
   PO:
             TF:
                                                                     58 mL
   IVF:
                                                                  2,706 mL
                                                                  1,425 mL
   Blood products:
   Total out:
                                                                  1,418 mL
                                                                    563 mL
   Urine:
                                                                  1,368 mL
                                                                    388 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,346 mL
                                                                    862 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 346 (346 - 346) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 65
   PIP: 17 cmH2O
   Plateau: 15 cmH2O
   Compliance: 45 cmH2O/mL
   SpO2: 95%
   ABG: 7.49/25/104/17/-1
   Ve: 10.2 L/min
   PaO2 / FiO2: 260
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   97 K/uL
   11.3 g/dL
   102 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.7 mEq/L
   34 mg/dL
   114 mEq/L
   145 mEq/L
   33.0 %
   27.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
   WBC
   4.2
   7.9
   27.3
   Hct
   27.2
   29.1
   33.0
   Plt
   116
   97
   Cr
   1.1
   1.0
   TCO2
   21
   19
   20
   21
   20
   20
   20
   Glucose
   162
   102
   Other labs: PT / PTT / INR:16.2/38.8/1.4, ALT / AST:1205/385, Alk Phos
   / T Bili:355/2.5, Amylase / Lipase:76/50, Differential-Neuts:71.0 %,
   Band:1.0 %, Lymph:3.0 %, Mono:3.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:3.3 mmol/L, Albumin:2.3 g/dL, LDH:1843 IU/L, Ca++:7.8
   mg/dL, Mg++:2.0 mg/dL, PO4:2.2 mg/dL
   Blood cultures:  NGTD since [**4-11**] VRE
   CSF [**4-16**]:  enterococcus
   CXR [**4-17**]:
   Nasogastric tube ends in the mid stomach, ET tube in standard
   placement.
   Opacification at the lung bases is probably a combination of
   atelectasis and
   small bilateral pleural effusion. Pulmonary edema has cleared from the
   upper
   lungs. Heart size normal although the configuration suggests left
   atrial
   enlargement. ET tube in standard placement. No pneumothorax.
   Assessment and Plan
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Improved today in that Likely multifactorial
   including recent SDH, prolonged asystolic arrest, CNS infection,
   possible recurrent CNS lymphoma.  Currently off all sedation, with
   reactive pupils but not following commands.  CSF drawn off of Omaya
   with gram positive cocci, likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port, the likely source, has
   now been removed.    Daptomycin was switched to linezolid for better
   CSF penetration, although linezolid will cause BM suppression.
   Gentamicin for synergy.  TTE was negative for vegetation [**4-15**], but
   given new finding of likely VRE in CSF, suspicion is high for
   endocarditis.
   - continue linezolid and gentamicin
   - gentamicin dose changed per BMT recs:  will check level after 3^rd
   dose
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   - may d/c meropenem now that low suspicion for any GNR process
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   She is s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off ilgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: NPO for TEE today, restart TF after
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 60-year-old woman with a lengthy history of Acute Lymphoblastic Leukemia (ALL) and past successful treatment, now with recurrence including Central Nervous System (CNS) involvement. She had a cardiac arrest, removal of Omaya port, and evacuation of Subdural Hematoma (SDH). Currently, she is in the Intensive Care Unit (ICU) for further care and follow-up.

The patient's current condition is as follows:

* Respiratory status: Intubated and ventilated, with primary metabolic alkalosis and over-breathing the ventilator.
* Neurological status: Altered mental status, not following commands, and not arousing to voice, but responding to noxious stimuli.
* Cardiovascular status: No longer requiring pressors, with a significant interval worsening of ejection fraction (EF) from 40% to 20% over the past two weeks.
* Renal status: No acute kidney injury (AKI) mentioned.
* Hepatic status: Elevated liver enzymes consistent with shock liver, now downtrending.
* Hematological status: WBC count improving, although many immature/atypical forms.
* Infectious status: VRE in CSF, likely seeded from blood, and Enterococcus in CSF, with suspicion of endocarditis.

Potential medical complications that can arise from the patient's current condition include:

1. Respiratory failure: Due to primary metabolic alkalosis and over-breathing the ventilator, the patient is at risk of developing respiratory failure.
2. Sepsis: With VRE and Enterococcus in the CSF, the patient is at risk of developing sepsis, which can lead to organ dysfunction and failure.
3. Endocarditis: The suspicion of endocarditis due to VRE in the CSF and the patient's history of cardiac arrest and cardiotoxic chemotherapy increases the risk of endocarditis.
4. Liver failure: The patient's elevated liver enzymes consistent with shock liver may progress to liver failure if not closely monitored and managed.
5. CNS complications: The patient's altered mental status and history of CNS involvement increase the risk of CNS complications, such as seizures, brain edema, and herniation.
6. Cardiovascular complications: The patient's significant interval worsening of EF and history of cardiotoxic chemotherapy increase the risk of cardiovascular complications, such as cardiac arrhythmias, cardiogenic shock, and cardiac arrest.
7. Bleeding complications: The patient's history of cardiac arrest and cardiotoxic chemotherapy increases the risk of bleeding complications, such as gastrointestinal bleeding, intracranial bleeding, and hemoptysis.

To mitigate these potential complications, the patient should be closely monitored and managed with the following:

* Respiratory support: Continue mechanical ventilation and adjust settings as needed to maintain adequate oxygenation and ventilation.
* Infection control: Continue antibiotics and antifungals as prescribed, and consider adding other antimicrobial agents as necessary.
* Cardiovascular support: Continue to monitor the patient's cardiac status and adjust therapy as needed to maintain adequate cardiac output and perfusion.
* Hematological support: Continue to monitor the patient's WBC count and adjust therapy as needed to prevent further complications.
* Nutritional support: Provide adequate nutrition and caloric intake to support the patient's recovery.
* Glycemic control: Continue to monitor the patient's blood glucose levels and adjust insulin therapy as needed to maintain euglycemia.
* Prophylaxis: Continue to provide prophylaxis for DVT, stress ulcer, and VAP as prescribed."
112508.0,247400,2176-04-18 06:47:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2176-4-18**] 01:36 AM
   - Neurosurgery recs Q4H neuro recs, avoid subQ heparin until [**4-18**],
   staples out in 2 weeks
   - ID recs decrease gentamicin from Q8H to Q12H, check peak/trough after
   4th dose
   - VRE in CSF
   - code status clarified with BMT and HCP:   full code
   - discussed current status with family including son/HCP
   - stopped Neupogen as counts are recovering
   - OGT placed, TF started
   - off sedation all day but not waking up (switched from fent/midaz
   drips to boluses)
   - NPO for ?TEE in AM, consented by TEE fellow
   - SBT tomorrow
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Vancomycin - [**2176-4-16**] 12:00 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Micafungin - [**2176-4-17**] 07:53 PM
   Acyclovir - [**2176-4-17**] 09:31 PM
   Meropenem - [**2176-4-18**] 12:24 AM
   Linezolid - [**2176-4-18**] 02:13 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-18**] 06:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.7
   Tcurrent: 36.6
C (97.9
   HR: 96 (91 - 116) bpm
   BP: 86/60(70) {86/60(70) - 120/83(97)} mmHg
   RR: 21 (20 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  2,764 mL
                                                                  1,425 mL
   PO:
             TF:
                                                                     58 mL
   IVF:
                                                                  2,706 mL
                                                                  1,425 mL
   Blood products:
   Total out:
                                                                  1,418 mL
                                                                    563 mL
   Urine:
                                                                  1,368 mL
                                                                    388 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,346 mL
                                                                    862 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 346 (346 - 346) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 65
   PIP: 17 cmH2O
   Plateau: 15 cmH2O
   Compliance: 45 cmH2O/mL
   SpO2: 95%
   ABG: 7.49/25/104/17/-1
   Ve: 10.2 L/min
   PaO2 / FiO2: 260
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   97 K/uL
   11.3 g/dL
   102 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.7 mEq/L
   34 mg/dL
   114 mEq/L
   145 mEq/L
   33.0 %
   27.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
   WBC
   4.2
   7.9
   27.3
   Hct
   27.2
   29.1
   33.0
   Plt
   116
   97
   Cr
   1.1
   1.0
   TCO2
   21
   19
   20
   21
   20
   20
   20
   Glucose
   162
   102
   Other labs: PT / PTT / INR:16.2/38.8/1.4, ALT / AST:1205/385, Alk Phos
   / T Bili:355/2.5, Amylase / Lipase:76/50, Differential-Neuts:71.0 %,
   Band:1.0 %, Lymph:3.0 %, Mono:3.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:3.3 mmol/L, Albumin:2.3 g/dL, LDH:1843 IU/L, Ca++:7.8
   mg/dL, Mg++:2.0 mg/dL, PO4:2.2 mg/dL
   Blood cultures:  NGTD since [**4-11**] VRE
   CSF [**4-16**]:  enterococcus
   CXR [**4-17**]:
   Nasogastric tube ends in the mid stomach, ET tube in standard
   placement.
   Opacification at the lung bases is probably a combination of
   atelectasis and
   small bilateral pleural effusion. Pulmonary edema has cleared from the
   upper
   lungs. Heart size normal although the configuration suggests left
   atrial
   enlargement. ET tube in standard placement. No pneumothorax.
   Assessment and Plan
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Improved today in that Likely multifactorial
   including recent SDH, prolonged asystolic arrest, CNS infection,
   possible recurrent CNS lymphoma.  Currently off all sedation, with
   reactive pupils but not following commands.  CSF drawn off of Omaya
   with gram positive cocci, likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port, the likely source, has
   now been removed.    Daptomycin was switched to linezolid for better
   CSF penetration, although linezolid will cause BM suppression.
   Gentamicin for synergy.  TTE was negative for vegetation [**4-15**], but
   given new finding of likely VRE in CSF, suspicion is high for
   endocarditis.
   - continue linezolid and gentamicin
   - gentamicin dose changed per BMT recs:  will check level after 3^rd
   dose
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   - may d/c meropenem now that low suspicion for any GNR process
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   She is s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off ilgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: NPO for TEE today, restart TF after
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2176-4-18**] 01:36 AM
   - Neurosurgery recs Q4H neuro recs, avoid subQ heparin until [**4-18**],
   staples out in 2 weeks
   - ID recs decrease gentamicin from Q8H to Q12H, check peak/trough after
   4th dose
   - VRE in CSF
   - code status clarified with BMT and HCP:   full code
   - discussed current status with family including son/HCP
   - stopped Neupogen as counts are recovering
   - OGT placed, TF started
   - off sedation all day but not waking up (switched from fent/midaz
   drips to boluses)
   - NPO for ?TEE in AM, consented by TEE fellow
   - SBT tomorrow
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Vancomycin - [**2176-4-16**] 12:00 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Micafungin - [**2176-4-17**] 07:53 PM
   Acyclovir - [**2176-4-17**] 09:31 PM
   Meropenem - [**2176-4-18**] 12:24 AM
   Linezolid - [**2176-4-18**] 02:13 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-18**] 06:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.7
   Tcurrent: 36.6
C (97.9
   HR: 96 (91 - 116) bpm
   BP: 86/60(70) {86/60(70) - 120/83(97)} mmHg
   RR: 21 (20 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  2,764 mL
                                                                  1,425 mL
   PO:
             TF:
                                                                     58 mL
   IVF:
                                                                  2,706 mL
                                                                  1,425 mL
   Blood products:
   Total out:
                                                                  1,418 mL
                                                                    563 mL
   Urine:
                                                                  1,368 mL
                                                                    388 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,346 mL
                                                                    862 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 346 (346 - 346) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 65
   PIP: 17 cmH2O
   Plateau: 15 cmH2O
   Compliance: 45 cmH2O/mL
   SpO2: 95%
   ABG: 7.49/25/104/17/-1
   Ve: 10.2 L/min
   PaO2 / FiO2: 260
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place
   Extremities: no edema
   Skin:  Warm
   Neurologic:does not follow commands, does not arouse to voice but does
   respond to noxious stimuli
   Labs / Radiology
   97 K/uL
   11.3 g/dL
   102 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.7 mEq/L
   34 mg/dL
   114 mEq/L
   145 mEq/L
   33.0 %
   27.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
   WBC
   4.2
   7.9
   27.3
   Hct
   27.2
   29.1
   33.0
   Plt
   116
   97
   Cr
   1.1
   1.0
   TCO2
   21
   19
   20
   21
   20
   20
   20
   Glucose
   162
   102
   Other labs: PT / PTT / INR:16.2/38.8/1.4, ALT / AST:1205/385, Alk Phos
   / T Bili:355/2.5, Amylase / Lipase:76/50, Differential-Neuts:71.0 %,
   Band:1.0 %, Lymph:3.0 %, Mono:3.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:3.3 mmol/L, Albumin:2.3 g/dL, LDH:1843 IU/L, Ca++:7.8
   mg/dL, Mg++:2.0 mg/dL, PO4:2.2 mg/dL
   Blood cultures:  NGTD since [**4-11**] VRE
   CSF [**4-16**]:  enterococcus
   CXR [**4-17**]:
   Nasogastric tube ends in the mid stomach, ET tube in standard
   placement.
   Opacification at the lung bases is probably a combination of
   atelectasis and
   small bilateral pleural effusion. Pulmonary edema has cleared from the
   upper
   lungs. Heart size normal although the configuration suggests left
   atrial
   enlargement. ET tube in standard placement. No pneumothorax.
   Assessment and Plan
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # ALTERED MENTAL STATUS:  Improved today in that Likely multifactorial
   including recent SDH, prolonged asystolic arrest, CNS infection,
   possible recurrent CNS lymphoma.  Currently off all sedation, with
   reactive pupils but not following commands.  CSF drawn off of Omaya
   with gram positive cocci, likely VRE that seeded from her blood.
   - follow neuro exam
   - would re-image head if exam changes
   - f/u neurosurgery recommnendation regarding management of SDH
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as below
   .
   # VRE:  Previously in blood, none since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port, the likely source, has
   now been removed.    Daptomycin was switched to linezolid for better
   CSF penetration, although linezolid will cause BM suppression.
   Gentamicin for synergy.  TTE was negative for vegetation [**4-15**], but
   given new finding of likely VRE in CSF, suspicion is high for
   endocarditis.
   - continue linezolid and gentamicin
   - gentamicin dose changed per BMT recs:  will check level after 3^rd
   dose
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - check gent levels and dose accordingly
   - may d/c meropenem now that low suspicion for any GNR process
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   She is s/p intrathecal MTX and DLI this admission.  Per BMT, will need
   further treatment for CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off ilgastrim
   - follow ANC
   .
   # RESPIRATORY ALKALOSIS:  intubated in the setting of cardiac arrest,
   currently with primary metabolic alkalosis and  over-breathing the
   ventilator.  Cause is most likely intracranial process (ongoing
   infection, recent surgery).  PE was on the differential but LENIs
   negative; unable to do CTA [**1-1**] contrast allergy.  Concern for the risk
   of seizure with alkalemia.   BP is not tolerating increased sedation to
   deal with this.
   - plan to give small boluses of sedation rather than gtt to attempt to
   control hyperventilation
   .
   # FEVERS:  afebrile since her evacuation procedure.  Her WBC count is
   improving, although many immature/atypical forms.  On linezolid,
   meropenem, gentamicin, micafungin, and acyclovir.
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   Consistent in time and magnitude with shock liver. Appear to possibly
   be at plateau earlier today. Follow closely.
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.  No longer requiring
   pressors.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Comments: NPO for TEE today, restart TF after
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, I summarize the patient's health progress in the ICU as follows:

The patient is a 60-year-old woman with a lengthy history of acute lymphoblastic leukemia (ALL) and past successful treatment, now with recurrence including central nervous system (CNS) involvement. She had a cardiac arrest, underwent removal of the Omaya port and evacuation of subdural hematoma (SDH), and is currently in the ICU for further care and management.

The patient's current condition is as follows:

* Airway: Intubated due to inability to protect airway and risk of aspiration.
* Respiratory: Alkalotic, likely due to intracranial process, with over-breathing the ventilator.
* Cardiovascular: No longer requiring pressors, with significant interval worsening of ejection fraction (EF) from 40% to 20% over the past 2 weeks.
* Neurological: Altered mental status, not following commands, with reactive pupils. CSF culture positive for VRE, likely seeded from the blood.
* Hematological: WBC count improving, although many immature/atypical forms.
* Infections: Fever unknown origin, likely due to enterococcal infection of the Omaya port, now treated with linezolid and gentamicin.
* Liver enzymes: Elevated, consistent with shock liver, now downtrending.
* Other: S/P asystolic arrest, likely secondary to calcium channel blocker (CCB) in the setting of a heart compromised by prior cardiotoxic chemotherapy.

The patient is currently receiving various medications, including linezolid, gentamicin, micafungin, and acyclovir. The plan is to continue these medications and monitor the patient's response.

Potential medical complications that can arise from the patient's current condition include:

1. Seizure risk due to alkalosis and ongoing intracranial process.
2. Risk of further CNS infection due to VRE in the CSF.
3. Risk of endocarditis due to suspected VRE infection.
4. Risk of respiratory complications due to over-breathing the ventilator.
5. Risk of cardiac complications due to compromised cardiac function and potential cardiac arrhythmias.
6. Risk of further liver damage due to shock liver.
7. Risk of bleeding due to platelet count <116,000/L.
8. Risk of infection due to immunocompromised state.

To manage these potential complications, the patient will require close monitoring and adjustment of medications as necessary. Further imaging studies, such as a repeat echo and CTA, may be necessary to evaluate the patient's cardiac and vascular status."
112508.0,247400,2176-04-18 06:47:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2176-4-18**] 01:36 AM
   - Neurosurgery recs Q4H neuro recs, avoid subQ heparin until [**4-18**],
   staples out in 2 weeks
   - ID recs decrease gentamicin from Q8H to Q12H, check peak/trough after
   4th dose
   - VRE in CSF
   - code status clarified with BMT and HCP:   full code
   - discussed current status with family including son/HCP
   - stopped Neupogen as counts are recovering
   - OGT placed, TF started
   - off sedation all day but not waking up (switched from fent/midaz
   drips to boluses)
   - NPO for ?TEE in AM, consented by TEE fellow
   - overnight BP trending down into the 80s, lactate rising
giving NS
   bolus in the morning
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Vancomycin - [**2176-4-16**] 12:00 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Micafungin - [**2176-4-17**] 07:53 PM
   Acyclovir - [**2176-4-17**] 09:31 PM
   Meropenem - [**2176-4-18**] 12:24 AM
   Linezolid - [**2176-4-18**] 02:13 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-18**] 06:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.7
   Tcurrent: 36.6
C (97.9
   HR: 96 (91 - 116) bpm
   BP: 86/60(70) {86/60(70) - 120/83(97)} mmHg
   RR: 21 (20 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  2,764 mL
                                                                  1,425 mL
   PO:
             TF:
                                                                     58 mL
   IVF:
                                                                  2,706 mL
                                                                  1,425 mL
   Blood products:
   Total out:
                                                                  1,418 mL
                                                                    563 mL
   Urine:
                                                                  1,368 mL
                                                                    388 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,346 mL
                                                                    862 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 346 (346 - 346) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 65
   PIP: 17 cmH2O
   Plateau: 15 cmH2O
   Compliance: 45 cmH2O/mL
   SpO2: 95%
   ABG: 7.49/25/104/17/-1
   Ve: 10.2 L/min
   PaO2 / FiO2: 260
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   97 K/uL
   11.3 g/dL
   102 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.7 mEq/L
   34 mg/dL
   114 mEq/L
   145 mEq/L
   33.0 %
   27.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
   WBC
   4.2
   7.9
   27.3
   Hct
   27.2
   29.1
   33.0
   Plt
   116
   97
   Cr
   1.1
   1.0
   TCO2
   21
   19
   20
   21
   20
   20
   20
   Glucose
   162
   102
   Other labs: PT / PTT / INR:16.2/38.8/1.4, ALT / AST:1205/385, Alk Phos
   / T Bili:355/2.5, Amylase / Lipase:76/50, Differential-Neuts:71.0 %,
   Band:1.0 %, Lymph:3.0 %, Mono:3.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:3.3 mmol/L, Albumin:2.3 g/dL, LDH:1843 IU/L, Ca++:7.8
   mg/dL, Mg++:2.0 mg/dL, PO4:2.2 mg/dL
   Blood cultures:  NGTD since [**4-11**] VRE
   CSF [**4-16**]:  enterococcus
   CXR [**4-17**]:
   Nasogastric tube ends in the mid stomach, ET tube in standard
   placement.
   Opacification at the lung bases is probably a combination of
   atelectasis and
   small bilateral pleural effusion. Pulmonary edema has cleared from the
   upper
   lungs. Heart size normal although the configuration suggests left
   atrial
   enlargement. ET tube in standard placement. No pneumothorax.
   Assessment and Plan
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port which was seeded has now
   been removed.    Daptomycin was switched to linezolid for better CSF
   penetration, although linezolid will cause BM suppression.  Gentamicin
   for synergy.  TTE was negative for vegetation [**4-15**], but given new
   finding of likely VRE in CSF, suspicion is high for endocarditis.
   Would need 8 weeks of abx if vegetation present vs 4 week if only CNS
   infection s/p source removal.
   - continue linezolid and gentamicin
   - after discussion with ID and high trough, gentamicin dose decreased:
   will check level after 4th dose tomorrow PM
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - d/c meropenem now that low suspicion for any GNR process
   # HYPOTENSION:  New this morning, SBP 80s, did not respond to 750 cc
   bolus so far.  Lactate also elevated, likely secondary to poor
   perfusion.  Differential includes sepsis, and her new leukocytosis
   would go along with this (although she is  not neutropenic, on very
   broad abx coverage, and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, adrenal insufficiency, CNS etiology, PE (but
   not hypoxic nor impressively more tachycardic).  Limbs are warm, neck
   veins difficult to assess, and there is some question about the
   accuracy of art line BP [**Location (un) 103**].  Regarding management, would prefer to
   give a pressor with inotropic activity such as levophed if needed.
   - check BP in all 4 limbs
   - assess neck veins
   - trend lactate
   - [**Last Name (un) **] stim
   - Infectious work-up:  repeat blood and urine cx, sputum cx, stool for
   c diff, monitor line for signs of infection
   - IVNS x 500 cc bolus now
   - consider Levophed if persistently hypotensive despite fluid boluses
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  However, off sedation she is not alert or following
   commands.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal MTX and
   DLI this admission.  Per BMT, will need further treatment for CNS
   lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   - discuss whether the fungal and viral coverage is still needed with
   BMT and ID
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest,
   with ongoing primary metabolic alkalosis.  Cause is most likely
   intracranial process (ongoing infection, recent surgery).  PE was on
   the differential but LENIs negative; unable to do CTA [**1-1**] contrast
   allergy.  There is some concern for the risk of seizure with alkalemia,
   but we are not able to give opiates to depress her respiratory drive
   because of hypotension.  Regarding her ventilated status, her
   neurologic exam is currently not such that she could protect her airway
   if extubated
   -continue mechanical ventilation at current settings for now
   - consider SBT if mental status improves.
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms), however very sharp bump today is also
   concerning for an infectious etiology.   She has been afebrile since
   her evacuation procedure and is on very broad coverage as above.  Will
   work-up for infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - stop meropenem, no longer  indicated anyway as above
   - follow clinically
   - would discuss if alternative antibiotic regimen could be constructed
   if rash persists/worsens and linezolid is possibly implicated
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.  INR climbing, which may be secondary to synthetic
   dysfunction after hepatic injury.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated and climbing.  Concern for DIC in this
   woman with cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:
   Comments: NPO for TEE today, restart TF after
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2176-4-18**] 01:36 AM
   - Neurosurgery recs Q4H neuro recs, avoid subQ heparin until [**4-18**],
   staples out in 2 weeks
   - ID recs decrease gentamicin from Q8H to Q12H, check peak/trough after
   4th dose
   - VRE in CSF
   - code status clarified with BMT and HCP:   full code
   - discussed current status with family including son/HCP
   - stopped Neupogen as counts are recovering
   - OGT placed, TF started
   - off sedation all day but not waking up (switched from fent/midaz
   drips to boluses)
   - NPO for ?TEE in AM, consented by TEE fellow
   - overnight BP trending down into the 80s, lactate rising
giving NS
   bolus in the morning
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Vancomycin - [**2176-4-16**] 12:00 AM
   Gentamicin - [**2176-4-17**] 04:18 AM
   Micafungin - [**2176-4-17**] 07:53 PM
   Acyclovir - [**2176-4-17**] 09:31 PM
   Meropenem - [**2176-4-18**] 12:24 AM
   Linezolid - [**2176-4-18**] 02:13 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-18**] 06:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.7
   Tcurrent: 36.6
C (97.9
   HR: 96 (91 - 116) bpm
   BP: 86/60(70) {86/60(70) - 120/83(97)} mmHg
   RR: 21 (20 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  2,764 mL
                                                                  1,425 mL
   PO:
             TF:
                                                                     58 mL
   IVF:
                                                                  2,706 mL
                                                                  1,425 mL
   Blood products:
   Total out:
                                                                  1,418 mL
                                                                    563 mL
   Urine:
                                                                  1,368 mL
                                                                    388 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,346 mL
                                                                    862 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 450 (450 - 450) mL
   Vt (Spontaneous): 346 (346 - 346) mL
   RR (Set): 12
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 65
   PIP: 17 cmH2O
   Plateau: 15 cmH2O
   Compliance: 45 cmH2O/mL
   SpO2: 95%
   ABG: 7.49/25/104/17/-1
   Ve: 10.2 L/min
   PaO2 / FiO2: 260
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   97 K/uL
   11.3 g/dL
   102 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.7 mEq/L
   34 mg/dL
   114 mEq/L
   145 mEq/L
   33.0 %
   27.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  01:50 AM
                             [**2176-4-16**]  04:36 AM
                             [**2176-4-16**]  06:34 AM
                             [**2176-4-16**]  10:50 AM
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
   WBC
   4.2
   7.9
   27.3
   Hct
   27.2
   29.1
   33.0
   Plt
   116
   97
   Cr
   1.1
   1.0
   TCO2
   21
   19
   20
   21
   20
   20
   20
   Glucose
   162
   102
   Other labs: PT / PTT / INR:16.2/38.8/1.4, ALT / AST:1205/385, Alk Phos
   / T Bili:355/2.5, Amylase / Lipase:76/50, Differential-Neuts:71.0 %,
   Band:1.0 %, Lymph:3.0 %, Mono:3.0 %, Eos:0.0 %, Fibrinogen:536 mg/dL,
   Lactic Acid:3.3 mmol/L, Albumin:2.3 g/dL, LDH:1843 IU/L, Ca++:7.8
   mg/dL, Mg++:2.0 mg/dL, PO4:2.2 mg/dL
   Blood cultures:  NGTD since [**4-11**] VRE
   CSF [**4-16**]:  enterococcus
   CXR [**4-17**]:
   Nasogastric tube ends in the mid stomach, ET tube in standard
   placement.
   Opacification at the lung bases is probably a combination of
   atelectasis and
   small bilateral pleural effusion. Pulmonary edema has cleared from the
   upper
   lungs. Heart size normal although the configuration suggests left
   atrial
   enlargement. ET tube in standard placement. No pneumothorax.
   Assessment and Plan
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port which was seeded has now
   been removed.    Daptomycin was switched to linezolid for better CSF
   penetration, although linezolid will cause BM suppression.  Gentamicin
   for synergy.  TTE was negative for vegetation [**4-15**], but given new
   finding of likely VRE in CSF, suspicion is high for endocarditis.
   Would need 8 weeks of abx if vegetation present vs 4 week if only CNS
   infection s/p source removal.
   - continue linezolid and gentamicin
   - after discussion with ID and high trough, gentamicin dose decreased:
   will check level after 4th dose tomorrow PM
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - d/c meropenem now that low suspicion for any GNR process
   # HYPOTENSION:  New this morning, SBP 80s, did not respond to 750 cc
   bolus so far.  Lactate also elevated, likely secondary to poor
   perfusion.  Differential includes sepsis, and her new leukocytosis
   would go along with this (although she is  not neutropenic, on very
   broad abx coverage, and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, adrenal insufficiency, CNS etiology, PE (but
   not hypoxic nor impressively more tachycardic).  Limbs are warm, neck
   veins difficult to assess, and there is some question about the
   accuracy of art line BP [**Location (un) 103**].  Regarding management, would prefer to
   give a pressor with inotropic activity such as levophed if needed.
   - check BP in all 4 limbs
   - assess neck veins
   - trend lactate
   - [**Last Name (un) **] stim
   - Infectious work-up:  repeat blood and urine cx, sputum cx, stool for
   c diff, monitor line for signs of infection
   - IVNS x 500 cc bolus now
   - consider Levophed if persistently hypotensive despite fluid boluses
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  However, off sedation she is not alert or following
   commands.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal MTX and
   DLI this admission.  Per BMT, will need further treatment for CNS
   lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   - discuss whether the fungal and viral coverage is still needed with
   BMT and ID
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest,
   with ongoing primary metabolic alkalosis.  Cause is most likely
   intracranial process (ongoing infection, recent surgery).  PE was on
   the differential but LENIs negative; unable to do CTA [**1-1**] contrast
   allergy.  There is some concern for the risk of seizure with alkalemia,
   but we are not able to give opiates to depress her respiratory drive
   because of hypotension.  Regarding her ventilated status, her
   neurologic exam is currently not such that she could protect her airway
   if extubated
   -continue mechanical ventilation at current settings for now
   - consider SBT if mental status improves.
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms), however very sharp bump today is also
   concerning for an infectious etiology.   She has been afebrile since
   her evacuation procedure and is on very broad coverage as above.  Will
   work-up for infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - stop meropenem, no longer  indicated anyway as above
   - follow clinically
   - would discuss if alternative antibiotic regimen could be constructed
   if rash persists/worsens and linezolid is possibly implicated
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.  INR climbing, which may be secondary to synthetic
   dysfunction after hepatic injury.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated and climbing.  Concern for DIC in this
   woman with cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:
   Comments: NPO for TEE today, restart TF after
   Glycemic Control:  insulin SS
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:  pneumoboots
   Stress ulcer:  PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition: full code (discussed with BMT and HCP)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) and a recent recurrence of the disease, including central nervous system (CNS) involvement. She has undergone cardiac arrest, removal of an Omaya port, and evacuation of a subdural hematoma (SDH). She is currently in the intensive care unit (ICU) for further care and monitoring.

The patient has several medical complications, including:

1. VRE in the CNS: The patient has a positive CSF culture for VRE, which is likely seeding from the removed Omaya port. This has led to the initiation of linezolid and gentamicin therapy.
2. Hypotension: The patient's blood pressure is trending down into the 80s, and she has required a 750 mL bolus of normal saline. The differential diagnosis includes sepsis, cardiogenic shock, volume depletion, adrenal insufficiency, CNS etiology, and pulmonary embolism.
3. Altered mental status: The patient is not alert or following commands, despite being off sedation. This is likely multifactorial, including recent SDH, prolonged asystolic arrest, CNS infection, and possible recurrent CNS lymphoma.
4. Respiratory failure: The patient is intubated and on mechanical ventilation due to intracranial processes, including ongoing infection and recent surgery.
5. Leukocytosis: The patient's white blood cell count is increasing, likely due to recovery of bone marrow function after chemotherapy. However, this may also be concerning for an infectious etiology.
6. Rash: The patient has developed a rash, which may be related to a drug allergy, possibly to meropenem or linezolid.
7. Elevated liver enzymes: The patient's liver enzymes are elevated, consistent with shock liver, and are now downtrending.
8. Coagulopathy: The patient is bleeding from lines, and her INR is slightly elevated and climbing, raising concern for disseminated intravascular coagulation (DIC).

The patient's medical plan includes:

1. Continue linezolid and gentamicin therapy for VRE infection.
2. Decrease gentamicin dose after discussion with ID and high trough.
3. Follow neuro exam and consider re-imaging head if exam deteriorates.
4. Continue broad-spectrum antimicrobial coverage, including acyclovir and micafungin.
5. Discuss further treatment for CNS lymphoma with BMT.
6. Stop meropenem due to suspected drug allergy.
7. Monitor LFTs and INR.
8. Repeat echo in 3-4 weeks to assess cardiac function.
9. Avoid nodal agents and replete lytes aggressively.
10. Check and follow serial DIC labs.

The patient's code status is full code, and she has been discussed with BMT and HCP."
112508.0,247400,2176-04-19 07:39:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 BLOOD CULTURED - At [**2176-4-18**] 11:26 AM
 SPUTUM CULTURE - At [**2176-4-18**] 11:26 AM
 URINE CULTURE - At [**2176-4-18**] 11:26 AM
 BLOOD CULTURED - At [**2176-4-18**] 12:52 PM
   [**4-18**]
   - Hypotension during the afternoon requiring norepinephrine, on/off
   overnight for borderline BP
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Micafungin - [**2176-4-18**] 07:35 PM
   Gentamicin - [**2176-4-18**] 08:59 PM
   Linezolid - [**2176-4-19**] 01:49 AM
   Acyclovir - [**2176-4-19**] 06:18 AM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-18**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-19**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98.1
   HR: 89 (80 - 110) bpm
   BP: 116/73(89) {73/47(58) - 136/86(104)} mmHg
   RR: 24 (14 - 27) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  5,499 mL
                                                                  1,535 mL
   PO:
             TF:
                                                                    217 mL
                                                                    253 mL
   IVF:
                                                                  5,283 mL
                                                                  1,202 mL
   Blood products:
   Total out:
                                                                  1,358 mL
                                                                    288 mL
   Urine:
                                                                  1,163 mL
                                                                    288 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,141 mL
                                                                  1,247 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 450 (450 - 450) mL
   PS : 5 cmH2O
   RR (Set): 12
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 63
   PIP: 18 cmH2O
   Plateau: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/24/134/15/-4
   Ve: 11 L/min
   PaO2 / FiO2: 335
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   90 K/uL
   12.3 g/dL
   157 mg/dL
   0.9 mg/dL
   15 mEq/L
   3.9 mEq/L
   33 mg/dL
   113 mEq/L
   140 mEq/L
   36.0 %
   30.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
                             [**2176-4-18**]  02:42 PM
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
   WBC
   4.2
   7.9
   20.7
   30.3
   Hct
   27.2
   29.1
   33.0
   36.0
   Plt
   116
   97
   91
   90
   Cr
   1.1
   1.0
   0.9
   0.9
   TCO2
   20
   20
   20
   18
   17
   Glucose
   162
   102
   117
   157
   Other labs: PT / PTT / INR:15.0/34.3/1.3, ALT / AST:464/117, Alk Phos /
   T Bili:460/1.7, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:3.2 mmol/L, Albumin:2.1 g/dL, LDH:1213 IU/L, Ca++:7.6
   mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   Imaging: CXR [**4-18**]: ET tube projects 2 cm above the carina. Interval
   improvement in
   pulmonary edema. Cardiac size is top normal. Bibasilar atelectases
   greater
   on the left side are unchanged. There is increase in left perihilar
   opacity
   to suggest atelectasis.
   CXR:
   Microbiology: bxc [**Date range (1) 6111**] ngtd
   ucx ngtd
   cryptococcus negative
   VRE (also amp R, linezolid S) in CSF [**4-15**]
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-19**] 06:27 AM 40 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 BLOOD CULTURED - At [**2176-4-18**] 11:26 AM
 SPUTUM CULTURE - At [**2176-4-18**] 11:26 AM
 URINE CULTURE - At [**2176-4-18**] 11:26 AM
 BLOOD CULTURED - At [**2176-4-18**] 12:52 PM
   [**4-18**]
   - Hypotension during the afternoon requiring norepinephrine, on/off
   overnight for borderline BP
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Micafungin - [**2176-4-18**] 07:35 PM
   Gentamicin - [**2176-4-18**] 08:59 PM
   Linezolid - [**2176-4-19**] 01:49 AM
   Acyclovir - [**2176-4-19**] 06:18 AM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-18**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-19**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98.1
   HR: 89 (80 - 110) bpm
   BP: 116/73(89) {73/47(58) - 136/86(104)} mmHg
   RR: 24 (14 - 27) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  5,499 mL
                                                                  1,535 mL
   PO:
             TF:
                                                                    217 mL
                                                                    253 mL
   IVF:
                                                                  5,283 mL
                                                                  1,202 mL
   Blood products:
   Total out:
                                                                  1,358 mL
                                                                    288 mL
   Urine:
                                                                  1,163 mL
                                                                    288 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,141 mL
                                                                  1,247 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 450 (450 - 450) mL
   PS : 5 cmH2O
   RR (Set): 12
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 63
   PIP: 18 cmH2O
   Plateau: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/24/134/15/-4
   Ve: 11 L/min
   PaO2 / FiO2: 335
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   90 K/uL
   12.3 g/dL
   157 mg/dL
   0.9 mg/dL
   15 mEq/L
   3.9 mEq/L
   33 mg/dL
   113 mEq/L
   140 mEq/L
   36.0 %
   30.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
                             [**2176-4-18**]  02:42 PM
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
   WBC
   4.2
   7.9
   20.7
   30.3
   Hct
   27.2
   29.1
   33.0
   36.0
   Plt
   116
   97
   91
   90
   Cr
   1.1
   1.0
   0.9
   0.9
   TCO2
   20
   20
   20
   18
   17
   Glucose
   162
   102
   117
   157
   Other labs: PT / PTT / INR:15.0/34.3/1.3, ALT / AST:464/117, Alk Phos /
   T Bili:460/1.7, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:3.2 mmol/L, Albumin:2.1 g/dL, LDH:1213 IU/L, Ca++:7.6
   mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   Imaging: CXR [**4-18**]: ET tube projects 2 cm above the carina. Interval
   improvement in
   pulmonary edema. Cardiac size is top normal. Bibasilar atelectases
   greater
   on the left side are unchanged. There is increase in left perihilar
   opacity
   to suggest atelectasis.
   CXR:
   Microbiology: bxc [**Date range (1) 6111**] ngtd
   ucx ngtd
   cryptococcus negative
   VRE (also amp R, linezolid S) in CSF [**4-15**]
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-19**] 06:27 AM 40 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 63-inch tall individual with a weight not specified, admitted to the ICU with a diagnosis of sepsis without organ dysfunction. The patient has a history of leukemia, acute (ALL, AML, cancer, malignant neoplasm).

The patient's vital signs are:

* Temperature: 36.9C (98.5F)
* Heart rate: 89 beats per minute (bpm)
* Blood pressure: 116/73 mmHg (89-136/73-86 mmHg)
* Respiratory rate: 24 inspirations per minute (insp/min)
* Oxygen saturation: 97%

The patient has a central venous catheter, arterial line, and multi-lumen catheter in place.

Laboratory results show:

* White blood cell count (WBC): 4.2-30.3 K/uL
* Hemoglobin (Hb): 12.3-36.0 g/dL
* Platelet count (Plt): 116-90 K/uL
* Creatinine (Cr): 1.1-0.9 mg/dL
* Blood urea nitrogen (BUN): 15-18 mg/dL
* Glucose: 162-157 mg/dL
* Lactic acid: 3.2 mmol/L
* Albumin: 2.1 g/dL
* LDH: 1213 IU/L
* Calcium (Ca++): 7.6 mg/dL
* Magnesium (Mg++): 2.5 mg/dL
* Phosphate (PO4): 2.4 mg/dL

Imaging studies show:

* Chest X-ray (CXR) on 4-18: ET tube projects 2 cm above the carina, with interval improvement in pulmonary edema, cardiac size is top normal, and bibasilar atelectases greater on the left side are unchanged, with an increase in left perihilar opacity to suggest atelectasis.

The patient's medical complications include:

1. Sepsis without organ dysfunction
2. Impaired skin integrity
3. Altered mental status (not delirium)
4. Fever, unknown origin (FUO, hyperthermia, pyrexia)
5. Risk for aspiration, altered gag, airway clearance, and cough due to inability to protect airway

Potential medical complications that can arise include:

1. Development of organ dysfunction
2. Septic shock
3. Respiratory failure
4. Cardiovascular instability
5. Neurological compromise
6. Gastrointestinal bleeding
7. Renal failure
8. Hepatic dysfunction
9. Coagulopathy
10. Infection-related complications, such as pneumonia, UTI, or septic arthritis.

The patient's ICU care plan includes:

1. Nutrition: Nutren Pulmonary (Full) at 40 mL/hour
2. Glycemic control: Monitoring and management of blood glucose levels
3. Prophylaxis: DVT prophylaxis, stress ulcer prophylaxis, and VAP prophylaxis
4. Code status: Full code
5. Disposition: ICU care continues."
112508.0,247400,2176-04-19 07:39:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 BLOOD CULTURED - At [**2176-4-18**] 11:26 AM
 SPUTUM CULTURE - At [**2176-4-18**] 11:26 AM
 URINE CULTURE - At [**2176-4-18**] 11:26 AM
 BLOOD CULTURED - At [**2176-4-18**] 12:52 PM
   [**4-18**]
   - Hypotension during the afternoon requiring norepinephrine, on/off
   overnight for borderline BP, discontinued at 8:30am
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Micafungin - [**2176-4-18**] 07:35 PM
   Gentamicin - [**2176-4-18**] 08:59 PM
   Linezolid - [**2176-4-19**] 01:49 AM
   Acyclovir - [**2176-4-19**] 06:18 AM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-18**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-19**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98.1
   HR: 89 (80 - 110) bpm
   BP: 116/73(89) {73/47(58) - 136/86(104)} mmHg
   RR: 24 (14 - 27) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  5,499 mL
                                                                  1,535 mL
   PO:
             TF:
                                                                    217 mL
                                                                    253 mL
   IVF:
                                                                  5,283 mL
                                                                  1,202 mL
   Blood products:
   Total out:
                                                                  1,358 mL
                                                                    288 mL
   Urine:
                                                                  1,163 mL
                                                                    288 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,141 mL
                                                                  1,247 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 450 (450 - 450) mL
   PS : 5 cmH2O
   RR (Set): 12
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 63
   PIP: 18 cmH2O
   Plateau: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/24/134/15/-4
   Ve: 11 L/min
   PaO2 / FiO2: 335
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   90 K/uL
   12.3 g/dL
   157 mg/dL
   0.9 mg/dL
   15 mEq/L
   3.9 mEq/L
   33 mg/dL
   113 mEq/L
   140 mEq/L
   36.0 %
   30.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
                             [**2176-4-18**]  02:42 PM
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
   WBC
   4.2
   7.9
   20.7
   30.3
   Hct
   27.2
   29.1
   33.0
   36.0
   Plt
   116
   97
   91
   90
   Cr
   1.1
   1.0
   0.9
   0.9
   TCO2
   20
   20
   20
   18
   17
   Glucose
   162
   102
   117
   157
   Other labs: PT / PTT / INR:15.0/34.3/1.3, ALT / AST:464/117, Alk Phos /
   T Bili:460/1.7, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:3.2 mmol/L, Albumin:2.1 g/dL, LDH:1213 IU/L, Ca++:7.6
   mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   Imaging: CXR [**4-18**]: ET tube projects 2 cm above the carina. Interval
   improvement in
   pulmonary edema. Cardiac size is top normal. Bibasilar atelectases
   greater
   on the left side are unchanged. There is increase in left perihilar
   opacity
   to suggest atelectasis.
   CXR:
   Microbiology: bxc [**Date range (1) 6111**] ngtd
   ucx ngtd
   cryptococcus negative
   VRE (also amp R, linezolid S) in CSF [**4-15**]
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now with VRE (amp R,
   linezolid S)  in CSF, presumably the same bacteria which was in the
   blood previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - d/w micro re: additional sensitivities: tigacycline?
   # HYPOTENSION:  New on [**4-18**],  did not respond to bolus and required
   levophed until this morning.  Lactate also elevated, likely secondary
   to poor perfusion.  Differential includes sepsis, and her new
   leukocytosis would go along with this (although ID feels that this is
   more likely [**1-1**] G-CSF and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, CNS etiology. Adreanl insufficeincy r/o by
   [**Last Name (un) **] stim. Limbs are warm, neck veins difficult to assess, and there is
   some question about the accuracy of art line BP [**Location (un) 103**].
   - monitor BP of pressors, low threshold to resume levophed to maintain
   MAP > 65
   - trend lactate
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest.
   Cause is most likely intracranial process (ongoing infection, recent
   surgery).  PE was on the differential but LENIs negative; unable to do
   CTA [**1-1**] contrast allergy.  There is some concern for the risk of
   seizure with alkalemia, but we are not able to give opiates to depress
   her respiratory drive because of hypotension.  Previously mental status
   has been major boundary to extubation, but improvement today permits
   SBT
   - SBT with possible extubation
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms) and GCSF, however very CONTINUED bump today
   to 30 is also concerning.   She has been afebrile since her evacuation
   procedure and is on very broad coverage as above.  Will work-up for
   infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Some concern for DIC in this woman with
   cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-19**] 06:27 AM 40 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: icu
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 BLOOD CULTURED - At [**2176-4-18**] 11:26 AM
 SPUTUM CULTURE - At [**2176-4-18**] 11:26 AM
 URINE CULTURE - At [**2176-4-18**] 11:26 AM
 BLOOD CULTURED - At [**2176-4-18**] 12:52 PM
   [**4-18**]
   - Hypotension during the afternoon requiring norepinephrine, on/off
   overnight for borderline BP, discontinued at 8:30am
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Micafungin - [**2176-4-18**] 07:35 PM
   Gentamicin - [**2176-4-18**] 08:59 PM
   Linezolid - [**2176-4-19**] 01:49 AM
   Acyclovir - [**2176-4-19**] 06:18 AM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-18**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-19**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98.1
   HR: 89 (80 - 110) bpm
   BP: 116/73(89) {73/47(58) - 136/86(104)} mmHg
   RR: 24 (14 - 27) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  5,499 mL
                                                                  1,535 mL
   PO:
             TF:
                                                                    217 mL
                                                                    253 mL
   IVF:
                                                                  5,283 mL
                                                                  1,202 mL
   Blood products:
   Total out:
                                                                  1,358 mL
                                                                    288 mL
   Urine:
                                                                  1,163 mL
                                                                    288 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,141 mL
                                                                  1,247 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 450 (450 - 450) mL
   PS : 5 cmH2O
   RR (Set): 12
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 63
   PIP: 18 cmH2O
   Plateau: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/24/134/15/-4
   Ve: 11 L/min
   PaO2 / FiO2: 335
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   90 K/uL
   12.3 g/dL
   157 mg/dL
   0.9 mg/dL
   15 mEq/L
   3.9 mEq/L
   33 mg/dL
   113 mEq/L
   140 mEq/L
   36.0 %
   30.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
                             [**2176-4-18**]  02:42 PM
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
   WBC
   4.2
   7.9
   20.7
   30.3
   Hct
   27.2
   29.1
   33.0
   36.0
   Plt
   116
   97
   91
   90
   Cr
   1.1
   1.0
   0.9
   0.9
   TCO2
   20
   20
   20
   18
   17
   Glucose
   162
   102
   117
   157
   Other labs: PT / PTT / INR:15.0/34.3/1.3, ALT / AST:464/117, Alk Phos /
   T Bili:460/1.7, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:3.2 mmol/L, Albumin:2.1 g/dL, LDH:1213 IU/L, Ca++:7.6
   mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   Imaging: CXR [**4-18**]: ET tube projects 2 cm above the carina. Interval
   improvement in
   pulmonary edema. Cardiac size is top normal. Bibasilar atelectases
   greater
   on the left side are unchanged. There is increase in left perihilar
   opacity
   to suggest atelectasis.
   CXR:
   Microbiology: bxc [**Date range (1) 6111**] ngtd
   ucx ngtd
   cryptococcus negative
   VRE (also amp R, linezolid S) in CSF [**4-15**]
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now with VRE (amp R,
   linezolid S)  in CSF, presumably the same bacteria which was in the
   blood previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - d/w micro re: additional sensitivities: tigacycline?
   # HYPOTENSION:  New on [**4-18**],  did not respond to bolus and required
   levophed until this morning.  Lactate also elevated, likely secondary
   to poor perfusion.  Differential includes sepsis, and her new
   leukocytosis would go along with this (although ID feels that this is
   more likely [**1-1**] G-CSF and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, CNS etiology. Adreanl insufficeincy r/o by
   [**Last Name (un) **] stim. Limbs are warm, neck veins difficult to assess, and there is
   some question about the accuracy of art line BP [**Location (un) 103**].
   - monitor BP of pressors, low threshold to resume levophed to maintain
   MAP > 65
   - trend lactate
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest.
   Cause is most likely intracranial process (ongoing infection, recent
   surgery).  PE was on the differential but LENIs negative; unable to do
   CTA [**1-1**] contrast allergy.  There is some concern for the risk of
   seizure with alkalemia, but we are not able to give opiates to depress
   her respiratory drive because of hypotension.  Previously mental status
   has been major boundary to extubation, but improvement today permits
   SBT
   - SBT with possible extubation
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms) and GCSF, however very CONTINUED bump today
   to 30 is also concerning.   She has been afebrile since her evacuation
   procedure and is on very broad coverage as above.  Will work-up for
   infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Some concern for DIC in this woman with
   cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-19**] 06:27 AM 40 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: icu<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) and recurrent CNS involvement. She was intubated after a cardiac arrest and has been receiving broad-spectrum antibiotics for a presumed enterococcal infection. The patient has developed hypotension, requiring norepinephrine, and has a elevated lactate level, suggesting poor perfusion. She also has leukocytosis, likely secondary to recovering white blood cell count, and a concerning rash. The patient's mental status has improved, but she remains intubated due to concerns about respiratory failure. She has elevated liver enzymes, consistent with shock liver, and is at risk for coagulopathy and disseminated intravascular coagulation (DIC).

Potential Medical Complications:

1. Sepsis: The patient's hypotension and elevated lactate level suggest ongoing sepsis, which could lead to multi-organ failure.
2. Respiratory Failure: The patient's respiratory status is unstable, and there is a risk of further deterioration, including respiratory acidosis and hypoxemia.
3. Coagulopathy: The patient's elevated INR and bleeding from lines suggest a risk of coagulopathy, which could lead to bleeding complications.
4. DIC: The patient's history of cancer and ongoing infection puts her at risk for DIC, which could lead to bleeding and organ dysfunction.
5. Cardiac Complications: The patient's cardiac function is compromised, and there is a risk of further deterioration, including cardiac arrhythmias and heart failure.
6. Neurological Complications: The patient's mental status is improving, but she remains at risk for further neurological deterioration, including seizures and brain edema.
7. Infection: The patient's ongoing infection could lead to further complications, including sepsis, organ failure, and death.
8. Gastrointestinal Complications: The patient's history of chemotherapy and ongoing infection puts her at risk for gastrointestinal complications, including nausea, vomiting, and diarrhea.

Recommendations:

1. Continue broad-spectrum antibiotics, including linezolid and gentamicin, to cover for potential enterococcal infection.
2. Monitor the patient's hemodynamic status closely and adjust norepinephrine as needed to maintain a mean arterial pressure (MAP) > 65 mmHg.
3. Trend the patient's lactate level and consider additional testing to rule out sepsis.
4. Continue to monitor the patient's respiratory status and consider extubation when stable.
5. Monitor the patient's coagulation status closely and consider additional testing to rule out DIC.
6. Consider repeat imaging of the patient's head to evaluate for potential neurological complications.
7. Discuss with the patient's oncologist the possibility of further treatment for CNS lymphoma.
8. Consider consultation with a cardiologist to evaluate the patient's cardiac function and recommend further management."
112508.0,247400,2176-04-19 07:39:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 BLOOD CULTURED - At [**2176-4-18**] 11:26 AM
 SPUTUM CULTURE - At [**2176-4-18**] 11:26 AM
 URINE CULTURE - At [**2176-4-18**] 11:26 AM
 BLOOD CULTURED - At [**2176-4-18**] 12:52 PM
   [**4-18**]
   - Hypotension during the afternoon requiring norepinephrine, on/off
   overnight for borderline BP
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Micafungin - [**2176-4-18**] 07:35 PM
   Gentamicin - [**2176-4-18**] 08:59 PM
   Linezolid - [**2176-4-19**] 01:49 AM
   Acyclovir - [**2176-4-19**] 06:18 AM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-18**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-19**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98.1
   HR: 89 (80 - 110) bpm
   BP: 116/73(89) {73/47(58) - 136/86(104)} mmHg
   RR: 24 (14 - 27) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  5,499 mL
                                                                  1,535 mL
   PO:
             TF:
                                                                    217 mL
                                                                    253 mL
   IVF:
                                                                  5,283 mL
                                                                  1,202 mL
   Blood products:
   Total out:
                                                                  1,358 mL
                                                                    288 mL
   Urine:
                                                                  1,163 mL
                                                                    288 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,141 mL
                                                                  1,247 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 450 (450 - 450) mL
   PS : 5 cmH2O
   RR (Set): 12
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 63
   PIP: 18 cmH2O
   Plateau: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/24/134/15/-4
   Ve: 11 L/min
   PaO2 / FiO2: 335
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   90 K/uL
   12.3 g/dL
   157 mg/dL
   0.9 mg/dL
   15 mEq/L
   3.9 mEq/L
   33 mg/dL
   113 mEq/L
   140 mEq/L
   36.0 %
   30.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
                             [**2176-4-18**]  02:42 PM
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
   WBC
   4.2
   7.9
   20.7
   30.3
   Hct
   27.2
   29.1
   33.0
   36.0
   Plt
   116
   97
   91
   90
   Cr
   1.1
   1.0
   0.9
   0.9
   TCO2
   20
   20
   20
   18
   17
   Glucose
   162
   102
   117
   157
   Other labs: PT / PTT / INR:15.0/34.3/1.3, ALT / AST:464/117, Alk Phos /
   T Bili:460/1.7, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:3.2 mmol/L, Albumin:2.1 g/dL, LDH:1213 IU/L, Ca++:7.6
   mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   Imaging: CXR [**4-18**]: ET tube projects 2 cm above the carina. Interval
   improvement in
   pulmonary edema. Cardiac size is top normal. Bibasilar atelectases
   greater
   on the left side are unchanged. There is increase in left perihilar
   opacity
   to suggest atelectasis.
   CXR:
   Microbiology: bxc [**Date range (1) 6111**] ngtd
   ucx ngtd
   cryptococcus negative
   VRE (also amp R, linezolid S) in CSF [**4-15**]
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port which was seeded has now
   been removed.    Daptomycin was switched to linezolid for better CSF
   penetration, although linezolid will cause BM suppression.  Gentamicin
   for synergy.  TTE was negative for vegetation [**4-15**], but given new
   finding of likely VRE in CSF, suspicion is high for endocarditis.
   Would need 8 weeks of abx if vegetation present vs 4 week if only CNS
   infection s/p source removal.
   - continue linezolid and gentamicin
   - after discussion with ID and high trough, gentamicin dose decreased:
   will check level after 4th dose tomorrow PM
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - d/c meropenem now that low suspicion for any GNR process
   # HYPOTENSION:  New this morning, SBP 80s, did not respond to 750 cc
   bolus so far.  Lactate also elevated, likely secondary to poor
   perfusion.  Differential includes sepsis, and her new leukocytosis
   would go along with this (although she is  not neutropenic, on very
   broad abx coverage, and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, adrenal insufficiency, CNS etiology, PE (but
   not hypoxic nor impressively more tachycardic).  Limbs are warm, neck
   veins difficult to assess, and there is some question about the
   accuracy of art line BP [**Location (un) 103**].  Regarding management, would prefer to
   give a pressor with inotropic activity such as levophed if needed.
   - check BP in all 4 limbs
   - assess neck veins
   - trend lactate
   - [**Last Name (un) **] stim
   - Infectious work-up:  repeat blood and urine cx, sputum cx, stool for
   c diff, monitor line for signs of infection
   - IVNS x 500 cc bolus now
   - consider Levophed if persistently hypotensive despite fluid boluses
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  However, off sedation she is not alert or following
   commands.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal MTX and
   DLI this admission.  Per BMT, will need further treatment for CNS
   lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   - discuss whether the fungal and viral coverage is still needed with
   BMT and ID
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest,
   with ongoing primary metabolic alkalosis.  Cause is most likely
   intracranial process (ongoing infection, recent surgery).  PE was on
   the differential but LENIs negative; unable to do CTA [**1-1**] contrast
   allergy.  There is some concern for the risk of seizure with alkalemia,
   but we are not able to give opiates to depress her respiratory drive
   because of hypotension.  Regarding her ventilated status, her
   neurologic exam is currently not such that she could protect her airway
   if extubated
   -continue mechanical ventilation at current settings for now
   - consider SBT if mental status improves.
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms), however very sharp bump today is also
   concerning for an infectious etiology.   She has been afebrile since
   her evacuation procedure and is on very broad coverage as above.  Will
   work-up for infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - stop meropenem, no longer  indicated anyway as above
   - follow clinically
   - would discuss if alternative antibiotic regimen could be constructed
   if rash persists/worsens and linezolid is possibly implicated
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.  INR climbing, which may be secondary to synthetic
   dysfunction after hepatic injury.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated and climbing.  Concern for DIC in this
   woman with cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-19**] 06:27 AM 40 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 BLOOD CULTURED - At [**2176-4-18**] 11:26 AM
 SPUTUM CULTURE - At [**2176-4-18**] 11:26 AM
 URINE CULTURE - At [**2176-4-18**] 11:26 AM
 BLOOD CULTURED - At [**2176-4-18**] 12:52 PM
   [**4-18**]
   - Hypotension during the afternoon requiring norepinephrine, on/off
   overnight for borderline BP
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Micafungin - [**2176-4-18**] 07:35 PM
   Gentamicin - [**2176-4-18**] 08:59 PM
   Linezolid - [**2176-4-19**] 01:49 AM
   Acyclovir - [**2176-4-19**] 06:18 AM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-18**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-19**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98.1
   HR: 89 (80 - 110) bpm
   BP: 116/73(89) {73/47(58) - 136/86(104)} mmHg
   RR: 24 (14 - 27) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  5,499 mL
                                                                  1,535 mL
   PO:
             TF:
                                                                    217 mL
                                                                    253 mL
   IVF:
                                                                  5,283 mL
                                                                  1,202 mL
   Blood products:
   Total out:
                                                                  1,358 mL
                                                                    288 mL
   Urine:
                                                                  1,163 mL
                                                                    288 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,141 mL
                                                                  1,247 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 450 (450 - 450) mL
   PS : 5 cmH2O
   RR (Set): 12
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 63
   PIP: 18 cmH2O
   Plateau: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/24/134/15/-4
   Ve: 11 L/min
   PaO2 / FiO2: 335
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   90 K/uL
   12.3 g/dL
   157 mg/dL
   0.9 mg/dL
   15 mEq/L
   3.9 mEq/L
   33 mg/dL
   113 mEq/L
   140 mEq/L
   36.0 %
   30.3 K/uL
        [image002.jpg]
                             [**2176-4-16**]  02:04 PM
                             [**2176-4-17**]  02:03 AM
                             [**2176-4-17**]  04:06 AM
                             [**2176-4-17**]  05:28 PM
                             [**2176-4-18**]  03:55 AM
                             [**2176-4-18**]  04:32 AM
                             [**2176-4-18**]  02:42 PM
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
   WBC
   4.2
   7.9
   20.7
   30.3
   Hct
   27.2
   29.1
   33.0
   36.0
   Plt
   116
   97
   91
   90
   Cr
   1.1
   1.0
   0.9
   0.9
   TCO2
   20
   20
   20
   18
   17
   Glucose
   162
   102
   117
   157
   Other labs: PT / PTT / INR:15.0/34.3/1.3, ALT / AST:464/117, Alk Phos /
   T Bili:460/1.7, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:3.2 mmol/L, Albumin:2.1 g/dL, LDH:1213 IU/L, Ca++:7.6
   mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   Imaging: CXR [**4-18**]: ET tube projects 2 cm above the carina. Interval
   improvement in
   pulmonary edema. Cardiac size is top normal. Bibasilar atelectases
   greater
   on the left side are unchanged. There is increase in left perihilar
   opacity
   to suggest atelectasis.
   CXR:
   Microbiology: bxc [**Date range (1) 6111**] ngtd
   ucx ngtd
   cryptococcus negative
   VRE (also amp R, linezolid S) in CSF [**4-15**]
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest, s/p removal of the
   Omaya port and evacuation of SDH; now returned to the [**Hospital Unit Name 10**] for further
   care and continued follow-up by both the ICU team and the BMT team.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now enterococcus in
   CSF, presumably the same bacteria.  Omaya port which was seeded has now
   been removed.    Daptomycin was switched to linezolid for better CSF
   penetration, although linezolid will cause BM suppression.  Gentamicin
   for synergy.  TTE was negative for vegetation [**4-15**], but given new
   finding of likely VRE in CSF, suspicion is high for endocarditis.
   Would need 8 weeks of abx if vegetation present vs 4 week if only CNS
   infection s/p source removal.
   - continue linezolid and gentamicin
   - after discussion with ID and high trough, gentamicin dose decreased:
   will check level after 4th dose tomorrow PM
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation
   - d/c meropenem now that low suspicion for any GNR process
   # HYPOTENSION:  New this morning, SBP 80s, did not respond to 750 cc
   bolus so far.  Lactate also elevated, likely secondary to poor
   perfusion.  Differential includes sepsis, and her new leukocytosis
   would go along with this (although she is  not neutropenic, on very
   broad abx coverage, and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, adrenal insufficiency, CNS etiology, PE (but
   not hypoxic nor impressively more tachycardic).  Limbs are warm, neck
   veins difficult to assess, and there is some question about the
   accuracy of art line BP [**Location (un) 103**].  Regarding management, would prefer to
   give a pressor with inotropic activity such as levophed if needed.
   - check BP in all 4 limbs
   - assess neck veins
   - trend lactate
   - [**Last Name (un) **] stim
   - Infectious work-up:  repeat blood and urine cx, sputum cx, stool for
   c diff, monitor line for signs of infection
   - IVNS x 500 cc bolus now
   - consider Levophed if persistently hypotensive despite fluid boluses
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  However, off sedation she is not alert or following
   commands.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Most likely cause of her bump in WBC today is recovery of BM.
   Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal MTX and
   DLI this admission.  Per BMT, will need further treatment for CNS
   lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   - discuss whether the fungal and viral coverage is still needed with
   BMT and ID
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest,
   with ongoing primary metabolic alkalosis.  Cause is most likely
   intracranial process (ongoing infection, recent surgery).  PE was on
   the differential but LENIs negative; unable to do CTA [**1-1**] contrast
   allergy.  There is some concern for the risk of seizure with alkalemia,
   but we are not able to give opiates to depress her respiratory drive
   because of hypotension.  Regarding her ventilated status, her
   neurologic exam is currently not such that she could protect her airway
   if extubated
   -continue mechanical ventilation at current settings for now
   - consider SBT if mental status improves.
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms), however very sharp bump today is also
   concerning for an infectious etiology.   She has been afebrile since
   her evacuation procedure and is on very broad coverage as above.  Will
   work-up for infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - stop meropenem, no longer  indicated anyway as above
   - follow clinically
   - would discuss if alternative antibiotic regimen could be constructed
   if rash persists/worsens and linezolid is possibly implicated
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.  INR climbing, which may be secondary to synthetic
   dysfunction after hepatic injury.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  likely was secondary to CCB in the setting of
   a heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated and climbing.  Concern for DIC in this
   woman with cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-19**] 06:27 AM 40 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   20 Gauge - [**2176-4-14**] 03:41 PM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) and recurrent CNS involvement. She was admitted to the ICU after a cardiac arrest, and is currently intubated and mechanically ventilated. She has a prolonged QT interval, and is at risk for arrhythmias. Her blood cultures are negative, but she has a high suspicion of VRE (vancomycin-resistant Enterococcus) in her CSF. She is receiving broad-spectrum antibiotics, including linezolid and gentamicin, and is also receiving antifungal and antiviral medications.

The patient has a complex medical history, including cardiac arrest, SDH, and recent surgery. She is at risk for sepsis, and has a high suspicion of endocarditis. Her mental status is altered, and she is not alert or following commands. She has a rash, which is concerning for a drug allergy, and her liver enzymes are elevated.

Potential Medical Complications:

1. Sepsis: The patient is at risk for sepsis due to her prolonged QT interval, and her high suspicion of VRE in her CSF.
2. Endocarditis: The patient has a high suspicion of endocarditis, which could lead to further complications, including heart failure and arrhythmias.
3. Respiratory failure: The patient is currently intubated and mechanically ventilated, and is at risk for further respiratory failure.
4. Cardiac arrest: The patient has a history of cardiac arrest, and is at risk for further cardiac events.
5. Neurological complications: The patient has a prolonged QT interval, and is at risk for neurological complications, including seizures and stroke.
6. Infection: The patient has a high suspicion of VRE in her CSF, and is at risk for further infections.
7. Bleeding: The patient has a coagulopathy, and is at risk for bleeding, including DIC.
8. Liver dysfunction: The patient's liver enzymes are elevated, and she is at risk for further liver dysfunction.

Recommendations:

1. Continue broad-spectrum antibiotics, including linezolid and gentamicin.
2. Repeat blood and urine cultures to monitor for signs of infection.
3. Monitor the patient's mental status closely, and consider re-imaging her head if her exam deteriorates.
4. Consider further treatment for CNS lymphoma, as recommended by the BMT team.
5. Continue mechanical ventilation at current settings, and consider SBT if the patient's mental status improves.
6. Monitor the patient's liver enzymes and INR closely, and consider further treatment if necessary.
7. Avoid nodal agents and replete lytes aggressively to prevent cardiac complications.
8. Consider further treatment for coagulopathy, including platelet transfusions and anticoagulant therapy.
9. Continue to monitor the patient's blood pressure and consider further treatment if necessary.
10. Consider further treatment for sepsis, including antibiotics and source control measures."
112508.0,247400,2176-04-20 06:56:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2176-4-19**] 03:01 PM
   - Extubated, with improved mental status over the course of the day and
   able to respond verbally and follow comands by evening
   - No TEE done
   - CVL femoral ok to stay unless spikes again
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-19**] 09:57 AM
   Micafungin - [**2176-4-19**] 07:58 PM
   Linezolid - [**2176-4-20**] 02:33 AM
   Acyclovir - [**2176-4-20**] 06:00 AM
   Infusions:
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-19**] 06:25 PM
   Heparin Sodium (Prophylaxis) - [**2176-4-19**] 11:11 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-20**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.4
C (95.8
   HR: 88 (83 - 107) bpm
   BP: 119/76(93) {88/60(72) - 132/87(105)} mmHg
   RR: 18 (15 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  3,364 mL
                                                                    568 mL
   PO:
             TF:
                                                                    542 mL
   IVF:
                                                                  2,743 mL
                                                                    568 mL
   Blood products:
   Total out:
                                                                  2,958 mL
                                                                    975 mL
   Urine:
                                                                  2,808 mL
                                                                    975 mL
   NG:
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                    406 mL
                                                                   -408 mL
   Respiratory support
   O2 Delivery Device: Face tent
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 330 (330 - 451) mL
   PS : 0 cmH2O
   RR (Spontaneous): 22
   PEEP: 0 cmH2O
   FiO2: 40%
   SpO2: 100%
   ABG: 7.48/28/124/19/0
   Ve: 9.8 L/min
   PaO2 / FiO2: 310
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   75 K/uL
   11.2 g/dL
   117 mg/dL
   0.9 mg/dL
   19 mEq/L
   3.7 mEq/L
   31 mg/dL
   111 mEq/L
   140 mEq/L
   31.3 %
   27.0 K/uL
        [image002.jpg]
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
   WBC
   30.3
   27.0
   Hct
   36.0
   29.9
   29.8
   31.3
   Plt
   90
   75
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   117
   157
   157
   137
   117
   Other labs: PT / PTT / INR:15.0/33.9/1.3, ALT / AST:262/68, Alk Phos /
   T Bili:447/1.3, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:863 IU/L, Ca++:7.8 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Since yesterday, ETT tip is now in expected position. Nasogastric tube
   ends
   below the diaphragm with its tip not imaged on this study. Pulmonary
   edema
   improved. Small left pleural effusion is unchanged. Severe left basal
   atelectasis is unchanged. Milder atelectasis at the right base is also
   stable. Heart size and hilar contours are normal.
   [**4-16**] CSF:   VRE (tigecycline sensitivities pending)
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now with VRE (amp R,
   linezolid S)  in CSF, presumably the same bacteria which was in the
   blood previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - d/w micro re: additional sensitivities: tigacycline?
   # HYPOTENSION:  New on [**4-18**],  did not respond to bolus and required
   levophed until this morning.  Lactate also elevated, likely secondary
   to poor perfusion.  Differential includes sepsis, and her new
   leukocytosis would go along with this (although ID feels that this is
   more likely [**1-1**] G-CSF and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, CNS etiology. Adreanl insufficeincy r/o by
   [**Last Name (un) **] stim. Limbs are warm, neck veins difficult to assess, and there is
   some question about the accuracy of art line BP [**Location (un) 103**].
   - monitor BP of pressors, low threshold to resume levophed to maintain
   MAP > 65
   - trend lactate
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest.
   Cause is most likely intracranial process (ongoing infection, recent
   surgery).  PE was on the differential but LENIs negative; unable to do
   CTA [**1-1**] contrast allergy.  There is some concern for the risk of
   seizure with alkalemia, but we are not able to give opiates to depress
   her respiratory drive because of hypotension.  Previously mental status
   has been major boundary to extubation, but improvement today permits
   SBT
   - SBT with possible extubation
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms) and GCSF, however very CONTINUED bump today
   to 30 is also concerning.   She has been afebrile since her evacuation
   procedure and is on very broad coverage as above.  Will work-up for
   infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Some concern for DIC in this woman with
   cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:  tube feeds
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2176-4-19**] 03:01 PM
   - Extubated, with improved mental status over the course of the day and
   able to respond verbally and follow comands by evening
   - No TEE done
   - CVL femoral ok to stay unless spikes again
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-19**] 09:57 AM
   Micafungin - [**2176-4-19**] 07:58 PM
   Linezolid - [**2176-4-20**] 02:33 AM
   Acyclovir - [**2176-4-20**] 06:00 AM
   Infusions:
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-19**] 06:25 PM
   Heparin Sodium (Prophylaxis) - [**2176-4-19**] 11:11 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-20**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.4
C (95.8
   HR: 88 (83 - 107) bpm
   BP: 119/76(93) {88/60(72) - 132/87(105)} mmHg
   RR: 18 (15 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  3,364 mL
                                                                    568 mL
   PO:
             TF:
                                                                    542 mL
   IVF:
                                                                  2,743 mL
                                                                    568 mL
   Blood products:
   Total out:
                                                                  2,958 mL
                                                                    975 mL
   Urine:
                                                                  2,808 mL
                                                                    975 mL
   NG:
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                    406 mL
                                                                   -408 mL
   Respiratory support
   O2 Delivery Device: Face tent
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 330 (330 - 451) mL
   PS : 0 cmH2O
   RR (Spontaneous): 22
   PEEP: 0 cmH2O
   FiO2: 40%
   SpO2: 100%
   ABG: 7.48/28/124/19/0
   Ve: 9.8 L/min
   PaO2 / FiO2: 310
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   75 K/uL
   11.2 g/dL
   117 mg/dL
   0.9 mg/dL
   19 mEq/L
   3.7 mEq/L
   31 mg/dL
   111 mEq/L
   140 mEq/L
   31.3 %
   27.0 K/uL
        [image002.jpg]
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
   WBC
   30.3
   27.0
   Hct
   36.0
   29.9
   29.8
   31.3
   Plt
   90
   75
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   117
   157
   157
   137
   117
   Other labs: PT / PTT / INR:15.0/33.9/1.3, ALT / AST:262/68, Alk Phos /
   T Bili:447/1.3, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:863 IU/L, Ca++:7.8 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Since yesterday, ETT tip is now in expected position. Nasogastric tube
   ends
   below the diaphragm with its tip not imaged on this study. Pulmonary
   edema
   improved. Small left pleural effusion is unchanged. Severe left basal
   atelectasis is unchanged. Milder atelectasis at the right base is also
   stable. Heart size and hilar contours are normal.
   [**4-16**] CSF:   VRE (tigecycline sensitivities pending)
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now with VRE (amp R,
   linezolid S)  in CSF, presumably the same bacteria which was in the
   blood previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - d/w micro re: additional sensitivities: tigacycline?
   # HYPOTENSION:  New on [**4-18**],  did not respond to bolus and required
   levophed until this morning.  Lactate also elevated, likely secondary
   to poor perfusion.  Differential includes sepsis, and her new
   leukocytosis would go along with this (although ID feels that this is
   more likely [**1-1**] G-CSF and blood cx repeatedly negative).  Also on the
   differential are cardiogenic shock (EF recently 20% in the post-arrest
   period), volume depletion, CNS etiology. Adreanl insufficeincy r/o by
   [**Last Name (un) **] stim. Limbs are warm, neck veins difficult to assess, and there is
   some question about the accuracy of art line BP [**Location (un) 103**].
   - monitor BP of pressors, low threshold to resume levophed to maintain
   MAP > 65
   - trend lactate
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest.
   Cause is most likely intracranial process (ongoing infection, recent
   surgery).  PE was on the differential but LENIs negative; unable to do
   CTA [**1-1**] contrast allergy.  There is some concern for the risk of
   seizure with alkalemia, but we are not able to give opiates to depress
   her respiratory drive because of hypotension.  Previously mental status
   has been major boundary to extubation, but improvement today permits
   SBT
   - SBT with possible extubation
   .
   # LEUKOCYTOSIS:   Most likely secondary to counts recovering after
   chemo (many immature forms) and GCSF, however very CONTINUED bump today
   to 30 is also concerning.   She has been afebrile since her evacuation
   procedure and is on very broad coverage as above.  Will work-up for
   infectious cause as above.
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Some concern for DIC in this woman with
   cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:  tube feeds
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided medical progress note, the patient is a 60-year-old woman with a lengthy history of acute lymphoblastic leukemia (ALL) and recent recurrence, including central nervous system (CNS) involvement. She was previously treated with hyper-CVAD and intrathecal chemotherapy, and is currently day +40 post-chemotherapy.

The patient was admitted to the intensive care unit (ICU) with sepsis without organ dysfunction, airway compromise, and altered mental status. She was intubated after a cardiac arrest and has been receiving mechanical ventilation.

The patient's current condition is as follows:

* Respiratory: She is intubated and receiving mechanical ventilation with a CPAP/PSV mode, with a Vt of 330 mL and a PEEP of 0 cmH2O. Her SpO2 is 100%.
* Cardiovascular: Her blood pressure is 119/76 mmHg, and she has a history of cardiac arrest and cardiogenic shock.
* Neurological: She has altered mental status, including a lack of response to commands, clinching of her eyes when they are opened, and withdrawal to stimulation.
* Hematological: Her white blood cell count is 30.3 K/uL, and she has a history of leukocytosis.
* Hepatic: Her liver enzymes are elevated, consistent with shock liver.
* Renal: Her creatinine is 0.9 mg/dL, and she has a history of acute kidney injury.
* Coagulation: Her INR is slightly elevated, and she is bleeding from her lines.

The patient has several potential medical complications, including:

* Sepsis: She has a high risk of developing sepsis due to her underlying cancer and recent infections.
* Organ dysfunction: She has already developed respiratory failure and is at risk for further organ dysfunction.
* Coagulopathy: Her INR is slightly elevated, and she is bleeding from her lines, which may indicate a coagulopathy.
* Liver dysfunction: Her liver enzymes are elevated, which may indicate liver dysfunction.
* Kidney dysfunction: Her creatinine is elevated, which may indicate kidney dysfunction.
* Cardiac dysfunction: She has a history of cardiac arrest and cardiogenic shock, and her ejection fraction is 20%.

The patient's treatment plan includes:

* Continued mechanical ventilation
* Antibiotics: Linezolid, gentamicin, and micafungin
* Anti-fungal therapy: Micafungin
* Anti-viral therapy: Acyclovir
* Pain management: Fentanyl
* Sedation: Midazolam
* Vasopressors: Levophed
* Blood pressure management: Monitor BP and adjust vasopressors as needed
* Lactate management: Trend lactate levels and adjust treatment as needed
* Neurological management: Follow neuro exam and consider repeat imaging if exam deteriorates
* Respiratory management: Continue SBT and consider extubation if patient is stable
* Hematological management: Monitor white blood cell count and adjust treatment as needed
* Hepatic management: Continue to monitor LFTs and INR
* Renal management: Monitor creatinine and adjust treatment as needed
* Coagulation management: Monitor INR and adjust treatment as needed

Overall, the patient requires close monitoring and management to prevent and treat potential complications."
112508.0,247400,2176-04-20 06:56:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2176-4-19**] 03:01 PM
   - Extubated, with improved mental status over the course of the day and
   able to respond verbally and follow comands by evening
   - No TEE done
   - CVL femoral ok to stay unless spikes again
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-19**] 09:57 AM
   Micafungin - [**2176-4-19**] 07:58 PM
   Linezolid - [**2176-4-20**] 02:33 AM
   Acyclovir - [**2176-4-20**] 06:00 AM
   Infusions:
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-19**] 06:25 PM
   Heparin Sodium (Prophylaxis) - [**2176-4-19**] 11:11 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-20**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.4
C (95.8
   HR: 88 (83 - 107) bpm
   BP: 119/76(93) {88/60(72) - 132/87(105)} mmHg
   RR: 18 (15 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  3,364 mL
                                                                    568 mL
   PO:
             TF:
                                                                    542 mL
   IVF:
                                                                  2,743 mL
                                                                    568 mL
   Blood products:
   Total out:
                                                                  2,958 mL
                                                                    975 mL
   Urine:
                                                                  2,808 mL
                                                                    975 mL
   NG:
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                    406 mL
                                                                   -408 mL
   Respiratory support
   O2 Delivery Device: Face tent
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 330 (330 - 451) mL
   PS : 0 cmH2O
   RR (Spontaneous): 22
   PEEP: 0 cmH2O
   FiO2: 40%
   SpO2: 100%
   ABG: 7.48/28/124/19/0
   Ve: 9.8 L/min
   PaO2 / FiO2: 310
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   75 K/uL
   11.2 g/dL
   117 mg/dL
   0.9 mg/dL
   19 mEq/L
   3.7 mEq/L
   31 mg/dL
   111 mEq/L
   140 mEq/L
   31.3 %
   27.0 K/uL
        [image002.jpg]
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
   WBC
   30.3
   27.0
   Hct
   36.0
   29.9
   29.8
   31.3
   Plt
   90
   75
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   117
   157
   157
   137
   117
   Other labs: PT / PTT / INR:15.0/33.9/1.3, ALT / AST:262/68, Alk Phos /
   T Bili:447/1.3, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:863 IU/L, Ca++:7.8 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Since yesterday, ETT tip is now in expected position. Nasogastric tube
   ends
   below the diaphragm with its tip not imaged on this study. Pulmonary
   edema
   improved. Small left pleural effusion is unchanged. Severe left basal
   atelectasis is unchanged. Milder atelectasis at the right base is also
   stable. Heart size and hilar contours are normal.
   [**4-16**] CSF:   VRE (tigecycline sensitivities pending)
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now with VRE (amp R,
   linezolid S)  in CSF, presumably the same bacteria which was in the
   blood previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - f/u tigacycline sensitivities as this may be a better choice in the
   long-run
   .
   # LEUKOCYTOSIS:   Most likely secondary to GCSF.  No blasts or
   singificant lymphs to suggest recurrence of ALL.  There is also some
   suspicion for infection given recent hypotensive episode.  However, she
   has been afebrile since the procedure.  She is now off pressors and
   hemodynamically stable, and she has been afebrile since her evacuation
   procedure and is on very broad coverage as above.   C diff negative x
   2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   .
   # HYPOTENSION:  Required levophed [**2089-4-17**].  Now  off pressors and
   hemodynamically stable.  Lactate now trending down.  Adrenal
   insufficiency ruled out by [**Last Name (un) **] stim.  Low suspicion for sepsis
   currently and all cx negative.  d
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest.
   Cause is most likely intracranial process (ongoing infection, recent
   surgery).  PE was on the differential but LENIs negative; unable to do
   CTA [**1-1**] contrast allergy.  There is some concern for the risk of
   seizure with alkalemia, but we are not able to give opiates to depress
   her respiratory drive because of hypotension.  Previously mental status
   has been major boundary to extubation, but improvement today permits
   SBT
   - SBT with possible extubation
   .
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Some concern for DIC in this woman with
   cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:  tube feeds
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2176-4-19**] 03:01 PM
   - Extubated, with improved mental status over the course of the day and
   able to respond verbally and follow comands by evening
   - No TEE done
   - CVL femoral ok to stay unless spikes again
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-19**] 09:57 AM
   Micafungin - [**2176-4-19**] 07:58 PM
   Linezolid - [**2176-4-20**] 02:33 AM
   Acyclovir - [**2176-4-20**] 06:00 AM
   Infusions:
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-19**] 06:25 PM
   Heparin Sodium (Prophylaxis) - [**2176-4-19**] 11:11 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-20**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.4
C (95.8
   HR: 88 (83 - 107) bpm
   BP: 119/76(93) {88/60(72) - 132/87(105)} mmHg
   RR: 18 (15 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  3,364 mL
                                                                    568 mL
   PO:
             TF:
                                                                    542 mL
   IVF:
                                                                  2,743 mL
                                                                    568 mL
   Blood products:
   Total out:
                                                                  2,958 mL
                                                                    975 mL
   Urine:
                                                                  2,808 mL
                                                                    975 mL
   NG:
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                    406 mL
                                                                   -408 mL
   Respiratory support
   O2 Delivery Device: Face tent
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 330 (330 - 451) mL
   PS : 0 cmH2O
   RR (Spontaneous): 22
   PEEP: 0 cmH2O
   FiO2: 40%
   SpO2: 100%
   ABG: 7.48/28/124/19/0
   Ve: 9.8 L/min
   PaO2 / FiO2: 310
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive
   Head, Ears, Nose, Throat: Endotracheal tube, dressing in place
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back
   Neurologic: pupils equal and reactive does not follow commands,
   clinches eyes when they are opened, withdraws to stimulation
   Labs / Radiology
   75 K/uL
   11.2 g/dL
   117 mg/dL
   0.9 mg/dL
   19 mEq/L
   3.7 mEq/L
   31 mg/dL
   111 mEq/L
   140 mEq/L
   31.3 %
   27.0 K/uL
        [image002.jpg]
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
   WBC
   30.3
   27.0
   Hct
   36.0
   29.9
   29.8
   31.3
   Plt
   90
   75
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   117
   157
   157
   137
   117
   Other labs: PT / PTT / INR:15.0/33.9/1.3, ALT / AST:262/68, Alk Phos /
   T Bili:447/1.3, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:863 IU/L, Ca++:7.8 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Since yesterday, ETT tip is now in expected position. Nasogastric tube
   ends
   below the diaphragm with its tip not imaged on this study. Pulmonary
   edema
   improved. Small left pleural effusion is unchanged. Severe left basal
   atelectasis is unchanged. Milder atelectasis at the right base is also
   stable. Heart size and hilar contours are normal.
   [**4-16**] CSF:   VRE (tigecycline sensitivities pending)
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but now with VRE (amp R,
   linezolid S)  in CSF, presumably the same bacteria which was in the
   blood previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE when stable for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - f/u tigacycline sensitivities as this may be a better choice in the
   long-run
   .
   # LEUKOCYTOSIS:   Most likely secondary to GCSF.  No blasts or
   singificant lymphs to suggest recurrence of ALL.  There is also some
   suspicion for infection given recent hypotensive episode.  However, she
   has been afebrile since the procedure.  She is now off pressors and
   hemodynamically stable, and she has been afebrile since her evacuation
   procedure and is on very broad coverage as above.   C diff negative x
   2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   .
   # HYPOTENSION:  Required levophed [**2089-4-17**].  Now  off pressors and
   hemodynamically stable.  Lactate now trending down.  Adrenal
   insufficiency ruled out by [**Last Name (un) **] stim.  Low suspicion for sepsis
   currently and all cx negative.  d
   # ALTERED MENTAL STATUS:  Improved today in that she now withdraws to
   stimulation.  This is likely multifactorial including recent SDH,
   prolonged asystolic arrest, CNS infection, possible recurrent CNS
   lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   .
   # RESPIRATORY FAILURE:  Intubated in the setting of cardiac arrest.
   Cause is most likely intracranial process (ongoing infection, recent
   surgery).  PE was on the differential but LENIs negative; unable to do
   CTA [**1-1**] contrast allergy.  There is some concern for the risk of
   seizure with alkalemia, but we are not able to give opiates to depress
   her respiratory drive because of hypotension.  Previously mental status
   has been major boundary to extubation, but improvement today permits
   SBT
   - SBT with possible extubation
   .
   .
   # RASH:  Concerning for a drug allergy.  After discussion with ID,
   meropenem is a likely culprit. Although it has been on for a month, it
   is possible to develop a new rash after this time.  Would also be
   concerned that linezolid could be contributing, since this was recently
   started, although this drug is much less likely to cause rash.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Some concern for DIC in this woman with
   cancer and ongoing infection.
   - check now and  follow serial DIC labs
   ICU Care
   Nutrition:  tube feeds
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL), who has undergone treatment for recurrence including CNS involvement. She was intubated due to cardiac arrest and has been receiving broad-spectrum antimicrobial therapy. Her current condition is:

* Sepsis without organ dysfunction
* Airway, inability to protect (risk for aspiration, altered gag, airway clearance, cough)
* Impaired skin integrity
* Altered mental status (not delirium)
* Fever, unknown origin (FUO, hyperthermia, pyrexia)

The patient's recent progress includes:

* Extubation after improvement in mental status
* Continued broad-spectrum antimicrobial therapy, including linezolid, gentamicin, and micafungin
* Removal of Omaya port and evacuation of subdural hematoma (SDH)
* Negative blood cultures since 4/11, but now with VRE (ampicillin-resistant, linezolid-sensitive) in CSF
* Daptomycin switched to linezolid for better CSF penetration

Potential medical complications:

1. Sepsis-related organ dysfunction: The patient's sepsis may lead to organ dysfunction, such as acute kidney injury, respiratory failure, or cardiac arrest.
2. Ventilator-associated pneumonia (VAP): The patient's prolonged intubation may increase the risk of VAP.
3. Coagulopathy: The patient's elevated INR and bleeding from lines may indicate a coagulopathy, which could worsen if not managed promptly.
4. Liver dysfunction: The patient's elevated liver enzymes may indicate liver dysfunction, which could worsen if not monitored closely.
5. Renal dysfunction: The patient's hypotension and sepsis may lead to renal dysfunction, which could worsen if not managed promptly.
6. Neurological deterioration: The patient's altered mental status and recent SDH may increase the risk of neurological deterioration, which could worsen if not monitored closely.
7. Infection-related complications: The patient's ongoing infection may lead to complications such as abscesses, empyemas, or septic shock.
8. Cardiovascular complications: The patient's recent cardiac arrest and EF decline may increase the risk of cardiovascular complications, such as arrhythmias, cardiogenic shock, or cardiac arrest.

Recommendations:

1. Continue broad-spectrum antimicrobial therapy to cover potential pathogens.
2. Monitor the patient's vital signs, including temperature, blood pressure, heart rate, and oxygen saturation, closely.
3. Monitor the patient's neurological status, including mental status, pupillary response, and motor function.
4. Monitor the patient's coagulation status, including INR and bleeding from lines.
5. Monitor the patient's liver and renal function, including LFTs and creatinine levels.
6. Consider repeat imaging of the head to monitor for neurological deterioration.
7. Consider repeat echo to monitor for cardiovascular complications.
8. Consider discussing with BMT further treatment options for CNS lymphoma."
112508.0,247400,2176-04-20 06:56:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2176-4-19**] 03:01 PM
   - Extubated, with improved mental status over the course of the day and
   able to respond verbally and follow comands by evening
   - No TEE done, will need to be done eventually but not emergent
   - CVL femoral ok to stay unless spikes again
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-19**] 09:57 AM
   Micafungin - [**2176-4-19**] 07:58 PM
   Linezolid - [**2176-4-20**] 02:33 AM
   Acyclovir - [**2176-4-20**] 06:00 AM
   Infusions:
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-19**] 06:25 PM
   Heparin Sodium (Prophylaxis) - [**2176-4-19**] 11:11 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-20**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.4
C (95.8
   HR: 88 (83 - 107) bpm
   BP: 119/76(93) {88/60(72) - 132/87(105)} mmHg
   RR: 18 (15 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  3,364 mL
                                                                    568 mL
   PO:
             TF:
                                                                    542 mL
   IVF:
                                                                  2,743 mL
                                                                    568 mL
   Blood products:
   Total out:
                                                                  2,958 mL
                                                                    975 mL
   Urine:
                                                                  2,808 mL
                                                                    975 mL
   NG:
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                    406 mL
                                                                   -408 mL
   Respiratory support
   O2 Delivery Device: Face tent
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 330 (330 - 451) mL
   PS : 0 cmH2O
   RR (Spontaneous): 22
   PEEP: 0 cmH2O
   FiO2: 40%
   SpO2: 100%
   ABG: 7.48/28/124/19/0
   Ve: 9.8 L/min
   PaO2 / FiO2: 310
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive, alert, appropriate,
   following commans
   Head, Ears, Nose, Throat:  face tent, breathing comfortably
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back,
   appears less erythematous than yesterday
   Neurologic: following commands and answering appropriately, can name
   [**1-2**] children
   Labs / Radiology
   75 K/uL
   11.2 g/dL
   117 mg/dL
   0.9 mg/dL
   19 mEq/L
   3.7 mEq/L
   31 mg/dL
   111 mEq/L
   140 mEq/L
   31.3 %
   27.0 K/uL
        [image002.jpg]
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
   WBC
   30.3
   27.0
   Hct
   36.0
   29.9
   29.8
   31.3
   Plt
   90
   75
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   117
   157
   157
   137
   117
   Other labs: PT / PTT / INR:15.0/33.9/1.3, ALT / AST:262/68, Alk Phos /
   T Bili:447/1.3, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:863 IU/L, Ca++:7.8 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Since yesterday, ETT tip is now in expected position. Nasogastric tube
   ends
   below the diaphragm with its tip not imaged on this study. Pulmonary
   edema
   improved. Small left pleural effusion is unchanged. Severe left basal
   atelectasis is unchanged. Milder atelectasis at the right base is also
   stable. Heart size and hilar contours are normal.
   [**4-16**] CSF:   VRE (tigecycline sensitivities pending)
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but VRE (amp R, linezolid
   S)  in CSF, presumably the same bacteria which was in the blood
   previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE next weak for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - f/u tigacycline sensitivities as this may be a better choice in the
   long-run
   - consider d/c gentamicin
   .
   # LEUKOCYTOSIS:   Most likely secondary to GCSF.  No blasts or
   singificant lymphs to suggest recurrence of ALL.  There is also some
   suspicion for infection given recent hypotensive episode.  However, she
   has been afebrile since the procedure.  She is now off pressors and
   hemodynamically stable, and she has been afebrile since her evacuation
   procedure and is on very broad coverage as above.   C diff negative x
   2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   .
   # HYPOTENSION:  Required levophed [**2089-4-17**].  Now  off pressors and
   hemodynamically stable.  Lactate now trending down.  Adrenal
   insufficiency ruled out by [**Last Name (un) **] stim.  Low suspicion for sepsis
   currently, afebrile and all cx negative.
   # ALTERED MENTAL STATUS:  Improved today, conversant.  This is likely
   multifactorial including recent SDH, prolonged asystolic arrest, CNS
   infection, possible recurrent CNS lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   - discuss with BMT stopping the acyclovir given that all viral cx
   negative
   .
   # RESPIRATORY FAILURE:  Now extubated, oxygenating well on face tent
   and with improvement in respiratory alkalosis.
   Likely has some volume overload as seen on cxr but making good urine.
   - allow auto-diuresis, aim for net even to negative.
   .
   # RASH:  Appears improved today.  Concerning for a drug allergy.
   Meropenem was a possible culprit, now off for 3 days.  After discussion
   with ID, meropenem is a likely culprit.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending except alk phos which remains elevated.  Tbili normal.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Low suspicion for DIC currently.
   .
   # ACCESS:  has clots in her upper extremity veins, access has been
   difficult.  Currently has femoral line.
   - discuss with IR changing line over a wire
   ICU Care
   Nutrition:  tube feeds
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2176-4-19**] 03:01 PM
   - Extubated, with improved mental status over the course of the day and
   able to respond verbally and follow comands by evening
   - No TEE done, will need to be done eventually but not emergent
   - CVL femoral ok to stay unless spikes again
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-19**] 09:57 AM
   Micafungin - [**2176-4-19**] 07:58 PM
   Linezolid - [**2176-4-20**] 02:33 AM
   Acyclovir - [**2176-4-20**] 06:00 AM
   Infusions:
   Other ICU medications:
   Furosemide (Lasix) - [**2176-4-19**] 06:25 PM
   Heparin Sodium (Prophylaxis) - [**2176-4-19**] 11:11 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-20**] 06:45 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.4
C (95.8
   HR: 88 (83 - 107) bpm
   BP: 119/76(93) {88/60(72) - 132/87(105)} mmHg
   RR: 18 (15 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  3,364 mL
                                                                    568 mL
   PO:
             TF:
                                                                    542 mL
   IVF:
                                                                  2,743 mL
                                                                    568 mL
   Blood products:
   Total out:
                                                                  2,958 mL
                                                                    975 mL
   Urine:
                                                                  2,808 mL
                                                                    975 mL
   NG:
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                    406 mL
                                                                   -408 mL
   Respiratory support
   O2 Delivery Device: Face tent
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 330 (330 - 451) mL
   PS : 0 cmH2O
   RR (Spontaneous): 22
   PEEP: 0 cmH2O
   FiO2: 40%
   SpO2: 100%
   ABG: 7.48/28/124/19/0
   Ve: 9.8 L/min
   PaO2 / FiO2: 310
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive, alert, appropriate,
   following commans
   Head, Ears, Nose, Throat:  face tent, breathing comfortably
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back,
   appears less erythematous than yesterday
   Neurologic: following commands and answering appropriately, can name
   [**1-2**] children
   Labs / Radiology
   75 K/uL
   11.2 g/dL
   117 mg/dL
   0.9 mg/dL
   19 mEq/L
   3.7 mEq/L
   31 mg/dL
   111 mEq/L
   140 mEq/L
   31.3 %
   27.0 K/uL
        [image002.jpg]
                             [**2176-4-18**]  07:36 PM
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
   WBC
   30.3
   27.0
   Hct
   36.0
   29.9
   29.8
   31.3
   Plt
   90
   75
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   117
   157
   157
   137
   117
   Other labs: PT / PTT / INR:15.0/33.9/1.3, ALT / AST:262/68, Alk Phos /
   T Bili:447/1.3, Amylase / Lipase:76/50, Differential-Neuts:83.0 %,
   Band:6.0 %, Lymph:1.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:655 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:863 IU/L, Ca++:7.8 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Since yesterday, ETT tip is now in expected position. Nasogastric tube
   ends
   below the diaphragm with its tip not imaged on this study. Pulmonary
   edema
   improved. Small left pleural effusion is unchanged. Severe left basal
   atelectasis is unchanged. Milder atelectasis at the right base is also
   stable. Heart size and hilar contours are normal.
   [**4-16**] CSF:   VRE (tigecycline sensitivities pending)
   Assessment and Plan
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   This is a 60 year old woman with a lengthy history of ALL and past
   successful treatment of this, now with recurrence including CNS
   involvement, and likely enterococcal infection of an Omaya port used
   for intrathecal chemotherapy; s/p cardiac arrest & intubated since, s/p
   removal of the Omaya port and evacuation of SDH.
   # VRE in CNS:  Blood cx negative since [**4-11**], but VRE (amp R, linezolid
   S)  in CSF, presumably the same bacteria which was in the blood
   previously.  Omaya port which was seeded has now been removed.
   Daptomycin was switched to linezolid for better CSF penetration,
   although linezolid will cause BM suppression.  Gentamicin for synergy.
   TTE was negative for vegetation [**4-15**], but given new finding of likely
   VRE in CSF, but sensitivity clearly less than TEE.  Would need 8 weeks
   of abx if vegetation present vs 4 week if only CNS infection s/p source
   removal.
   - continue linezolid (D1=[**4-16**]) and gentamicin (D1=[**4-15**])
   - after discussion with ID and high trough, gentamicin dose decreased
   TO Q 24
   - f/u culture data and sensitivities
   - TEE next weak for r/o vegetation to determine lenghth of TX
   - meropenem d/c
ed ([**4-18**]) now that low suspicion for any GNR process
   - f/u tigacycline sensitivities as this may be a better choice in the
   long-run
   - consider d/c gentamicin
   .
   # LEUKOCYTOSIS:   Most likely secondary to GCSF.  No blasts or
   singificant lymphs to suggest recurrence of ALL.  There is also some
   suspicion for infection given recent hypotensive episode.  However, she
   has been afebrile since the procedure.  She is now off pressors and
   hemodynamically stable, and she has been afebrile since her evacuation
   procedure and is on very broad coverage as above.   C diff negative x
   2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   .
   # HYPOTENSION:  Required levophed [**2089-4-17**].  Now  off pressors and
   hemodynamically stable.  Lactate now trending down.  Adrenal
   insufficiency ruled out by [**Last Name (un) **] stim.  Low suspicion for sepsis
   currently, afebrile and all cx negative.
   # ALTERED MENTAL STATUS:  Improved today, conversant.  This is likely
   multifactorial including recent SDH, prolonged asystolic arrest, CNS
   infection, possible recurrent CNS lymphoma.
   - follow neuro exam
   - would re-image head if exam deteriorates; per neuro no role curretly
   for repeat LP
   - f/u neurosurgery recs
   - f/u CNS cultures
   - discuss with BMT possible further treatment of CNS lymphoma, as
   below.
   .
   # ALL:  Currently day +40 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid/gent.
   - discuss with BMT stopping the acyclovir given that all viral cx
   negative
   .
   # RESPIRATORY FAILURE:  Now extubated, oxygenating well on face tent
   and with improvement in respiratory alkalosis.
   Likely has some volume overload as seen on cxr but making good urine.
   - allow auto-diuresis, aim for net even to negative.
   .
   # RASH:  Appears improved today.  Concerning for a drug allergy.
   Meropenem was a possible culprit, now off for 3 days.  After discussion
   with ID, meropenem is a likely culprit.
   - monitor rash now off meropenem
   # ELEVATED LIVER ENZYMES:  consistent with shock liver.  Now
   downtrending except alk phos which remains elevated.  Tbili normal.
   - continue to monitor LFTs and INR
   .
   # S/P ASYSTOLIC ARREST:  temporally realted to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   .
   # COAGULOPATHY:  per discussion with nursing, patient is bleeding from
   lines.  INR slightly elevated.  Low suspicion for DIC currently.
   .
   # ACCESS:  has clots in her upper extremity veins, access has been
   difficult.  Currently has femoral line.
   - discuss with IR changing line over a wire
   ICU Care
   Nutrition:  tube feeds
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: boots
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 60-year-old woman with a history of acute lymphoblastic leukemia (ALL) who has recently experienced a recurrence of the disease, including CNS involvement. She was intubated due to cardiac arrest and has been receiving treatment for an enterococcal infection of an Omaya port used for intrathecal chemotherapy. The patient has been improving, with improved mental status, and was recently extubated. She is currently receiving broad-spectrum antimicrobial therapy, including linezolid and gentamicin, and is being monitored for potential complications.

Potential Medical Complications:

1. Sepsis: The patient has a history of sepsis and is currently receiving broad-spectrum antimicrobial therapy. There is a risk of developing sepsis again, particularly if the patient's underlying condition worsens or if the antibiotics are ineffective.
2. Organ Dysfunction: The patient has a history of organ dysfunction, including cardiac arrest, and may be at risk for developing further organ dysfunction, particularly if the sepsis worsens.
3. Leukocytosis: The patient has leukocytosis, which may be a sign of infection or inflammation. Further evaluation is needed to determine the cause of the leukocytosis.
4. Hypotension: The patient has had episodes of hypotension, which may be related to sepsis or other underlying conditions. Further evaluation is needed to determine the cause of the hypotension.
5. Altered Mental Status: The patient has had altered mental status, which may be related to sepsis, CNS infection, or other underlying conditions. Further evaluation is needed to determine the cause of the altered mental status.
6. Respiratory Failure: The patient has had respiratory failure, which may be related to sepsis, pneumonia, or other underlying conditions. Further evaluation is needed to determine the cause of the respiratory failure.
7. Rash: The patient has developed a rash, which may be related to an allergic reaction or other underlying conditions. Further evaluation is needed to determine the cause of the rash.
8. Elevated Liver Enzymes: The patient has elevated liver enzymes, which may be related to shock liver or other underlying conditions. Further evaluation is needed to determine the cause of the elevated liver enzymes.
9. Coagulopathy: The patient has a coagulopathy, which may be related to sepsis or other underlying conditions. Further evaluation is needed to determine the cause of the coagulopathy.
10. Access: The patient has had difficulty with access, including clots in her upper extremity veins. Further evaluation is needed to determine the cause of the access issues and to develop a plan for managing the patient's access needs."
112508.0,247400,2176-04-21 07:17:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   NGT placed/TF started
   Femoral line changed over wire by IR
   c diff x 2 negative, 3rd pending
   d/c'ed gentamicin per ID
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-20**] 07:35 PM
   Linezolid - [**2176-4-21**] 02:30 AM
   Acyclovir - [**2176-4-21**] 06:22 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-20**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-20**] 01:16 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-21**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 98 (82 - 105) bpm
   BP: 128/83(101) {95/60(74) - 128/83(101)} mmHg
   RR: 18 (15 - 28) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  1,500 mL
                                                                    532 mL
   PO:
             TF:
             86 mL
   IVF:
                                                                  1,500 mL
                                                                    447 mL
   Blood products:
   Total out:
                                                                  2,044 mL
                                                                    335 mL
   Urine:
                                                                  2,044 mL
                                                                    335 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -544 mL
                                                                    197 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///18/
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive, alert, appropriate,
   following commands
   Head, Ears, Nose, Throat:  PERRL
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back,
   appears less erythematous than yesterday
   Neurologic: following commands and answering appropriately but slowly
   Labs / Radiology
   73 K/uL
   11.0 g/dL
   111 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.6 mEq/L
   28 mg/dL
   109 mEq/L
   137 mEq/L
   32.2 %
   23.7 K/uL
        [image002.jpg]  Ca++:7.6 mg/dL, Mg++:1.6 mg/dL, PO4:3.2 mg/dL
   Differential-Neuts:87.0 %, Band:5.0 %, Lymph:3.0 %, Mono:1.0 %, Eos:0.0
   %,
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
   WBC
   30.3
   27.0
   32.1
   23.7
   Hct
   36.0
   29.9
   29.8
   31.3
   32.2
   Plt
   90
   75
   73
   73
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   157
   157
   137
   117
   111
   ALT: 161 AP: 455 Tbili: 1.1
   AST: 52 LDH: 721
   PT: 15.2  PTT: 34.3  INR: 1.3
   Fibrinogen: 484
   Imaging: None
   Microbiology: [**4-21**]: Cath tip culture P
   [**Date range (1) 6157**] BCx pending
   Assessment and Plan
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  She is now doing
   well and awake s/p extubation, afebrile and her WBC count is trending
   downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   despite risk of CNS penetration. No TEE performed.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks) gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia, c. diff, ALL.
   Diff not consistent with return of ALL. C diff negative x 2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.
   -Trend LFTs and INR
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 20 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition: floor transfer
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   NGT placed/TF started
   Femoral line changed over wire by IR
   c diff x 2 negative, 3rd pending
   d/c'ed gentamicin per ID
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-20**] 07:35 PM
   Linezolid - [**2176-4-21**] 02:30 AM
   Acyclovir - [**2176-4-21**] 06:22 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-20**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-20**] 01:16 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-21**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 98 (82 - 105) bpm
   BP: 128/83(101) {95/60(74) - 128/83(101)} mmHg
   RR: 18 (15 - 28) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  1,500 mL
                                                                    532 mL
   PO:
             TF:
             86 mL
   IVF:
                                                                  1,500 mL
                                                                    447 mL
   Blood products:
   Total out:
                                                                  2,044 mL
                                                                    335 mL
   Urine:
                                                                  2,044 mL
                                                                    335 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -544 mL
                                                                    197 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///18/
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive, alert, appropriate,
   following commands
   Head, Ears, Nose, Throat:  PERRL
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back,
   appears less erythematous than yesterday
   Neurologic: following commands and answering appropriately but slowly
   Labs / Radiology
   73 K/uL
   11.0 g/dL
   111 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.6 mEq/L
   28 mg/dL
   109 mEq/L
   137 mEq/L
   32.2 %
   23.7 K/uL
        [image002.jpg]  Ca++:7.6 mg/dL, Mg++:1.6 mg/dL, PO4:3.2 mg/dL
   Differential-Neuts:87.0 %, Band:5.0 %, Lymph:3.0 %, Mono:1.0 %, Eos:0.0
   %,
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
   WBC
   30.3
   27.0
   32.1
   23.7
   Hct
   36.0
   29.9
   29.8
   31.3
   32.2
   Plt
   90
   75
   73
   73
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   157
   157
   137
   117
   111
   ALT: 161 AP: 455 Tbili: 1.1
   AST: 52 LDH: 721
   PT: 15.2  PTT: 34.3  INR: 1.3
   Fibrinogen: 484
   Imaging: None
   Microbiology: [**4-21**]: Cath tip culture P
   [**Date range (1) 6157**] BCx pending
   Assessment and Plan
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  She is now doing
   well and awake s/p extubation, afebrile and her WBC count is trending
   downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   despite risk of CNS penetration. No TEE performed.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks) gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia, c. diff, ALL.
   Diff not consistent with return of ALL. C diff negative x 2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.
   -Trend LFTs and INR
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 20 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition: floor transfer<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 60-year-old woman with recurrent acute lymphoblastic leukemia (ALL) with central nervous system (CNS) involvement, who underwent Omaya removal due to vancomycin-resistant Enterococcus (VRE) contamination and subdural hematoma (SDH) evacuation. She is currently awake and afebrile, with a trending downward white blood cell (WBC) count.

The patient has several medical conditions and allergies:

* Allergies: Sulfa (Sulfonamides), Rash; Penicillins, Rash; Latex, Hives; Wheezing; Red Dye, Headache; Darvon (Oral) (Propoxyphene Hcl), Nausea/Vomiting; Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa), Nausea/Vomiting; Aspirin, Nausea/Vomiting; Aspartame, Unknown; Fentanyl, Arrhythmia/Palpitation.
* Current medications:
	+ Linezolid (D1=[**4-16**])
	+ Acyclovir
	+ Micafungin
	+ Pantoprazole (Protonix)
	+ Heparin Sodium (Prophylaxis)

The patient's vital signs are:

* Temperature: 36C (96.8F)
* Heart rate: 98 bpm (82-105 bpm)
* Blood pressure: 128/83 mmHg (101/60-128/83 mmHg)
* Respiratory rate: 18 inspirations per minute
* SpO2: 95%
* Heart rhythm: Sinus rhythm

The patient's laboratory results show:

* WBC: 30.3, 27.0, 32.1, 23.7
* Hct: 36.0, 29.9, 29.8, 31.3, 32.2
* Plt: 90, 75, 73, 73
* Cr: 0.9, 0.9, 0.9, 0.9
* TCO2: 17, 16, 18, 18, 21
* Glucose: 157, 157, 137, 117, 111
* ALT: 161, AP: 455, Tbili: 1.1
* AST: 52, LDH: 721
* PT: 15.2, PTT: 34.3, INR: 1.3
* Fibrinogen: 484

The patient's imaging and microbiology results are:

* Imaging: None
* Microbiology: [**4-21**]: Cath tip culture P, [**Date range (1) 6157**] BCx pending

The patient's assessment and plan include:

* Continuing linezolid (D1=[**4-16**]) for CNS penetration
* Discontinuing gentamicin per ID
* Following up on culture data and sensitivities
* Deferring TEE at this time
* Following up on tigacycline sensitivities for long-term therapy
* Monitoring for leukocytosis and c. diff
* Continuing acyclovir, micafungin, and linezolid
* Following up on BMT recommendations
* Trending LFTs and INR

Potential medical complications that can arise from the patient's conditions and medications include:

* Leukocytosis and c. diff
* Shock liver
* Drug rash
* Elevated liver enzymes
* CNS lymphoma
* VRE contamination
* SDH evacuation

It is essential to continue monitoring the patient's condition and adjusting the treatment plan as necessary to prevent and manage these potential complications."
112508.0,247400,2176-04-21 07:17:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   NGT placed/TF started
   Femoral line changed over wire by IR
   c diff x 2 negative, 3rd pending
   d/c'ed gentamicin per ID
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-20**] 07:35 PM
   Linezolid - [**2176-4-21**] 02:30 AM
   Acyclovir - [**2176-4-21**] 06:22 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-20**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-20**] 01:16 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-21**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 98 (82 - 105) bpm
   BP: 128/83(101) {95/60(74) - 128/83(101)} mmHg
   RR: 18 (15 - 28) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  1,500 mL
                                                                    532 mL
   PO:
             TF:
             86 mL
   IVF:
                                                                  1,500 mL
                                                                    447 mL
   Blood products:
   Total out:
                                                                  2,044 mL
                                                                    335 mL
   Urine:
                                                                  2,044 mL
                                                                    335 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -544 mL
                                                                    197 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///18/
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive, alert, appropriate,
   following commans
   Head, Ears, Nose, Throat:  face tent, breathing comfortably
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back,
   appears less erythematous than yesterday
   Neurologic: following commands and answering appropriately, can name
   [**1-2**] children
   Labs / Radiology
   73 K/uL
   11.0 g/dL
   111 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.6 mEq/L
   28 mg/dL
   109 mEq/L
   137 mEq/L
   32.2 %
   23.7 K/uL
        [image002.jpg]  Ca++:7.6 mg/dL, Mg++:1.6 mg/dL, PO4:3.2 mg/dL
   Differential-Neuts:87.0 %, Band:5.0 %, Lymph:3.0 %, Mono:1.0 %, Eos:0.0
   %,
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
   WBC
   30.3
   27.0
   32.1
   23.7
   Hct
   36.0
   29.9
   29.8
   31.3
   32.2
   Plt
   90
   75
   73
   73
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   157
   157
   137
   117
   111
   ALT: 161 AP: 455 Tbili: 1.1
   AST: 52 LDH: 721
   PT: 15.2  PTT: 34.3  INR: 1.3
   Fibrinogen: 484
   Imaging: None
   Microbiology: [**4-21**]: Cath tip culture P
   [**Date range (1) 6157**] BCx pending
   Assessment and Plan
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  She is now doing
   well and awake s/p extubation, afebrile and her WBC count is trending
   downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   despite risk of CNS penetration. No TEE performed.  Will need 4-8 weeks
   of Linezolid.
   - continue linezolid (D1=[**4-16**]), gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - ?TEE next week for r/o vegetation to determine lenghth of TX
   - f/u tigacycline sensitivities as this may be a better choice in the
   long-run
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia, c. diff, ALL.
   Diff not consistent with return of ALL. C diff negative x 2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid
   # RESPIRATORY FAILURE:  Now extubated, oxygenating well on face tent
   and with improvement in respiratory alkalosis.
   Likely has some volume overload as seen on cxr but making good urine.
   - allow auto-diuresis, aim for net even to negative.
   # DRUH RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.
   -Trend LFTs and INR
   # S/P ASYSTOLIC ARREST:  temporally related to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 20 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU/Potential floor transfer
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   NGT placed/TF started
   Femoral line changed over wire by IR
   c diff x 2 negative, 3rd pending
   d/c'ed gentamicin per ID
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-20**] 07:35 PM
   Linezolid - [**2176-4-21**] 02:30 AM
   Acyclovir - [**2176-4-21**] 06:22 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-20**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-20**] 01:16 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-21**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 98 (82 - 105) bpm
   BP: 128/83(101) {95/60(74) - 128/83(101)} mmHg
   RR: 18 (15 - 28) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  1,500 mL
                                                                    532 mL
   PO:
             TF:
             86 mL
   IVF:
                                                                  1,500 mL
                                                                    447 mL
   Blood products:
   Total out:
                                                                  2,044 mL
                                                                    335 mL
   Urine:
                                                                  2,044 mL
                                                                    335 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -544 mL
                                                                    197 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///18/
   Physical Examination
   Eyes / Conjunctiva: pupils equal and reactive, alert, appropriate,
   following commans
   Head, Ears, Nose, Throat:  face tent, breathing comfortably
   Cardiovascular: normal S1/S2
   Peripheral Vascular: DP pulses intact
   Respiratory / Chest: lungs clear anteriorly
   Abdominal: Soft, Bowel sounds present, ostomy bag in place with  brown
   liquid stool, no apparent abdominal tenderness
   Extremities: warm
   Skin:  diffuse maculopapular erythematous, blanching rash on back,
   appears less erythematous than yesterday
   Neurologic: following commands and answering appropriately, can name
   [**1-2**] children
   Labs / Radiology
   73 K/uL
   11.0 g/dL
   111 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.6 mEq/L
   28 mg/dL
   109 mEq/L
   137 mEq/L
   32.2 %
   23.7 K/uL
        [image002.jpg]  Ca++:7.6 mg/dL, Mg++:1.6 mg/dL, PO4:3.2 mg/dL
   Differential-Neuts:87.0 %, Band:5.0 %, Lymph:3.0 %, Mono:1.0 %, Eos:0.0
   %,
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
   WBC
   30.3
   27.0
   32.1
   23.7
   Hct
   36.0
   29.9
   29.8
   31.3
   32.2
   Plt
   90
   75
   73
   73
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   157
   157
   137
   117
   111
   ALT: 161 AP: 455 Tbili: 1.1
   AST: 52 LDH: 721
   PT: 15.2  PTT: 34.3  INR: 1.3
   Fibrinogen: 484
   Imaging: None
   Microbiology: [**4-21**]: Cath tip culture P
   [**Date range (1) 6157**] BCx pending
   Assessment and Plan
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  She is now doing
   well and awake s/p extubation, afebrile and her WBC count is trending
   downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   despite risk of CNS penetration. No TEE performed.  Will need 4-8 weeks
   of Linezolid.
   - continue linezolid (D1=[**4-16**]), gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - ?TEE next week for r/o vegetation to determine lenghth of TX
   - f/u tigacycline sensitivities as this may be a better choice in the
   long-run
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia, c. diff, ALL.
   Diff not consistent with return of ALL. C diff negative x 2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - now off filgastrim
   - follow CBC/diff
   - continue broad-spectrum antimicrobial including acyclovir, micafungin
   in addition to linezolid
   # RESPIRATORY FAILURE:  Now extubated, oxygenating well on face tent
   and with improvement in respiratory alkalosis.
   Likely has some volume overload as seen on cxr but making good urine.
   - allow auto-diuresis, aim for net even to negative.
   # DRUH RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.
   -Trend LFTs and INR
   # S/P ASYSTOLIC ARREST:  temporally related to CCB in the setting of a
   heart compromised by prior cardiotoxic chemotherapy.  Recent echo
   showed significant interval worsening of EF (40%-->20%) over the past 2
   weeks without any focal wall motion abnormalities.
   - repeat echo in [**3-4**] weeks
   - avoid nodal agents
   - replete lytes aggressively, with particular attention to calcium
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 20 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU/Potential floor transfer<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, here is a summary of the information and potential medical complications that can arise:

**Current Status:**

* The patient is a 60-year-old woman with recurrent acute lymphoblastic leukemia (ALL) with central nervous system (CNS) involvement, who has undergone Omaya removal and SDH evacuation due to VRE contamination.
* She is currently awake and extubated, afebrile, and her WBC count is trending downward.
* She has a diffuse maculopapular erythematous rash on her back, which appears to be improving.

**Potential Medical Complications:**

1. **CNS VRE:** The patient is at risk for CNS VRE recurrence, and linezolid is being used for greater CNS penetration. However, this may also increase the risk of CNS toxicity.
2. **Leukocytosis:** The patient's WBC count is elevated, and it is unclear whether this is due to return of ALL or another condition. Further evaluation is needed to determine the cause.
3. **Respiratory Failure:** The patient has a history of respiratory failure and is at risk for further complications. Close monitoring of her respiratory status is necessary.
4. **Liver Enzyme Elevation:** The patient's liver enzymes are elevated, consistent with shock liver. Close monitoring of LFTs and INR is necessary to prevent liver dysfunction.
5. **Cardiac Complications:** The patient has a history of cardiotoxic chemotherapy, which may have compromised her cardiac function. Further evaluation with echocardiogram is necessary to assess her cardiac status.
6. **Catheter-Related Complications:** The patient has a femoral line and a multi-lumen catheter in place. Close monitoring for catheter-related complications, such as infection or thrombosis, is necessary.
7. **Infection:** The patient has a history of C. difficile infection and is at risk for further infections, particularly with her immunocompromised status.
8. **Gastrointestinal Complications:** The patient has a history of gastrointestinal toxicity from chemotherapy, and close monitoring for gastrointestinal complications, such as nausea, vomiting, and diarrhea, is necessary.

**Plan:**

* Continue linezolid and acyclovir for CNS penetration and antiviral coverage.
* Monitor for signs of CNS VRE recurrence and adjust therapy as necessary.
* Repeat echocardiogram in 3-4 weeks to assess cardiac function.
* Trend LFTs and INR to monitor liver function.
* Avoid nodal agents and replete lytes aggressively to prevent cardiac complications.
* Monitor for signs of respiratory failure and adjust therapy as necessary.
* Continue to monitor for signs of infection and adjust therapy as necessary.
* Consider further evaluation with imaging studies, such as CT or MRI, to assess for signs of CNS lymphoma."
112508.0,247400,2176-04-21 07:17:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   NGT placed/TF started
   Femoral line changed over wire by IR
   c diff x 2 negative, 3rd pending
   d/c'ed gentamicin per ID
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-20**] 07:35 PM
   Linezolid - [**2176-4-21**] 02:30 AM
   Acyclovir - [**2176-4-21**] 06:22 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-20**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-20**] 01:16 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-21**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 98 (82 - 105) bpm
   BP: 128/83(101) {95/60(74) - 128/83(101)} mmHg
   RR: 18 (15 - 28) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  1,500 mL
                                                                    532 mL
   PO:
             TF:
             86 mL
   IVF:
                                                                  1,500 mL
                                                                    447 mL
   Blood products:
   Total out:
                                                                  2,044 mL
                                                                    335 mL
   Urine:
                                                                  2,044 mL
                                                                    335 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -544 mL
                                                                    197 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///18/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   73 K/uL
   11.0 g/dL
   111 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.6 mEq/L
   28 mg/dL
   109 mEq/L
   137 mEq/L
   32.2 %
   23.7 K/uL
        [image002.jpg]  Ca++:7.6 mg/dL, Mg++:1.6 mg/dL, PO4:3.2 mg/dL
   Differential-Neuts:87.0 %, Band:5.0 %, Lymph:3.0 %, Mono:1.0 %, Eos:0.0
   %,
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
   WBC
   30.3
   27.0
   32.1
   23.7
   Hct
   36.0
   29.9
   29.8
   31.3
   32.2
   Plt
   90
   75
   73
   73
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   157
   157
   137
   117
   111
   ALT: 161 AP: 455 Tbili: 1.1
   AST: 52 LDH: 721
   PT: 15.2  PTT: 34.3  INR: 1.3
   Fibrinogen: 484
   Imaging: None
   Microbiology: [**4-21**]: Cath tip culture P
   [**Date range (1) 6157**] BCx pending
   Assessment and Plan
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 20 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU/Potential floor transfer
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   NGT placed/TF started
   Femoral line changed over wire by IR
   c diff x 2 negative, 3rd pending
   d/c'ed gentamicin per ID
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Meropenem - [**2176-4-18**] 07:42 AM
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-20**] 07:35 PM
   Linezolid - [**2176-4-21**] 02:30 AM
   Acyclovir - [**2176-4-21**] 06:22 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-20**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-20**] 01:16 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-21**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 98 (82 - 105) bpm
   BP: 128/83(101) {95/60(74) - 128/83(101)} mmHg
   RR: 18 (15 - 28) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 63 Inch
             Total In:
                                                                  1,500 mL
                                                                    532 mL
   PO:
             TF:
             86 mL
   IVF:
                                                                  1,500 mL
                                                                    447 mL
   Blood products:
   Total out:
                                                                  2,044 mL
                                                                    335 mL
   Urine:
                                                                  2,044 mL
                                                                    335 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -544 mL
                                                                    197 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///18/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   73 K/uL
   11.0 g/dL
   111 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.6 mEq/L
   28 mg/dL
   109 mEq/L
   137 mEq/L
   32.2 %
   23.7 K/uL
        [image002.jpg]  Ca++:7.6 mg/dL, Mg++:1.6 mg/dL, PO4:3.2 mg/dL
   Differential-Neuts:87.0 %, Band:5.0 %, Lymph:3.0 %, Mono:1.0 %, Eos:0.0
   %,
                             [**2176-4-19**]  12:29 AM
                             [**2176-4-19**]  04:24 AM
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
   WBC
   30.3
   27.0
   32.1
   23.7
   Hct
   36.0
   29.9
   29.8
   31.3
   32.2
   Plt
   90
   75
   73
   73
   Cr
   0.9
   0.9
   0.9
   0.9
   TCO2
   17
   16
   18
   18
   21
   Glucose
   157
   157
   137
   117
   111
   ALT: 161 AP: 455 Tbili: 1.1
   AST: 52 LDH: 721
   PT: 15.2  PTT: 34.3  INR: 1.3
   Fibrinogen: 484
   Imaging: None
   Microbiology: [**4-21**]: Cath tip culture P
   [**Date range (1) 6157**] BCx pending
   Assessment and Plan
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 20 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Arterial Line - [**2176-4-16**] 12:48 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:ICU/Potential floor transfer<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a critically ill individual in the Intensive Care Unit (ICU) with a complex medical history and multiple comorbidities. The patient's vital signs are stable, with a temperature of 36C, heart rate of 98 beats per minute, and blood pressure of 128/83 mmHg. The patient's respiratory status is stable, with an SpO2 of 95% on room air. The patient's hemodynamic monitoring shows a fluid balance of -544 mL over the past 24 hours.

The patient's laboratory results show elevated white blood cell count, neutrophil count, and lactate dehydrogenase (LDH), indicating possible sepsis or infection. The patient's liver function tests (LFTs) are abnormal, with elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. The patient's kidney function is normal, with a creatinine level of 0.9 mg/dL.

The patient's imaging studies are pending, and the microbiology results show a positive culture from the catheter tip. The patient's medical history is significant for a history of sulfonamide allergy, penicillin allergy, and latex allergy.

Potential Medical Complications:

1. Sepsis: Given the patient's elevated white blood cell count, neutrophil count, and LDH levels, there is a high risk of sepsis or infection.
2. Liver Dysfunction: The patient's abnormal LFTs may indicate liver dysfunction, which can lead to coagulopathy, bleeding, and other complications.
3. Kidney Injury: Although the patient's creatinine level is normal, there is a risk of kidney injury due to the patient's underlying medical conditions and medications.
4. Blood Clotting Disorders: The patient's abnormal PT, PTT, and INR levels may indicate a bleeding or clotting disorder, which can lead to bleeding, thrombosis, or other complications.
5. Respiratory Failure: The patient's respiratory status is stable, but there is a risk of respiratory failure due to the patient's underlying medical conditions and medications.
6. Cardiac Arrest: The patient's cardiac rhythm is normal, but there is a risk of cardiac arrest due to the patient's underlying medical conditions and medications.
7. Infection: The patient's positive culture from the catheter tip may indicate a central line-associated bloodstream infection (CLABSI), which can lead to sepsis, organ failure, and death.
8. Gastrointestinal Bleeding: The patient's abnormal LFTs may indicate liver dysfunction, which can lead to gastrointestinal bleeding, particularly if the patient is taking anticoagulant medications.

Based on this information, it is essential to closely monitor the patient's vital signs, laboratory results, and imaging studies to detect any potential complications early and initiate appropriate interventions to prevent or manage these complications."
112508.0,247400,2176-04-22 07:09:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 24-hour-old ICU admission with a chief complaint of arterial line stop. The patient has a history of leukemia and has undergone multiple antibiotic courses, including Gentamicin, Micafungin, Linezolid, and Acyclovir. The patient's vital signs are stable, with a temperature of 35.6C, heart rate of 106 bpm, blood pressure of 106/73 mmHg, and oxygen saturation of 96%. The patient's respiratory support is minimal, with no oxygen delivery device in use. The patient's physical examination is limited due to the lack of assessment in certain areas, such as peripheral vascular, skin, neurologic, and gastrointestinal systems.

The patient's laboratory results show elevated white blood cell count, platelet count, and liver enzymes. The patient's blood cultures are pending, with CDIFF negative and pending results. The patient's electrolyte levels are within normal limits, except for a slightly elevated potassium level.

The patient's assessment and plan include cardiac dysrhythmia, alteration in nutrition, sepsis without organ dysfunction, airway inability to protect, impaired skin integrity, altered mental status, and fever of unknown origin.

Potential medical complications that can arise include:

1. Sepsis progression to septic shock: The patient's sepsis without organ dysfunction may progress to septic shock, which can lead to multi-organ failure and death.
2. Respiratory failure: The patient's airway inability to protect may lead to respiratory failure, which can require intubation and mechanical ventilation.
3. Skin breakdown: The patient's impaired skin integrity may lead to skin breakdown, which can increase the risk of infection and morbidity.
4. Leukemia relapse: The patient's history of leukemia may increase the risk of relapse, which can lead to further complications and mortality.
5. Electrolyte imbalance: The patient's slightly elevated potassium level may lead to electrolyte imbalance, which can cause cardiac arrhythmias and other complications.
6. Infection: The patient's fever of unknown origin may indicate an underlying infection, which can spread to other parts of the body and cause further complications.
7. Nutritional deficiencies: The patient's alteration in nutrition may lead to nutritional deficiencies, which can cause further complications and morbidity.
8. Cardiovascular complications: The patient's cardiac dysrhythmia may lead to cardiovascular complications, such as arrhythmias, heart failure, and cardiac arrest."
112508.0,247400,2176-04-22 07:09:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  She is now doing
   well and awake s/p extubation, afebrile and her WBC count is trending
   downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   despite risk of CNS penetration. No TEE performed.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks) gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia, c. diff, ALL.
   Diff not consistent with return of ALL. C diff negative x 2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.
   -Trend LFTs and INR
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  She is now doing
   well and awake s/p extubation, afebrile and her WBC count is trending
   downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   despite risk of CNS penetration. No TEE performed.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks) gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia, c. diff, ALL.
   Diff not consistent with return of ALL. C diff negative x 2.
   - f/u repeat c diff
   - f/u blood and sputum cx
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.
   -Trend LFTs and INR
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 60-year-old woman with recurrent acute lymphoblastic leukemia (ALL) and central nervous system (CNS) involvement, who has undergone Omaya removal and SDH evacuation due to VRE contamination. She is currently awake and afebrile, with a trending downward white blood cell count.

Potential medical complications that can arise include:

1. Sepsis: The patient has a history of sepsis and is currently on linezolid, which may increase the risk of sepsis.
2. Cardiac dysrhythmia: The patient's cardiac rhythm is noted as sinus tachycardia, which may be a sign of underlying cardiac disease.
3. Impaired skin integrity: The patient has a history of skin rash and is currently on multiple medications, which may increase the risk of skin complications.
4. Altered mental status: The patient has a history of altered mental status, which may be related to her underlying condition or medication side effects.
5. Fever, unknown origin: The patient has a fever of unknown origin, which may be related to an underlying infection or medication side effect.
6. Leukocytosis: The patient has leukocytosis, which may be related to her underlying condition or medication side effects.
7. C. difficile infection: The patient has had two negative C. difficile tests, but the risk of C. difficile infection is still present.
8. Liver enzyme elevation: The patient has elevated liver enzymes, which may be related to her underlying condition or medication side effects.
9. Nutritional compromise: The patient is receiving nutrition through a central line, which may increase the risk of complications such as line infections or malnutrition.
10. VAP: The patient is at risk for ventilator-associated pneumonia (VAP) due to her prolonged mechanical ventilation.

Based on the patient's medical history and current condition, it is essential to closely monitor her for any signs of complications and adjust her treatment plan accordingly."
112508.0,247400,2176-04-22 16:23:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  Intubated for
   cardiac arrest thought to be secondary to CCB in the setting of
   hypocalcemia. She is now doing well and awake s/p extubation, afebrile
   and her WBC count is trending downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   (compared to daptomycin) despite risk of CNS penetration. No VRE in
   blood for over one week.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks); gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time given recent extubation, would pursue
   within one week.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia vs c. diff vs
   ALL.  Diff not consistent with return of ALL per BMT. C diff negative x
   3 with a fourth pending. According to ID, timing and pattern fits best
   with GCST effect.  Now trending down over last two days.
   - f/u repeat c diff
   - f/u blood and sputum cx
   - continue to trend with differential
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.  Alk
   P only marker not trending down. Abd exam benign, would continue to
   trend at this point.
   -Trend LFTs and INR
   # Elevated PTT: Isolated elevation today, [**Last Name **] problem: Likely a
   spurious lab value; will repeat, if truly high, will send mixing
   studies
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
 consider S+S
   eval
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM ***(FEMORAL)***
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  Intubated for
   cardiac arrest thought to be secondary to CCB in the setting of
   hypocalcemia. She is now doing well and awake s/p extubation, afebrile
   and her WBC count is trending downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   (compared to daptomycin) despite risk of CNS penetration. No VRE in
   blood for over one week.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks); gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time given recent extubation, would pursue
   within one week.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia vs c. diff vs
   ALL.  Diff not consistent with return of ALL per BMT. C diff negative x
   3 with a fourth pending. According to ID, timing and pattern fits best
   with GCST effect.  Now trending down over last two days.
   - f/u repeat c diff
   - f/u blood and sputum cx
   - continue to trend with differential
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.  Alk
   P only marker not trending down. Abd exam benign, would continue to
   trend at this point.
   -Trend LFTs and INR
   # Elevated PTT: Isolated elevation today, [**Last Name **] problem: Likely a
   spurious lab value; will repeat, if truly high, will send mixing
   studies
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
 consider S+S
   eval
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM ***(FEMORAL)***
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 60-year-old woman with recurrent acute lymphoblastic leukemia (ALL) with central nervous system (CNS) involvement, who underwent Omaya removal and SDH evacuation. She was intubated for cardiac arrest thought to be secondary to calcium channel blocker (CCB) in the setting of hypocalcemia. She is now extubated and awake, afebrile, and her WBC count is trending downward.

The patient has several medical conditions and allergies, including:

* Sulfa (Sulfonamides) allergy with rash
* Penicillins allergy with rash
* Latex allergy with hives and wheezing
* Red dye allergy with headache and ""thra""
* Darvon (Oral) (Propoxyphene Hcl) allergy with nausea and vomiting
* Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa) allergy with nausea and vomiting
* Aspirin allergy with nausea and vomiting
* Aspartame allergy with unknown symptoms
* Fentanyl allergy with arrhythmia and palpitations

The patient has received several medications, including:

* Gentamicin (antibiotic) discontinued
* Micafungin (antifungal) continued
* Linezolid (antibiotic) continued
* Acyclovir (antiviral) continued
* Pantoprazole (Protonix) (proton pump inhibitor) continued
* Heparin Sodium (Prophylaxis) (anticoagulant) continued

The patient's vital signs are:

* Temperature: 35.6C (96F)
* Heart rate: 106 beats per minute (bpm)
* Blood pressure: 106/73 mmHg
* Respiratory rate: 16 inspirations per minute (insp/min)
* SpO2: 96%
* Heart rhythm: Sinus tachycardia

The patient's laboratory results show:

* White blood cell count (WBC): 27.0 x 10^9/L (normal range: 4.5-11.0 x 10^9/L)
* Hemoglobin (Hb): 10.6 g/dL (normal range: 12.0-16.0 g/dL)
* Platelet count (Plt): 75 x 10^9/L (normal range: 150-450 x 10^9/L)
* Creatinine (Cr): 0.9 mg/dL (normal range: 0.5-1.1 mg/dL)
* Total carbon dioxide (TCO2): 16 mmol/L (normal range: 22-30 mmol/L)
* Glucose: 157 mg/dL (normal range: 70-110 mg/dL)
* Other laboratory results show elevated liver enzymes, elevated lactate dehydrogenase (LDH), and elevated calcium levels.

The patient's medical complications and potential risks include:

* Cardiac dysrhythmia
* Alteration in nutrition
* Sepsis without organ dysfunction
* Airway, inability to protect (risk for aspiration, altered gag, airway clearance, cough)
* Impaired skin integrity
* Fever, unknown origin (FUO, hypertension, pyrexia)
* Elevated liver enzymes
* Isolated elevation in PTT (likely a spurious lab value)

The patient's plan of care includes:

* Continuing linezolid for greater CNS penetration
* Discontinuing gentamicin
* Following up on culture data and sensitivities
* Trending with differential
* Continuing acyclovir, micafungin, and linezolid
* Trending liver enzymes and INR
* Repeating PTT if truly high
* Continuing ICU care, including nutrition, glycemic control, and prophylaxis for DVT and stress ulcer."
112508.0,247400,2176-04-22 16:23:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  Intubated for
   cardiac arrest thought to be secondary to CCB in the setting of
   hypocalcemia. She is now doing well and awake s/p extubation, afebrile
   and her WBC count is trending downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   (compared to daptomycin) despite risk of CNS penetration. No VRE in
   blood for over one week.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks); gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time given recent extubation, would pursue
   within one week.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia vs c. diff vs
   ALL.  Diff not consistent with return of ALL per BMT. C diff negative x
   3 with a fourth pending. According to ID, timing and pattern fits best
   with GCST effect.  Now trending down over last two days.
   - f/u repeat c diff
   - f/u blood and sputum cx
   - continue to trend with differential
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.  Alk
   P only marker not trending down. Abd exam benign, would continue to
   trend at this point.
   -Trend LFTs and INR
   # Elevated PTT: Isolated elevation today, [**Last Name **] problem: Likely a
   spurious lab value; will repeat, if truly high, will send mixing
   studies
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
 consider S+S
   eval
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM ***(FEMORAL)***
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR
   ------ Protected Section ------
   Physical Exam: Vitals as above:
   Clean stapled incision over right  head.
   Good arir movt bilaterally with crackles at bases and mild diffuse
   ronchi
   RRR no M/r/g
   Neuro: maintains appropriate eye contact. Intermittently conversant
   (limited to [**12-1**] word answers); moves all 4 ext, but not always to
   commands, CN2-12 intact, affect blunted
   Abd: ostomy in place, NTND +BS
   ------ Protected Section Addendum Entered By:[**Name (NI) 6135**] [**Name8 (MD) 5998**], MD
   on:[**2176-4-22**] 17:02 ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - STOP [**2176-4-21**] 06:00 PM
   - Called out, bed assigned then ID attending expressed concern about
   her floor suitability, recommended staying in the ICU
   Allergies:
   Sulfa (Sulfonamides)
   Rash;
   Penicillins
   Rash;
   Latex
   Hives; Wheezing
   Red Dye
   Headache; ""thra
   Darvon (Oral) (Propoxyphene Hcl)
   Nausea/Vomiting
   Percodan (Oral) (Oxycodone Hcl/Oxycodon Ter/Asa)
   Nausea/Vomiting
   Aspirin
   Nausea/Vomiting
   Aspartame
   Unknown;
   Fentanyl
   Arrhythmia/Palp
   Last dose of Antibiotics:
   Gentamicin - [**2176-4-20**] 08:00 AM
   Micafungin - [**2176-4-21**] 08:00 PM
   Linezolid - [**2176-4-22**] 02:21 AM
   Acyclovir - [**2176-4-22**] 06:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2176-4-21**] 08:01 AM
   Heparin Sodium (Prophylaxis) - [**2176-4-22**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2176-4-22**] 07:08 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 106 (96 - 114) bpm
   BP: 106/73(79) {101/58(69) - 119/83(90)} mmHg
   RR: 16 (16 - 35) insp/min
   SpO2: 96%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 63 Inch
             Total In:
                                                                  1,817 mL
                                                                    621 mL
   PO:
             TF:
                                                                    422 mL
                                                                    191 mL
   IVF:
                                                                    925 mL
                                                                    300 mL
   Blood products:
   Total out:
                                                                  1,475 mL
                                                                    950 mL
   Urine:
                                                                  1,475 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    342 mL
                                                                   -329 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   78 K/uL
   10.6 g/dL
   122 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.6 mEq/L
   25 mg/dL
   105 mEq/L
   137 mEq/L
   31.5 %
   17.9 K/uL
        [image002.jpg]
                             [**2176-4-19**]  09:46 AM
                             [**2176-4-19**]  01:59 PM
                             [**2176-4-19**]  03:40 PM
                             [**2176-4-19**]  04:18 PM
                             [**2176-4-20**]  12:39 AM
                             [**2176-4-20**]  12:47 AM
                             [**2176-4-20**]  05:42 AM
                             [**2176-4-21**]  04:38 AM
                             [**2176-4-21**]  02:57 PM
                             [**2176-4-22**]  04:17 AM
   WBC
   27.0
   32.1
   23.7
   17.9
   Hct
   29.9
   29.8
   31.3
   32.2
   31.5
   Plt
   75
   73
   73
   78
   Cr
   0.9
   0.9
   0.9
   0.9
   0.9
   TCO2
   16
   18
   18
   21
   Glucose
   157
   137
   117
   111
   185
   122
   Other labs: PT / PTT / INR:14.2/63.8/1.2, ALT / AST:119/52, Alk Phos /
   T Bili:562/0.8, Amylase / Lipase:76/50, Differential-Neuts:78.0 %,
   Band:7.0 %, Lymph:2.0 %, Mono:2.0 %, Eos:1.0 %, Fibrinogen:484 mg/dL,
   Lactic Acid:2.5 mmol/L, Albumin:2.1 g/dL, LDH:737 IU/L, Ca++:7.6 mg/dL,
   Mg++:1.8 mg/dL, PO4:2.9 mg/dL
   Microbiology: BCX: [**4-16**], [**4-17**], [**4-18**], [**4-19**], ALL NGTD
   UCX: [**4-18**] NGTD
   CDIFF negative x3, [**4-22**] PENDING
   Fem Line Cx NGTD
   Assessment and Plan
 CARDIAC DYSRHYTHMIA OTHER
 ALTERATION IN NUTRITION
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 AIRWAY, INABILITY TO PROTECT (RISK FOR ASPIRATION, ALTERED GAG,
   AIRWAY CLEARANCE, COUGH)
 IMPAIRED SKIN INTEGRITY
 .H/O LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 FEVER, UNKNOWN ORIGIN (FUO, HYPERTHERMIA, PYREXIA)
   A 60 year old woman with recurrent ALL with CNS involvement s/p Omaya
   removal due to VRE contamination & SDH evacuation.  Intubated for
   cardiac arrest thought to be secondary to CCB in the setting of
   hypocalcemia. She is now doing well and awake s/p extubation, afebrile
   and her WBC count is trending downward.
   # CNS VRE:  S/P Omaya removal, on linezolid for greater CNS penetration
   (compared to daptomycin) despite risk of CNS penetration. No VRE in
   blood for over one week.
   - continue linezolid (D1=[**4-16**]), course to be determined by TEE (4 vs 8
   weeks); gentamicin D/C
d per ID
   - f/u culture data and sensitivities
   - TEE deferred at this time given recent extubation, would pursue
   within one week.
   - f/u tigacycline sensitivities for long-term therapy
   # LEUKOCYTOSIS:   GCSF vs culture negative bacteremia vs c. diff vs
   ALL.  Diff not consistent with return of ALL per BMT. C diff negative x
   3 with a fourth pending. According to ID, timing and pattern fits best
   with GCST effect.  Now trending down over last two days.
   - f/u repeat c diff
   - f/u blood and sputum cx
   - continue to trend with differential
   # ALL:  Currently day +43 s/p hyper-CVAD.  She is also s/p intrathecal
   MTX and DLI this admission.  Per BMT, will need further treatment for
   CNS lymphoma in the future.
   - f/u BMT recommendations
   - follow CBC/diff
   - continue acyclovir, micafungin in addition to linezolid
   # DRUG RASH:  Appears improved today.  Evidence suggests this is due to
   Meropenem.
   # ELEVATED LIVER ENZYMES:  Consistent with shock liver, resolving.  Alk
   P only marker not trending down. Abd exam benign, would continue to
   trend at this point.
   -Trend LFTs and INR
   # Elevated PTT: Isolated elevation today, [**Last Name **] problem: Likely a
   spurious lab value; will repeat, if truly high, will send mixing
   studies
   ICU Care
   Nutrition:
   Nutren Pulmonary (Full) - [**2176-4-21**] 02:53 AM 30 mL/hour
 consider S+S
   eval
   Glycemic Control:
   Lines:
   Multi Lumen - [**2176-4-14**] 06:36 AM ***(FEMORAL)***
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: CALL OUT TO FLOOR
   ------ Protected Section ------
   Physical Exam: Vitals as above:
   Clean stapled incision over right  head.
   Good arir movt bilaterally with crackles at bases and mild diffuse
   ronchi
   RRR no M/r/g
   Neuro: maintains appropriate eye contact. Intermittently conversant
   (limited to [**12-1**] word answers); moves all 4 ext, but not always to
   commands, CN2-12 intact, affect blunted
   Abd: ostomy in place, NTND +BS
   ------ Protected Section Addendum Entered By:[**Name (NI) 6135**] [**Name8 (MD) 5998**], MD
   on:[**2176-4-22**] 17:02 ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's current condition as follows:

* The patient is a 60-year-old woman with a history of recurrent acute lymphoblastic leukemia (ALL) with central nervous system (CNS) involvement.
* She was intubated for cardiac arrest thought to be secondary to calcium channel blocker (CCB) in the setting of hypocalcemia.
* She is now extubated and awake, afebrile, and her white blood cell (WBC) count is trending downward.
* She has a central venous catheter (CVC) and is receiving linezolid for greater CNS penetration, despite the risk of CNS penetration.
* Her platelet count is stable, and her liver enzymes are slightly elevated, consistent with shock liver, which is resolving.
* Her prothrombin time (PT) is slightly elevated, but the ID specialist suspects it may be a spurious lab value.
* She has a history of VRE contamination and SDH evacuation, and is currently on micafungin and acyclovir in addition to linezolid.
* Her nutrition is being managed with Nutren Pulmonary, and her glycemic control is being monitored.

Potential medical complications that may arise include:

1. Sepsis: The patient's WBC count is trending downward, but she is still at risk for sepsis, especially given her history of ALL and CNS involvement.
2. Infection: The patient's prolonged hospitalization and immunosuppressive therapy make her susceptible to infections, including ventilator-associated pneumonia (VAP) and central line-associated bloodstream infection (CLABSI).
3. Bleeding: The patient's platelet count is stable, but she is at risk for bleeding due to her platelet count and the use of anticoagulant therapy.
4. Liver dysfunction: The patient's liver enzymes are slightly elevated, and further monitoring is needed to ensure that this is not a sign of liver dysfunction or failure.
5. Cardiovascular complications: The patient's history of cardiac arrest and hypocalcemia make her at risk for future cardiovascular complications, including arrhythmias and cardiac failure.
6. Neurological complications: The patient's history of CNS involvement and her current use of antineoplastic therapy make her at risk for neurological complications, including seizures, cerebral edema, and cognitive impairment.
7. Gastrointestinal complications: The patient's history of abdominal surgery and her current use of antineoplastic therapy make her at risk for gastrointestinal complications, including nausea, vomiting, and bowel obstruction.
8. Respiratory complications: The patient's history of intubation and her current use of antineoplastic therapy make her at risk for respiratory complications, including ventilator-associated lung injury and respiratory failure."
